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Wet bead milling, in which the drug is milled in presence of stabilisers such as 
polymers and surfactants, has enabled the formulation of poorly water-soluble drugs 
as nanoparticles, with five products having reached the market. During the milling 
process, the polymer and/or surfactant adsorbs onto the freshly cleaved drug surfaces 
to provide ionic or steric stabilisation. Despite the success of wet bead milling, 
mastery of the mechanism behind nanoparticle stabilization is still lacking. To 
investigate whether any relationship exists between drug, stabiliser and stabilisation, 
eight structurally different poorly water-soluble drugs were milled in presence of 
thirteen different pharmaceutically acceptable stabilisers and the resultant particle 
size determined by photon correlation spectroscopy. Nanoparticles of the BCS class 
II drug, griseofulvin, could only be produced in presence of anionic stabilisers 
namely sodium dodecyl sulphate, aerosol-OT or hydroxypropylmethylcellulose 
acetate succinate. Surfactant adsorption isotherms obtained indirectly by measuring 
their depletion from solution revealed a maximum surfactant adsorption of ~ 2.2 
mg/m
2
 on the griseofulvin nanoparticle surfaces. The use of ionic 
surfactants/polymers in oral formulations is however sub-optimal. Consequently, 
polymer-surfactant co-stabilisation, used to take advantage of the synergy between 
ionic and non-ionic stabilisers, was investigated by the inclusion of the non-ionic 
polymer hydroxypropylmethylcellulose (HPMC) into the anionic surfactant-drug 
slurry prior to milling. The effect of varying HPMC molecular weight and 
concentration on griseofulvin nanoparticle production was established. Polymer 
adsorption isotherms were obtained directly via small angle neutron scattering. 
Inclusion of HPMC in the milling slurry resulted in its co-adsorption with anionic 
surfactant on the griseofulvin nanoparticle surfaces and a corresponding reduction in 
the amount of anionic surfactant adsorbed. Notably HPMC on its own could not 
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1.1 Drug bioavailability from oral dosage forms 
 
Bioavailability is a measure of the rate and extent at which a drug reaches the 
systemic circulation, and thereby accesses its site(s) of action. The vast majority of 
drugs marketed worldwide are orally administered and as a consequence their 
efficacy is dependent on their relative bioavailability (Custodio et al, 2008). The 
relative bioavailability of an orally administered compound is obtained by comparing 
the compound‘s oral bioavailability to that of an equal amount of the intravenously 
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delivered compound. Unlike the intravenous route in which drugs are injected 
directly into the systemic circulation, oral dosage forms must first undergo, 
depending upon the formulation in which they are contained, 
disintegration/disaggregation, followed by dissolution and absorption across the 
gastrointestinal membrane prior to entry into the systemic circulation. In addition, 
orally administered drugs may undergo metabolism in the liver, the so called ‗first 
pass effect‘. The bioavailability of orally administered drugs therefore is the 
superposition of two processes, namely absorption across the gastrointestinal 
membrane and first pass metabolism as illustrated in Figure 1.1. 
 
 
Figure 1.1: Diagrammatic representation of the steps that may influence the 
bioavailability of an orally administered drug (van de Waterbreemd et al, 2003). 
 
The amount of drug absorbed across the gastrointestinal membrane is determined by 
its solubility and permeability. Prior to absorption, orally administered drug must 
generally first undergo dissolution. The only exception to this requirement is when a 
drug is administered in the form of a solution. Dissolution rate is dependent on the 
particle size of a drug, with smaller particles exhibiting a higher dissolution rate. 
However, prior to dissolution some formulations must undergo additional steps. For 
example, a tablet must first undergo disintegration into granules, followed by 
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Figure 1.2: Major steps following the oral administration of a tablet (Rubinstein et 
al, 1977). 
 
Other factors that affect the dissolution of a drug include its pKa, log P and the pH 
and volume of the intestinal contents. Log P is defined as the ratio of distribution of 
the unionized form of a drug between octanol and water at equilibrium. A high log P 
value is therefore usually taken to indicate a high lipophilicity (Lindenberg et al, 
2004), although it is important to note that because log P is a distribution ratio, a 
high log P does not necessarily mean that the drug has a high solubility in 
organic/lipophilic phases. Slow dissolution of a drug invariably leads to poor 
bioavailability, thus necessitating formulation attempts to increase the apparent 
water-solubility of such drugs. The drug may also undergo complexation with 
formulation excipients, ingested food or other drugs within the gastrointestinal tract, 
thereby reducing the fraction of the drug available for dissolution. 
Subsequent to dissolution, the drug will undergo diffusion through the intestinal 
media followed by permeation through the intestinal wall. The main site of 
absorption is the small intestine due to its rich blood supply which corresponds to 
about 25% of cardiac output, and its high surface area due to the presence of a brush 
border consisting of villi and microvilli (Ganong 2005). Absorption of drugs from 
the gastrointestinal tract is mainly via transcellular pathways such as passive or 
facilitated diffusion, active transport or endocytosis, although transport may also 
occur via paracellular pathways through tight junctions (Figure 1.3). Only unionized 
Slow dissolution Moderate 
dissolution 
Rapid dissolution 
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drug can be absorbed passively through the lipophilic intestinal membranes (Hogben 













Figure 1.3: Mechanisms of intestinal drug absorption (adapted from Ganong 2005). 
 
Drug absorption in the gastrointestinal tract is affected by physiological factors such 
as gastrointestinal pH, motility, blood flow, tract length and surface area as well as 
by physiochemical drug factors e.g. log P, molecular size, pKa, and the presence of 
other drugs or food in the gut (Orme 1984). 
Transport can also occur in the other direction, for example intestinal efflux 
transporters reduce net drug absorption by pumping drug back into intestinal lumen. 
P-glycoprotein (p-gp), an efflux transporter, has been shown to reduce the absorption 
of cyclosporine (Lown et al, 1997) amongst other drugs. In addition, drug may be 
metabolized during its transit through the gut wall. Finally, the first pass effect 
reduces the amount of drug reaching the systemic circulation unaltered as drug 
reaching the liver may be altered by way of enzymatic biotransformation. As a 
consequence, the bioavailability of an orally administered drug is the fraction that 
survives the various barriers it encounters during its passage from the gut lumen to 
the systemic circulation (Kwan 1997). 
 
1.2 Poorly water-soluble drugs and their classification 
 
The poor water solubility of many drugs poses a significant challenge to the 
pharmaceutical industry entailing significant resources in time and money. An 
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estimated 40% of newly discovered active pharmaceutical compounds are poorly 
water-soluble (Lipinski, 2002). As drug discovery screening does not generally 
discriminate against solubility but rather on lipophilicity, highly lipophilic but poorly 
water-soluble drugs frequently end up in the drug development pipeline (Chaubal, 
2004). However, many of these poorly water-soluble compounds have promising 
therapeutic potential thereby warranting further research into their formulation.  
Poor water solubility, in practical terms refers to the scenario in which the 
dissolution of a dose of drug takes longer than its transit through the absorptive sites 
in the gastrointestinal solubility resulting in its poor bioavailability. Dissolution rate, 
defined as amount of solid that goes into solution per unit time under standardized 
conditions of liquid/solid interface, temperature and solvent composition, is a 
function of the drug‘s aqueous solubility and it‘s dose:solubility ratio. The 
dose:solubility ratio is defined as the volume of liquid required to completely 
dissolve a particular dose of drug. An aqueous solubility of below 100 µg/mL and a 
dose:solubility ratio of greater than one litre is often linked with poor-water 
solubility (Dressman et al, 2001). 
Poorly water-soluble drugs often exhibit inadequate clinical performance due to their 
poor, erratic dissolution and bioavailability profiles, high fed-fasted ratio, and high 
inter-patient variability. Table 1.1 gives the USP definition of solubility. Many drug 
classification systems incorporate the drug‘s aqueous solubility as a critical defining 
parameter. 
 
Table 1.1: Solubility definition in the USP (USP 26, NF 21, 2003). 
 
Description forms 
(solubility definition)  
 
Parts of solvent 
required to dissolve 





Very soluble (VS) <1 >1000 
Freely soluble (FS) From 1 to 10 100–1000 
Soluble (S) From 10 to 30 33–100 
Sparingly soluble (SPS) From 30 to 100 10–33 
Slightly soluble (SS) From 100 to 1000 1–10 
Very slightly soluble (VSS) From 1000 to 10,000 0.1–1 
Practically insoluble (PI) >10.000 <0.1 
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Biopharmaceutics Classification System 
The Biopharmaceutics Classification System (BCS) divides drugs into four main 
classes according to their aqueous solubility and intestinal permeability (Figure 1.4). 
The BCS is based on the understanding that the dissolution of a drug is chiefly 
determined by its intrinsic aqueous solubility while its absorption is determined by 
its permeability properties (Amidon et al, 1995). The BCS is widely used in the 
design and development of innovative drugs, new dosage forms, clinical 
pharmacology and drug regulation. Aqueous solubility is assessed by measuring the 
volume of aqueous solvent required to dissolve the highest dose of drug at 37°C in 
the pH range of 1 to 7.5. Intestinal permeability refers to the ability of a compound to 
transverse the gastrointestinal membrane by passive diffusion, active or facilitated 
transport. In order to assess intestinal permeability, pharmacokinetic data from 
humans, human perfusion data, data from in vivo or in situ animal models or 
validated cell cultured monolayers are frequently used. Computational methods such 
as calculation of log P have also been employed.  
 
 
Figure 1.4: Biopharmaceutics classification system (Rautio et al, 2008).  
 
BCS class I drugs are highly soluble and highly permeable. A drug is termed highly 
permeable when a 90% bioavailability is achieved relative to an intravenously 
administered dose. A highly soluble drug is one in which the highest dose strength is 
soluble in 250 mL water over the pH range 1-7.5. Such compounds are suitable for 
oral delivery as they exhibit both a high dissolution rate and high bioavailability. 
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Activity may only be limited by gastric emptying time. Examples of BCS class I 
drugs include metoprolol, propanolol and verapamil. 
BCS class II drugs are highly permeable but poorly water-soluble and display 
dissolution rate limited activity. Current research into dissolution enhancement 
techniques e.g. micronization, complexation, solubilisation among others, often 
involves the use of many drugs from this class. Examples of BCS class II drugs 
include griseofulvin, cephalexin, carbamazepine and naproxen. 
BCS class III drugs are highly water-soluble but poorly permeable. Their activity is 
permeability rate limited and consequently their formulation frequently involves the 
use of penetration enhancers. Examples of BCS class III drugs include amoxicillin, 
ranitidine, methyl dopa, losartan and atenolol. 
BCS class IV drugs display both low water-solubility and permeability. These are 
the most difficult drugs to formulate; portraying both dissolution and permeability 
rate limited activity. Nonetheless a number of compounds in this class are available 
on the market. Examples of BCS class IV drugs include frusemide and 
hydrochlorothiazide (Lenneras et al, 2007). 
The FDA issued guidance to industry on waivers of in vivo bioavailability and 
bioequivalence studies on immediate release solid dose forms of BCS class І drugs 
in August 2000 (Guidance CHER/FDA, 2000). Since then, further extensions to the 
biowaivers have been proposed for rapidly dissolving BCS class III compounds 
provided that the excipients do not affect drug permeability (Yu et al, 2002). These 
extensions have been adopted in recent WHO guidelines (WHO 2006). 
 
Developablility Classification System 
The Developability Classification System (DCS) is a recent revision of the BCS and 
attempts to categorise drugs according to factors which limit their oral absorption. It 
is not designed as a regulatory classification for assurance of bioavailability, but 
rather as a guideline in early product development. The DCS incorporates an 
estimate of human fasted intestinal solubility as a primary measure of in vivo 
solubility using biorelevant dissolution media, a solubility limited absorbable dose 
(SLAD) and dissolution rate expressed as a target drug particle size rather than the 
dose/solubility ratio. The introduction of a target particle size provides additional 
information on any potential dissolution rate sensitivity.  
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Assumptions necessary for the DCS include the use of single values for solubility 
and permeability in the upper small intestine as the region of interest for oral 
absorption, a total volume of fluid available in the GI tract in the fasted state for drug 
dissolution of about 500 mL, a compensatory permeability and solubility for highly 
permeable/low solubility compounds and a dissolution number (Dn) relating 
dissolution rate and solubility. 
SLAD is the product of an estimate of small intestine solubility, fluid volume (500 
mL) and a permeability dependent multiplier. It provides an estimate of the dose 
above which oral absorption is likely to be limited by intestinal solubility. SLAD 
divides class II compounds into classes IIa and IIb, and shifts the boundaries 
between class I and II high permeability drugs and between class III and IV low 
permeability drugs (Figure 1.5). The subdivision of class II drugs can help define 
optimal formulation strategies in product development. Class IIa drugs display 
dissolution rate limited activity. Control of factors affecting drug release such as 
particle size, surface area and wettability are critical in their formulation. Class IIb 
compounds on the other hand are solubility limited and therefore these drugs may 
need to be formulated in an already solubilised form (Butler et al, 2010). Table 1.2 




Figure 1.5: Developability classification system (Butler et al, 2010). 
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Table 1.2: DCS reclassification of selected drugs (Butler et al, 2010). 
 




















Digoxin 0.5 mg I/III 0.017 0.9 I/III 8.5 32 
Paracetamol 500 mg I 14 1.3 I 9100 900 
Griseofulvin 500 mg II 0.019 8.7 IIb 83 34 
Mefenamic acid 250 mg II 0.036 14 IIa 280 42 
Ibuprofen 400 mg II 1.46 12 I 8800 300 
Dipyridamole 100 mg II 0.023 1.5 IIb 17b 37b 
Acyclovir 800 mg IV 1.3 0.25 IV 650 280 
Furosemide 80 mg IV 1.7 0.6 III 850 120c 
a: Solubility limited absorbable dose. b: For dipyridamole, which is soluble in the stomach, these intestinal solubility derived parameters will be of less significance. c: For 
furosemide, the target particle size was calculated using a shorter intestinal transit time (0.5 h), assuming absorption is limited to the upper small intestine. d: Fasted state 
simulated intestinal fluid. e: particle size below which 90% of the particle size distribution (by volume) is found f: permeability coefficient. 
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1.3 Dissolution enhancement 
 
Dissolution is the process by which a solid substance undergoes mass transfer from a 
solid surface into a liquid phase. Dissolution rate is measured under standardized 
conditions of temperature, solvent volume and composition. 
The widely accepted drug dissolution theory is the Film Theory. This theory 
postulates a two step process; firstly formation of a stagnant diffusive layer saturated 
with drug substance around the particle, followed by the diffusion of drug from this 













Figure 1.6: Diffusion layer model for drug dissolution showing the boundary layer 
with drug concentration Cs and the bulk solution with drug concentration Cb. 
 
Drug dissolution may follow first order kinetics under non-sink conditions 
(dissolution rate is dependent on drug concentration in bulk) whereby the volume of 
the dissolution media is less than three times that required to form a saturated drug 
solution. However, under sink conditions (in vivo) where the drug is rapidly 
absorbed and the drug concentration in bulk approaches zero, dissolution follows 
zero order kinetics (dissolution rate is independent of drug concentration in bulk). 
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where dQ/dt is the dissolution rate, D is the diffusion coefficient of drug, SA is the 
effective surface area, Cs is the concentration of drug at boundary layer, Cb is the 
concentration of drug in bulk and h is the thickness of diffusion boundary. 
 
Dissolution rate can thus be enhanced by increasing the diffusion coefficient of the 
drug, the saturation concentration of the drug in the bulk solution, its surface area 
and/or by decreasing the thickness of boundary layer. 
 
Increasing saturation solubility 
1.3.1 Polymorphism 
Many classes of drugs are known to exhibit polymorphism. Polymorphs possess 
different lattice energies and physico-chemical properties such as melting point, 
solubility, heat of fusion, density, e.t.c. Enhanced dissolution rates of a drug can be 
achieved by the selection of metastable polymorphs with higher apparent solubilities 
than the stable, crystalline form.   
The use of the term polymorphic forms variably refers to crystalline forms that have 
different arrangements and/or conformations of the molecules in the crystal lattice, 
amorphous forms consisting of disordered arrangements of molecules that do not 
possess a distinguishable crystal lattice, or solvates which are crystal forms 
containing either stoichiometric or nonstoichiometric amounts of a solvent. If the 
incorporated solvent is water, the solvate is commonly known as a hydrate (Byrn et 
al, 2000). Examples of drugs exhibiting polymorphism include steroids, barbiturates, 
and sulphonamides (Higuchi et al, 1967). Commercial exploitation of metastable 




Solubilization is defined as the preparation of a thermodynamically stable isotropic 
solution of a substance normally insoluble or very slightly soluble in a given solvent 
by the introduction of additional amphiphilic component(s). The amphiphilic 
component, namely a surfactant, must be introduced either at the critical micellar 
concentration (cmc) or a concentration above it. 
Micelles are surfactant aggregates with an anisotropic water distribution within their 
structure. In aqueous solvents, the water concentration decreases from the surface 
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towards the core of the micelle, where it is completely excluded from the 
hydrophobic core. Consequently, the average spatial position of a solubilized drug in 
a micelle will depend on its polarity - nonpolar molecules will be solubilised in the 
micellar core, and substances with intermediate polarity will be distributed along the 
surfactant molecules in intermediate positions (Rangel-Yagui et al, 2005). 
Microemulsions are single phase, optically isotropic, thermodynamically stable 
solutions of water, oil and amphiphile (Danielsson et al, 1981). By virtue of their oil 
core, oil-in-water microemulsions generally have a greater solubilising power than 
their corresponding micellar solutions. 
Nanoemulsions are often confused with microemulsions but differ in that they are 
kinetically (as opposed to thermodynamically) stable and comprise of slightly larger 
sized droplets. (Anton et al, 2011).  
The inclusion of hydrophobic drugs in micelles, microemulsions or nanoemulsions 
to increase their apparent aqueous solubility has been widely used in drug delivery 
(Lawrence et al, 2000). Surfactant toxicity and formulation instability upon dilution 
are major challenges faced with this technique of increasing the apparent aqueous 
solubility of a drug. 
 
1.3.3 pH adjustment 
The majority of drugs are either weak acids or bases. The degree of ionization of 
these drugs is governed both by their dissociation constants (pKa) and the pH of the 
dissolution medium. The pKa, which can be calculated from the Henderson-
Hasselbalch Equation, is the pH at which 50% of the drug is ionized. pH 
modification can be used to increase the presence of the ionized species of drug in 
solution thereby enhancing its dissolution rate and solubility (Otzurk et al, 1988). 
Drugs that make good candidates for increasing their solubility by this method are 
those that ionize between pH 2-8. Examples of drugs formulated in buffer systems 
include; amikacin sulphate (pH 3.5-5.5 citrate buffer), midazolam hydrochloride (pH 
3) and acetylsalicylic acid (magnesium oxide or calcium carbonate buffer). 
Precipitation of a drug upon dilution with the intestinal contents, which may be at pH 
at which drug is less soluble, as well as toxicity and tolerability issues associated 
with extreme pHs, are among the drawbacks of this technique. 
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1.3.4 Salt formation 
Salts of acidic/basic drugs usually have a higher aqueous solubility than their 
corresponding free acid or base. This is due to their higher ionization causing a rapid 
saturation of the diffusion layer surrounding the drug. A careful assessment of the 
interrelationship between the intrinsic solubility, pKa and possible salt forms is 
necessary when formulating poorly water-soluble drugs as salts. With the increased 
number of extremely poorly water-soluble drug compounds currently in 
development, strong anions or cations are required for effective salt formation. 
About 77% of the salts of basic drugs approved by FDA (1995-2006) were prepared 
using relatively strong counterions, namely the hydrochloride, methanesulfonate, 
hydrobromide/bromide, sulfate/bisulfate and nitrate. Similarly, 73% of the salts of 
acidic drugs were prepared with strong alkalis such as NaOH and KOH (Serajuddin 
2007). The use of these strong counterions may lead to toxicity concerns when the 
salt is administered orally. Examples of drugs formulated as salts to increase 
dissolution include theophylline as the isobutanolamine salt and penicillin V as the 
potassium salt, among others. Pharmaceutical salts also have other actions e.g. 
reducing drug toxicity, organoleptic properties, prolonging drug action and 
improving drug stability (Berge et al, 1977). 
 
1.3.5 Complexation 
Poorly water-soluble drugs can be complexed with a soluble intermediate (such as a 
cyclodextrin, caffeine or donor acceptor) to form a soluble intermolecular complex. 
Cylodextrins are cyclic oligosaccharides formed by the enzymatic hydrolysis of 
starch. They generally contain 6, 7 or 8 glucose units, linked by α-(1, 4) bonds and 
are known as α-, β-, γ- cyclodextrins respectively. Cyclodextrins possess a 
hydrophilic exterior with a hydrophobic interior cavity into which poorly water-
soluble drugs can be incooperated. The interaction between the drug and 
cyclodextrin is governed by hydrophobic interactions, van der Waals forces and 
hydrogen bonding. The water-soluble inclusion complexes formed by cyclodextrins 
frequently exhibit new, physico-chemical characteristics compared with the original 
guest molecules, including better stability, higher water solubility, increased 
bioavailability and/or decreased undesirable side effects. β-cyclodextrin has been 
widely used for drug delivery because it is readily available and interacts with a wide 
variety of pharmaceutical compounds. However, the low water solubility and 
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nephrotoxicity of β-cyclodextrin has lead to development of more water-soluble 
alternatives such as 2-hydroxypropyl-β-cyclodextrin, methyl-β-cyclodextrin and 
sulfobutyl ether-β-cyclodextrin. 
There are currently over 30 cyclodextrin-linked drugs on the market. These include 
alprostadil, cefotiam hexetil HCl (α-cyclodextrin); dexamethasone, nicotine, 
nitroglycerin, piroxicam (β-cylodextrin); cisapride, indomethacin, mitomycin (2-
hydroxypropyl-β-cyclodextrin); diclofenac sodium (2-hydroxypropyl-γ-cyclodextrin) 
(Loftsson et al, 2005). 
 
1.3.6 Prodrugs 
Prodrugs are inactive derivatives of a drug that undergo enzymatic or chemical 
conversion in vivo to yield the active parent drug moiety which then exerts its 
desired pharmacological action. Common functional groups that are amenable to 
prodrug design include carboxylic, hydroxyl, amine, phosphate/phosphonate and 
carbonyl groups, which can be modified to esters, carbonates, carbamates, amides, 
phosphates and oximes.  
49% of all prodrugs in the market are esters (Ettmayer et al, 2004). Phosphate esters 
of hydroxyl and amine functionalities are commonly used to improve drug solubility 
e.g. sulindac, miproxfene phosphate TAT-59, fosamprenavir, estramustine 
phosphate, prednisolone phosphate and fludarabine phosphate (Rautio et al, 2008). 
 
1.3.7 Solid dispersions 
Solid dispersions are two component systems comprising of a hydrophilic matrix 
(amorphous or crystalline) and hydrophobic drug (amorphous, crystalline or 
molecularly dispersed). Categories of solid dispersions include simple eutectic 
mixtures, glass solutions, solid solutions and amorphous precipitates in a crystalline 
carrier (Chiou et al, 1971; Brientechbach 2002).  
Techniques such as the fusion method, hot melt extrusion, the solvent method and 
supercritical fluid technologies are used to produce solid dispersions. Limitations 
encountered with solid dispersions include laborious, expensive preparation methods 
and scale up of manufacture as well as the difficulty in further formulating the solid 
dispersion into a dosage form. Gris-PEG by Novartis (griseofulvin in polyethylene 
glycol), Cesamet by Lily (nabilone in polyvinylpyrrolidone), Sporanox by Janssen 
Pharmaceutica (itraconazole in hypromellose and polyethylene glycol 20,000 
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sprayed on sugar spheres), Rezulin by Parke-Davis (troglitazone formulation), 
Zoladex parenteral implants (geoserelin in polylactidecoglycolide), Depotprofact 
(buserelin in polylactidecoglycolide), Kaletra by Abbott (lopinavir/ritonavir) and 
Norvir by Abbott (ritonavir) are among the solid dispersion products currently on the 
market (Dhihendra et al, 2009). 
 
Increasing surface area  
The surface area of a drug is a critical factor in determining its dissolution rate. The 
effective surface area available for dissolution is a function of both particle size and 
the ability of the fluid to wet the drug particles. 
 
1.3.8 Wetting 
Most poorly water-soluble drugs are also poorly wetted. Low levels of surfactant 
have historically been included in many drug formulations to improve drug wetting 
properties (Singh et al, 1968). The beneficial effect of surfactants on the drug 
wetting processes is as a result of their adsorption at the solid drug-liquid interface 
resulting in a change of interfacial tension - surfactants can reduce the liquid-air 
and/or liquid-solid interfacial tension. The hydrophobic chains of the surfactant 
typically adsorb onto the hydrophobic surface of the drug particle, while their 
hydrophilic head extends towards the aqueous solution. Native surfactants present in 
the gastrointestinal tract e.g. bile salts, have also been shown to improve drug 
wetting. 
 
1.3.9 Particle size reduction  
In comparison to other factors in the Noyes Whitney equation, particle size reduction 
has the greatest impact on drug dissolution. A reduction of particle size leads to an 
increase in surface area, thereby increasing dissolution rate. Micronisation, which is 
reduction of particle size to within the 1-10 μm size range, is widely exploited in the 
pharmaceutical industry. The required reduction in particle size is generally achieved 
by mechanical processes such as milling, cutting, crushing, and grinding. Equipment 
used for comminution includes ball mills, hammer mills, fluid energy mills, pin 
mills, rotary cutters and colloid mills. The selection of the type of mill to be used 
depends on factors such as the physical properties of the material, the operation 
process, auxillary equipment and safety. A further reduction of particle size to within 
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the nanometer size range is envisaged to further increase dissolution rate and 




Figure 1.7: Variation of drug bioavailability with particle size (Merisko-Liversidge 
et al, 2003). 
 
However dry milling, often used for micronisation, can only yield microparticles, i.e. 
particles within the 1-10 μm size range. Attempts to further reduce particle size 
below 1 μm, leads to aggregation and clumping of powder in the mill due to high 
van der Waals forces (Parrott 1974).  
 
1.4 Nanoparticle production 
 
Recent technological advances in the understanding of colloidal systems has allowed 
the formulation of nanometre sized crystalline drug particles in a reproducible 
manner. These nano-sized drug crystals are often stabilized by surfactants and/or 
polymers adsorbed onto their surfaces thereby overcoming the high surface energy 
of nanoparticles.  
Nanoparticles may be manufactured by ‗top down‘ approaches which involve 
breaking down of large particles into smaller ones e.g. media milling, high pressure 
homogenization or by ‗bottom up‘ approaches involving controlled 
precipitation/crystallization to obtain the desired particle size (Figure 1.8).  
 





Figure 1.8: Schematic representation of top down and bottom up approaches to 
nanoparticle production (Verma et al, 2009).  
 
Table 1.3 lists the nanocrystalline drugs currently on the market. The nanoparticles 
are all produced via the ‗top down‘ approaches namely media milling and high 
pressure homogenization. Nanoparticle formulations exhibit a rapid onset of action, a 
reduced fed-fasted ratio, improved bioavailability and an increased therapeutic 
effectiveness (Chaubal 2004). Nanoparticles enhance dissolution by increasing not 
only surface area, but also by increasing the saturation solubility of the drug. Such 
nanoparticulate systems can also be used to target drug delivery to specific sites. For 
example, thiamine coated nanoparticles have demonstrated a preferential uptake in 
the brain, utilising the blood-brain barrier thiamine transporters (Lockman et al, 
2003). 
The nanosuspensions can be transformed into solid products using well-defined unit 
operations such as freeze-drying, spray drying, pellization and granulation (Mersiko-
Liversidge et al, 2003, 2008; van Eerdenburgh et al, 2008; Yunhui et al, 2007). 
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Techniques for nanoparticle production include: 
 
1.4.1 Precipitation 
Typically, the drug is first dissolved in a solvent followed by the addition of a 
miscible anti-solvent. The drug then precipitates out of solution and is recovered by 
solvent evaporation. The resultant nanoparticles are stabilised by surfactants added 
to the drug solution and/or anti-solvent during processing. Controlled conditions are 
required to achieve a high nucleation rate and a low growth rate. Mixing processes 
vary and include the infusion of anti-solvent into solvent ensuring low levels of 
supersaturation and a narrow size range of the resultant nanoparticles (Violante et al, 
1991), while the rapid addition of solvent to anti-solvent leads to high levels of 
supersaturation and consequently rapid nucleation producing smaller nanoparticles 
(Mahajan et al, 1993). 
The disadvantages of the precipitation method include the difficulty in controlling 
crystal growth, the difficulty in obtaining a narrow size distribution, the requirement 
that the drug is soluble in one solvent, toxicity and environmental concerns of the 
non-aqueous solvents used (Kipp 2004). Recent advances in precipitation technology 
include the use of gravity (Chen et al, 2004), ultrasonication (Kumar et al, 2009), 
liquid nitrogen for freeze drying (Waard et al 2008; Yanga et al, 2008), and acid-
base neutralization reactions (Chen et al, 2008). Precipitation has also been coupled 
to high pressure homogeniztion using NANOEDGE technology (Kipp 2004). 
Nanoparticles have also been obtained by the evaporation of the solvent from 
emulsions and microemulsions, which contain drug in the hydrophobic phase.  
 
1.4.2 High pressure homogenisation 
High pressure homogenization is patented by Skyepharma under the tradename 
Disso Cubes
®. Currently one drug formulated using the ‗Disso Cubes‘ formulation 
technology, namely Triglide
®
, is available on the market (Table 1.3). A suspension 
containing drug and stabiliser solution is pumped through a narrow gap at high 
pressure (15,000-30,000 psi). The suspension flows through the very thin aperture 
(about 25 µm) at extremely high velocity. To maintain constant energy, this high 
flow is compensated by a dramatic decrease in static pressure below the vapor 
pressure of water, causing boiling of the suspension to occur. As the suspension exits 
the gap, the pressure suddenly rises to ambient pressure and the vapor bubbles 
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implode (or cavitate). This implosion generates considerable local energy as 
turbulent flow and heat.  
Particle size reduction variously occurs via implosion (cavitation) forces, high shear 
forces and interparticle impact. The high pressure homogenizer consists of a high-
pressure plunger pump and a subsequent homogenezing valve (Figure 1.9). 
Homogenizers are available in different capacities ranging from 40 mL (for lab use) 




Figure 1.9: Schematic representation of high-pressure homogenization process 
(Patravale et al, 2004). 
 
The particle size reduction achieved is dependent on the number of homogenisation 
cycles used, the temperature and the power density of the homogeniser. Advantages 
of this technique include low contamination levels, ease of scale-up, little batch-
batch variation and a narrow size distribution of the resultant nanoparticles. 
Drawbacks include the clogging of the gaps with concentrated drug formulations and 
a prerequisite for micronisation of the drug before loading into the homogeniser 
(Muller et al, 1999; Kipp 2004). 
 
1.4.3 Supercritical fluid processing 
Supercritical fluids (SCFs) such as CO2 have been used for nanoparticle production 
due to their mix of gas-like and liquid-like properties. In addition to advantages such 
as gas-like diffusivities, tunable solvent power/selectivity and ease of elimination, 
   Chapter 1 Introduction 
54 
 
SCFs can be employed as solvents, anti-solvents or reaction media (Reverchon et al, 
2006).  
 
Rapid expansion of supercritical solutions 
Rapid expansion of supercritical solutions (RESS) is employed for drugs soluble in 
SCFs. Supercritical CO2 is the preferred solvent for RESS though other solvents 
such as propane, pentane, methane, acetone amongst others may be used. The 
process entails saturation of the supercritical fluid with the drug substrate. The 
resultant solution is then depressurised through a heated nozzle into a low pressure 
chamber resulting in a high degree of drug supersaturation leading to homogeneous 
nucleation (Figure 1.10).  
 
 
Figure 1.10: The rapid expansion supercritical solution process is shown in a 
schematic representation (Byrappa et al, 2008). 
 
The RESS parameters such as temperature, pressure drop, e.t.c. as well as the 
chemical nature of the drug influence the morphology of the resultant nanoparticles. 
RESS is particularly attractive as it eliminates the need for organic solvents in 
nanoparticle production. A major limitation of RESS is that many high molecular 
weight drug compounds with polar bonds have negligible solubility in supercritical 
CO2 (Byrappa et al, 2008). In addition, it is also difficult to control particle size and 
morphology using this technique. 
 
Supercritical anti-solvent precipitation 
For CO2 insoluble drugs, supercritical anti-solvent (SAS) entails first dissolving the 
drug in an organic solvent, then atomizing the solution in an excess continuum of 
   Chapter 1 Introduction 
55 
 
flowing supercritical fluid (Figure 1.11). The underlying principle being that when a 
drug solution is expanded sufficiently by an anti-solvent, supersaturation and 
nucleation occurs due to the lower solubility strength (Byrappa et al, 2008). The 
prerequisites for a successful SAS process are the complete miscibility of the liquid 




Figure 1.11: The supercritical anti-solvent precipitation process is shown 
schematically (Byrappa et al, 2008). 
 
Recently, several modifications of the RESS and SAS processes have been 
employed for nanoparticle production. These include supercritical assisted 
atomization, sol/gel formation among others (Reverchon 2003). 
 
1.4.4 Media milling 
Wet bead milling (WBM) utilises the Elan ‗Nanocrystal‘ technology in which 
crystalline drug is milled in the presence of a solution of stabilisers yielding 
nanometer sized drug particles. Currently five drugs formulated using ‗Nanocrystal‘ 










are available in the market (van Eeerdenburgh et al, 2008; FDA 2009).  
In order to wet bead mill a drug, a slurry consisting of drug, water and stabiliser 
along with milling media are loaded into the mill. Figure 1.12 shows a cross section 
of the media mill. The drug concentration used generally ranges from 1 to 400 
mg/mL. The milling media consists of spherical glass, yttrium zirconia stabilised, 
ceramic or plastic (highly cross linked polystyrene resin) beads of 0.4-3 mm 
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diameter. The slurry and milling media are rotated at a very high shear rate either by 
paddles in the milling chamber, or by oscillation of the milling chamber. Mills can 
be operated in either the re-circulation or batch mode. The milling media fractures 
the drug crystals into a homogeneous nanocrystalline dispersion, which is then 
screened to separate it from the milling media. Milling is usually carried out under 
controlled temperature by the use of coolants. Particle size reduction is achieved 





Figure 1.12: The media milling process is shown schematically (Merisko-Liversidge 
et al, 2003). 
 
WBM offers advantages over other nanosizing techniques, such as minimal batch-to-
batch variation, eliminating the need for the pre-micronization of drugs, avoiding the 
need for the use of organic solvents, the resultant narrow particle size polydispersity 
and the easy scale up to industrial level.  
The main drawbacks in this technique are product contamination by the milling 
media and the possibility of milling induced disorder in the drug crystalline lattice. 
There is a need to test the milling process in order to ensure that any shedding by the 
milling media is minimal and any product contamination is below acceptable levels 
for pharmaceutical products. Secondly, the nanocrystalline drug has to be screened 
for any amorphous transitions or crystal defects using techniques such as solution 
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calorimetry, dynamic scanning calorimetry, moisture sorption and X-ray powder 
diffraction (Iaccocca et al, 2009). 
 
1.5 Nanoparticle stabilisation 
 
Owing to their high surface area to volume ratio, nanoparticles have a tendency to 
aggregate due to van der Waals forces. Stabilisers act to cancel out the attractive 
nature of the van der Waals forces by introducing repulsive steric or electrostatic 
forces at the nanoparticle surface. 
 
Adsorption 
Adsorption usually occurs at interfaces be it the air-liquid, the liquid-liquid or the 
solid-liquid interface. At the solid-liquid interface, adsorption results from the 
interplay of electrostatic interactions, van der Waals forces, hydrogen bonding and 
covalent bonding between the adsorbing species and the solid surface as well as 
interactions between the adsorbed species. It is an equilibrium process with depletion 
and adsorption occurring simultaneously. 
Adsorption can either be classified as physical or chemical. Physical adsorption 
usually occurs due to van der Waals forces or electrostatic charges between the 
adsorbate and the adsorbent and is usually weak and reversible. Chemical adsorption 
on the other hand is much stronger and irreversible and occurs due to covalent 
bonding between the adsorbate and the adsorbent. 
Adsorption isotherms have been extensively used to characterise adsorption and they 
represent the amount adsorbed as a function of adsorbate concentration at a constant 
temperature. Adsorption density, which is the amount of adsorbate deposited at the 
interface, is usually measured by depletion of the adsorbate from solution. 





CC if                                                   (Equation 1.2) 
 
where Γ is the adsorption density, Ci and Cf are the initial and final concentrations of 
adsorbate in solution, V is the volume of solution, and W is the mass of the 
adsorbent. 
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1.5.1 Electrostatic (ionic) stabilisation 
Colloidal particles may bear a surface charge originating from the ionization of 
surface groups, the differential loss of ions from the crystal lattice or the adsorption 
of charged species (ions or ionic surfactants). A negatively charged particle attracts 
positive counterions surrounding the particle. The electrical double layer is the layer 
surrounding a dispersed particle and includes the ions adsorbed directly onto the 
particle surface and an outer layer of countercharged ions in the dispersion medium. 
As shown in Figure 1.13, the electrical double layer is overall electrically neutral and 
consists of three parts: 
- Surface charge: charged ions adsorbed on the particle surface.       
- Stern layer: counterions (charged opposite to the surface charge) attracted to the 
particle surface and closely attached to it by the electrostatic force.             
- Diffuse layer: a film of the dispersion medium (solvent) adjacent to the particle. 
The diffuse layer contains  a higher concentration of the counterion than in the bulk. 
The charge of the ions in the diffuse layer is influenced by the electrostatic force of 




Figure 1.13: The electrical double layer (Kopeliovich 2011).  
 
The electrical potential within the electric double layer has a maximum value at the 
surface of the particle (surface potential). The potential drops with an increase in 
distance from the particle surface and reaches zero at the boundary of the electric 
 
   Chapter 1 Introduction 
59 
 
double layer. When a colloidal particle moves in the dispersion medium, a layer of 
the surrounding liquid- whose boundary is known as the slipping plane remains 
―attached‖ to the particle.  The value of the electric potential at the slipping plane is 
called zeta potential, which is a very important parameter in the theory of the 
interaction of colloidal particles. Stable, charged, particles typically possess zeta 
potentials of above +30 mV or below -30 mV. Zeta potential is affected by pH, 
conductivity and the concentration of functional component (Li et al, 2007). 
 
DVLO theory 
In considering the interaction between two hydrophobic colloidal particles 
Derjaguin, Landau, Verwey and Overbeek came up with a theory (Derjaguin et al, 
1941; Verwey et al 1948). This theory assumes that the total force (VT) acting on the 
particles is a summation of the attractive (VA) and repulsive forces (VR) between the 
two particles as depicted in Figure 1.14. 
 
VT = VR + VA                                                    (Equation 1.3) 
 
Figure 1.14: Potential energy curve for two approaching nanoparticles (Rabinow 
2004). 
 
The repulsive forces on the particles arise due to the osmotic effect brought about by 
increase in the number of charged species on the overlap of diffuse parts of the 
electrical double layer. These repulsive forces are a function of the interparticulate 
distance as shown: 
 
 





 exp (-kD)                                           (Equation 1.4) 
 
where π is the solvent permeability, Ɛ is the permittivity of the polar liquid, a is the 
radius of the spherical particle, k is a function of the ionic composition, ξ is the zeta 
potential and D is the distance between particles. 
 
The attractive forces present in the system are mainly van der Waals forces, which 







                                           (Equation 1.5) 
                                        
 
 
where A is the Hamaker constant. 
 
As the particles approach each other, there is a greater increase in the repulsive 
forces relative to the attractive forces. The maximum repulsion between the particles 
occurs at a separation known as the primary maximum (VM). In order for the 
particles to aggregate (which occurs at the primary minimum (VD)) the particles have 
to overcome these repulsive forces. The higher the intensity of the primary maxima, 
the more stable the suspension (Rabinow 2004).  
The secondary minima (VS) is the point at which weak, reversible flocculation 
occurs. Ionic stabilisers introduce an electrostatic charge on the particle surface 
leading to repulsion between particles. Ionic stabilisation can be achieved by ionic 
surfactants and/or polymers e.g. sodium dodecyl sulphate, dodecyl trimethyl 
ammonium bromide and hypromellose acetate succinate.  
The DVLO theory only holds for dilute colloidal suspensions in which no other 
forces besides van der Waals and electrostatic forces are present and if the geometry 
of the particles is simple and the electrical double layer is purely diffusive. 
Disadvantages of electrostatic stabilisation include sensitivity to the presence of 
electrolytes, decreased efficacy in non-aqueous dispersion media and high solid 
content. In addition, electrostatically-stabilised systems will overtime undergo 
aggregation as they are thermodynamically metastable (Napper 1983).  
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1.5.2 Steric stabilisation 
Stabilisation of lyophobic colloids by non-ionic polymers/surfactants (a result of 
steric forces, VS) was not originally described by the DLVO theory. Equation 1.3 
was later modified to account for steric stabilisation by non-ionic 
polymers/surfactants (Figure 1.15). 
 




Figure 1.15: Potential energy curve for two approaching nanoparticles showing 
influence of steric forces (Birdi 2009).  
 
As with charged stabilisers, steric stabilisers adsorb on the particle surface and 
provide a physical barrier to aggregation. However in this case, the stabilisation is 
provided by the entropic or osmotic constraints imposed by the stabilisers. For two 
particles coated with non-ionic polymers or surfactants to aggregate, the hydrophilic 
chains of the stabiliser have to be compressed which is entropically unstable and 
causes a repulsion between the particles. In other cases, the osmotic stress created by 
the encroaching steric layers leads to an influx of solvent molecules, which serve to 
keep the particles apart (Osmond et al, 1975). Steric stabilisation of particles can be 
achieved by a range of non-ionic surfactants and/or polymers including the 
Tweens, Brij, hypromellose and polyvinylpyrrolidone. 
Figure 1.16 shows particles stabilised sterically by a polymer, where the thickness of 
polymer chain adsorbed on the particle is d. At a distance of 2d the polymer chains 
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either interpenetrate or are compressed, causing the two approaching particles to 
repel each other.  
Steric stabilisation comprises of two main contributors; an entropic term (repulsive) 
which is due to change of conformation of polymers as they approach each other and 
an enthaphic term, which depends on the polymer-polymer versus polymer-solvent 
interactions. When two hydrated polymer molecules approach each other, the water 




Figure 1.16: Steric stabilisation of particles by polymer layer with thickness of d 
(Shi 2002). 
 
Steric stabilisation offers several advantages over electrostatic stabilisation 
including: equal efficacy in both aqueous and non aqueous dispersion media, relative 
insensitivity to the presence of electrolytes, equal efficacy at both high and low solid 
conditions and reversibility of flocculation. Sterically stabilised systems are 
thermodynamically stable (Napper 1983). 
 
Polymeric stabilisation may also occur via other mechanisms including depletion 
flocculation, bridging flocculation and electrostatic stabilisation. 
 
Depletion flocculation 
Flocculation refers to the formation of reversible loosely packed aggregates within a 
colloidal suspension. Polymers can stabilise colloids via this mechanism without 
necessarily being adsorbed onto the colloidal particles. In such a case, the polymers 
exist freely in solution. As two colloidal particles approach each other, the 
intercolloidal distance is depleted of polymer, leading to an osmotic gradient which 
causes an influx of solvent between the two particles, which acts to keep the particles 
apart (Figure 1.17). 




Figure 1.17: Depletion flocculation (Shi 2002). 
 
Bridging flocculation  
When a polymer chain is long enough to adsorb onto the surface of two particles 
(Figure 1.18A) or long enough to interact with another polymer chain absorbed on a 
different particle (Figure 1.18B), loosely formed aggregates of particle are formed. 
 
 
Figure 1.18: Bridging flocculation (Shi 2002). 
 
1.5.3 Electrosteric stabilisation 
Electrosteric stabilisation is achieved by the combined use of non-ionic polymers 
and ionic surfactants, which often complement each other in terms of their 
mechanism of stabilisation. Firstly, entropic steric interactions are more sensitive to 
temperature fluctuations than electrostatic stabilisation. Therefore the inclusion of an 
ionic surfactant could help protect a polymer-stabilised formulation from 
temperature cycling effects.  Secondly, there is a synergy between ionic and non-
ionic stabilisers e.g. inclusion of a polymer in a formulation stabilised by an ionic 
surfactant could decrease self-repulsion and thereby allow greater coverage by the 
surfactant (Rabinow 2004). Electrosteric stabilisation can also be achieved using 
charged polymers or polymeric surfactants. Although not much literature is currently 
available on electrosteric stabilisation, interest in it as a mechanism of stabilisation is 
growing. 





1.6.1 Surfactant classification and properties 
Surfactants are amphiphilic molecules; having a polar/hydrophilic head group and a 
non-polar/hydrophobic tail group (Figure 1.19). As such surfactants, in the 
monomeric form, have limited solubility in any solvent and instead tend to adsorb at 






Figure 1.19: The structure of a surfactant. 
 
Surfactants are divided into four classes according to their head group charge (Table 
1.4). Anionic surfactants have a negatively charged head group e.g. sulphate, 
sulphonate, while cationic surfactants have a positively charged group e.g. amine. 
Anionic/cationic surfactants are usually incompatible with other charged 
compounds, as well as sensitive to hard water, salts and preservatives. These charged 
surfactants, in particular cationics, are frequently irritating to physiological 
membranes. 
In zwitterionic surfactants the head group bears both a positive and negative charges 
in close proximity, thus they behave as effectively neutral. Zwitterionics are 
compatible with other charged compounds, display low skin/eye irritation and are 
thus widely used in dermatological preparations.  
Non-ionic surfactants bear no head group charge, are compatible with other charged 
compounds and are unaffected by electrolytes or hard water. These surfactants are 
widely used in drug delivery; however they are particularly sensitive to temperature 
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a + b + c + d = 20
 
 
1.6.2 Surfactant adsorption at the air-liquid interface 
Surfactant adsorption at the air-liquid interface depends on the polarity of the liquid. 
When dissolved in an aqueous solvent such as water, the hydrophobic tail aligns 
itself towards the air while hydrophilic head remains in contact with the water. This 
alignment leads to a reduction in surface tension due to disruption of the ordered 
water structure. As the surfactant concentration is increased, more and more of the 
surfactant is adsorbed at the air-water interface leading to a further reduction in 
surface tension. The surfactant in the bulk is in constant equilibrium with that on the 
surface. Once the surfactant monolayer at the air-water interface is saturated, there is 
no appreciable change in surface tension upon the addition of further surfactant.  
   Chapter 1 Introduction 
66 
 
At this point any more surfactant monomers in the bulk tend to come together to 
form aggregates known as micelles (Figure 1.20). These micelles will be in dynamic 
equilibrium with surfactant monomers in solution and will constantly break down 
and reform (Attwood et al, 1983). In a polar solvent such as water, the hydrophilic 
head groups of the surfactant molecules comprising the micelle are oriented towards 
the solvent, while the hydrophobic tails form the core of the aggregate. Micelle 
formation involves a balance between hydrophilic forces (including hydration and 
head group charge) which oppose aggregation, and hydrophobic forces (e.g. the 
increase in entropy of the system) which promote aggregation. Micellisation is 
inherently an ‗energy saving‘ process as the hydrophobic portion of the surfactant 
molecule is ―protected‖ from contact with the bulk phase. In the core of the micelle, 
the fluidity of the hydrophobic portion of the surfactant molecule resembles that of 
hydrocarbon oil thereby increasing the entropy of the system. In non-polar solvents, 
reverse micelles with a hydrophilic core and hydrophobic tails oriented towards the 




Figure 1.20: The formation of micelles (Liu et al, 1996).  
 
The concentration at which the surfactants form micelles is known as the critical 
micelle concentration (cmc). The cmc is usually marked by a sudden change in 
physical properties of the solution e.g. light scattering, conductivity, osmotic 
pressure and surface tension. These properties are either sensitive to surfactant 
monomers e.g. surface tension and osmotic pressure or micelles e.g. light scattering, 
explaining why some discrepancy is seen between the cmc determined using 
different techniques. Surface tension is widely used to study the micellisation 
properties of surfactants. The surface tension of a liquid decreases with increasing 
surfactant concentration upto the cmc above which no further appreciable decrease in 
surface tension is noticed (Figure 1.21). 
 





Figure 1.21: Change in the surface tension of water with increasing surfactant 
concentration. The attached illustrations show surfactant orientation and the onset of 
micellisation. 
 
1.6.3 Surfactant adsorption at the liquid-solid interface 
Surfactants are self-assembled systems that may adopt various types of aggregate in 
solution depending on the molecular architecture of the surfactant and the properties 
of the dispersion media. Figure 1.22 shows some aggregate structures that may be 
formed by surfactants in solution. 
 
 
Figure 1.22: Various aggregates that may be formed by surfactants in solution. 
 
The fact that surfactants self-assemble, coupled to the fact that surfactants may cause 
adsorbent ionization makes the interpretation of surfactant isotherms challenging. 
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The nature of adsorbent and the surfactant charge are critical determinants in the 
adsorption process (Duro et al, 1999). 
Surfactants may adsorb onto a solid surface via mechanisms including electrostatic 
interaction, covalent bonding, lateral surfactant chain-chain interactions, hydrogen 
bonding and non-polar bonding between surfactant and solid surface. In addition 
solvation or desolvation of any species during adsorption may contribute to the net 
free energy of adsorption (Somasundaran et al, 1998). 
 
The net driving force for surfactant adsorption is given by the equation: 
 





adsG is the adsorption force, 

elecG is the electrostatic 
interaction,

chemG is the covalent bonding,

ccG  is the cohesive lateral chain – 
chain interactions among the adsorbed species, 

scG  interaction between 
hydrocarbon chains of the adsorbate and the hydrophobic sites on the solid surface, 

HG is the hydrogen bonding and  





Ionic surfactants usually adsorb onto oppositely charged surfaces via electrostatic 
interactions to form a typical log-log Somasudaran Fleutcher type isotherm (Figure 
1.23). This isotherm is divided into four distinct regions, namely Regions I-IV 
(Chandar et al, 1986; Somasundaran et al, 1966; 1997; 1998). 
  





Figure 1.23: The adsorption isotherm of sodium dodecyl sulfate onto positively 
charged alumina at pH 6.5. The illustrations show the growth of surface aggregates 
and orientation of surfactant molecules (Chandar et al, 1986). 
 
Region I: 
At low surfactant concentrations, adsorption is governed by electrostatic 
interactions between the surfactant head group and the solid surface. The 
adsorption isotherm in this region has a slope of unity as there are no 
inhibitions to the adsorption process. The surfactant molecules are usually 
lying flat on the surface at this stage. 
Region II: 
A marked increase in adsorption is observed. This can be attributed to 
surfactant aggregation due to lateral chain-chain interactions and the 
formation of solloids (surface colloids) e.g. hemimicelles and admicelles. 
Electrostatic interactions between the solid surface and the surfactant 
head group are still in play. The area per surfactant molecule decreases 
with surfactant adsorption due to surfactant-surfactant repulsion and 
association. 
Region III:  
A decrease in surfactant adsorption is observed. Electrostatic adsorption 
forces are no longer operative due to the neutralisation of the charged 
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surface by the pre-adsorbed surfactant. In this region surfactant 
adsorption is governed only by the lateral attraction between the adsorbed 
surfactant molecules. 
Region IV:  
This region is denoted by the formation of a plateau, which indicates 
maximum surface coverage due either to micelle formation in the bulk or 
monolayer coverage. Higher surfactant concentrations may lead to 
multilayer formation due to the reversal of the orientation of charge at the 
solid surface. 
  
Adsorption of ionic surfactants is usually reversible. There is not much literature 
describing the adsorption of ionic surfactants onto neutral or oppositely charged 
surfaces, though it would be expected that the adsorption of ionic surfactant onto 
these surfaces would be minimal. 
 
Non-ionic surfactants 
Non-ionic surfactants usually adsorb onto solid surfaces due to hydrogen bonding 
and not electrostatic or covalent bonding. Most non-ionic surfactants possess polar 
groups capable of forming hydrogen bonds with hydroxyl groups on the solid 
surface. Their adsorption is usually lower and weaker as compared to ionic 
surfactants. Thus the absorption of non-ionic surfactants is easily reversible with 
only a weak hysteresis. One marked difference in the adsorption isotherms obtained 
for non-ionic surfactants in comparison to that of ionic surfactants is that Region III 
is characterised by a sharp increase in adsorption. This is due to absence of an 




Zwitterionic surfactants adsorb onto solid surfaces due to both hydrophobic 
interactions of the tail group and ion dipole interactions between the adsorbent and 










1.7.1 Polymer classification and properties 
Polymers are high molecular weight macromolecules with self-repeating units 
(monomers). They are usually classified according to their  




Linear                                    Branched                                     Cross-linked 
 
 charge: uncharged and charged (known as polyelectrolytes) 
 substitution pattern:  
- homopolymers constituting the same monomer unit   
 AAAAAAA 
- copolymers made up of different monomer units, which could be 
            Random:   BAABBABA                               Alternate:   ABABABAB 
            Block:       AABBAABB                               Graft:          AAAAAAA 
                                                                                                               B 
                                                                                                               BBBA                
                            
 origin: natural or synthetic – cellulose or rubber 
 
Polymers soluble in a particular liquid, first undergoes imbibition, which is swelling 
due to ingress of solvent, followed by the formation of a true solution. The formation 
of a true solution is governed by polymer chain-solvent interactions, which must 
exceed the interaction between the polymer-polymer chains and the solvent-solvent 
molecules. The conformation which a polymer adopts in solution depends on the 
















       Coiled                                    Ideal polymer chain                       Extended                     
in a bad solvent                               in a theta solvent                     in a good solvent                     
 
Figure 1.24: Conformation of a polymer chain in different solvents. 
 
The ideal polymer chain conformation is one in which there can be no interaction 
between the individual monomer units; this can only be achieved in what is known 
as a theta solvent. In good solvents, the monomer-solvent interaction is more 
favourable than the monomer-monomer interaction resulting in an extended polymer 
conformation. In bad solvents, the monomer-monomer interaction is greater than that 
between the monomer-solvent leading to a collapse of the polymer chains and their 
phase separation from the solvent (Jannick et al, 1990). In a theta solvent the 
monomer-monomer interactions exactly balance the monomer-solvent interactions 
leading to the random flight configuration of the polymer chain. 
The conformation of a polymer in solution is also influenced by its concentration. In 




 are observed. C
** 
divides the dilute and semi-dilute concentrations, while C
* 
separates the range 
between extremely dilute and dilute polymer solutions. C
* 
is the concentration at 
which polymer molecules begin to overlap (Dondos et al, 1992; 1993).  
 
1.7.2 Polymer adsorption at the air-liquid interface 
Polymers such as the cellulosics are surface active due to presence of partially 
charged groups on the cellulose backbone (Mezdoura et al, 2007; Nahringbauer 
1995; Um et al, 1997; Pereza et al, 2008). The resultant surface activity of the 
polymer is dependent upon its concentration, with high polymer concentrations 
reaching equilibrium very quickly (seconds), while low polymer concentrations 
reach equilibrium much slower (hours). Variation in the surface tension of the 
polymer solution with time follows a sigmoidal curve (Figure 1.25). 
 




Figure 1.25: Evolution of surface tension of hydroxypropyl cellulose (HPC) in water 













 g/L at 20 °C (Mezdoura et al, 2007). 
 
Three distinct phases in the conformation of the polymer chains are observed during 
the aging of the liquid surface.   
Induction period: 
The first phase is the induction period in which the surface tension does 
not change. This indicates that there is an energy barrier to the adsorption 
of polymer at the air-liquid interface. 
Surface coverage:  
A rapid decrease in surface tension occurs as the polymer starts to adsorb 
at the liquid surface. In this region, the kinetics of absorption depends on 
the surface coverage. Polymer adsorption at the surface occurs via: (i) 
transport of the molecules from the bulk to the subsurface by diffusion, 
(ii) spreading or unfolding of the adsorbed molecules, (iii) attachment of 
molecules/polymer segments from the subsurface to the surface, (iv) 
rearrangement of the adsorbed molecules/polymer segments between the 
surface and the subsurface. Here, the subsurface represents the very thin 
region of the bulk solution immediately next to the surface 
Macromolecules adsorbed at the air–water interface appear as trains, 
loops, and tails. Trains are sequences of macromolecule segments in 
actual contact with the surface, whereas loops and tails are sequences of 
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macromolecule segments located in the solution. Loops have both ends 
connected to trains, whereas a tail occurs at one or both ends of the 
macromolecule chain (Nahringbauer 1995). The reduction in surface 
tension depends on the number of train segments adsorbed at the surface. 
This means that the surface properties of a macromolecule depends upon 
the length and distribution of trains, loops, and tails 
Mesophase region:  
The last region is the mesophase region at which there is no change in 
surface tension. Here, the system is in equilibrium and only reordering of 
the polymer segments within the surface layer takes place.  
 
1.7.3 Polymer adsorption at the liquid-solid interface 
Polymer adsorption onto a solid surface occurs when the polymer-solid interactions 
are more favourable than those between the polymer-polymer and the polymer-
solvent. Polymers are composed of many monomer units therefore a slight attractive 
force between the monomer and solid surface is amplified many times in the 
polymer (Rao et al, 2003). Note that polymer adsorption can be governed by 
electrostatic interactions, hydrogen bonding, van der Waals and hydrophobic forces 
(Duro et al, 1999).  
The adsorption energy parameter (xs) is a dimensionless unit used to assess the 









                                      (Equation 1.8) 
 
where xs is the adsorption energy parameter, us is the adsorption energy of solvent 
molecule, up is the adsorption energy of polymer molecule, k is a constant and T is 
temperature. 
 
Adsorption can only occur when xs is greater than zero. For a value of xs less than or 
equal to zero, polymer adsorption cannot occur since the gain in the free energy is 
not sufficient to compensate for the loss of translational entropy of the chains upon 
adsorption. 
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An isolated neutral polymer chain next to a surface adsorbs in form of loops, trains 
and tails. The points of attachment to the solid are known as trains, separated by the 
non-adsorbing segments – known as loops and tails. Adsorption of polymers is 
characteristically different from that of small molecules due to the large number of 
possible conformations that can be attained upon adsorption (Figure 1.26). The 
structure of an adsorbed film depends upon the inherent characteristics of the 
polymer as well as the quantity of polymer adsorbed. At low levels of coverage the 
polymer chains predominantly lie flat forming ‗trains‘ at the surface, while at high 
levels of coverage the hydrophilic groups project towards the aqueous phase forming 




Figure 1.26: The different polymer adsorption mechanisms: (a) adsorption of a 
homopolymer, where each monomer has the same interaction with the substrate. The 
‗tail‘, ‗train‘ and ‗loop‘ sections of the adsorbing chain are shown; (b) grafting of an 
end-functionalized polymer via a chemical or a physical bond, and; (c) adsorption of 
a diblock copolymer where one of the two block is attached to the substrate surface, 
while the other is not (Netz 2003). 
 
Polymer adsorption isotherms generally display a high affinity of the polymer for the 
surface and a plateau level in the order of a few mg/m
2
. Polymer adsorption onto a 
solid surface tends to increase with decreasing solvent quality and increasing 
temperature or polymer concentration. In theta solvents, polymer adsorption 
increases with polymer molecular weight, regardless of whether the polymer has a 
low or high molecular weight.  
Adsorption kinetics are dependent on polymer molecular weight with low molecular 
polymers adsorbing first, but being replaced by better adsorbing higher molecular 
polymers. 
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Adsorption energy depends on both the nature of the solvent and the surface, as well 
as the competition between the polymer and solvent for binding sites. Polymer 
adsorption can often be accompanied by a change in the conformation of the chain 
compared to that in the bulk (Netz 2003).  
 
1.8 Polymer-surfactant mixtures 
 
1.8.1 Polymer-surfactant systems and properties 
Polymer-surfactant systems have widely been used in cosmetology, mineral 
processing, petroleum, detergency, paint, pharmaceutical industries among other 
fields. The synergy between polymers and surfactants is often used to achieve the 
desired result. Polymers and surfactants associate in solution thus modifying its 
solution, rheological and interfacial properties. Interactions in these systems are 
governed by the charge, hydrophobicity, hydrophilicity, size and concentration of 
both polymer and surfactant. Electrostatic charge is the most important characteristic 
forming the basis for classification of polymer-surfactant systems (Table 1.5). 
 















































































From the nature of the ionic charges, the polymer-surfactant system interactions can 
be deduced. No or minimal interaction is expected in polymer-surfactant systems 












) as well as cases in 
which the polymer is rigid and sterically hindered. 








), complexes are 
formed due to mutual electrostatic interactions. Single surfactant molecules may be 
bound linearly along the polymer chain or onto multiple polymer sites leading to 
intra/intermolecular bridging. 
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) are governed by the 
polymer molecule wrapping its self around the surfactant micelles. The polymer 
chains are known to partially penetrate the polar head group of micelles, reducing 
their water content, forming a ‗pearl necklace‘ arrangement. Techniques such as 
NMR, neutron scattering, fluorescence spectroscopy have been used to elucidate 
structure of polymer-surfactant complexes. 
 
1.8.2 Polymer-surfactant adsorption at the air-liquid interface 
Surface tension can be used to study polymer-surfactant interactions at the air-liquid 
interface with characteristic changes in the surfactant adsorption isotherm being 
observed in the presence of different types of polymer (Goddard 2002). These 
variations in surface tension are dependent on the charge and concentration of both 
the polymer and surfactant in solution. 
 
Weakly interacting systems 








) are mainly 
governed by ‗weak‘ hydrophobic forces. In such systems, three transition/break 
points in the surface tension (T1, T2 and T3) are observed (Figure 1.27). The first 
break point (T1), which occurs at a concentration lower than the surfactant cmc, is 
known as the critical aggregation concentration (cac). At this concentration, mixed 
complexes comprising of surfactant micelles and polymer are formed in the bulk 
solution. The cac typically occurs at a lower concentration than the cmc, implying 
that polymer-surfactant complexation is energetically more favourable than 
micellisation. At T2 the polymer chains are saturated with surfactant micelles, any 
more surfactant added to the system is not bound onto the polymer chains and thus 
leads to further decrease in surface tension. T2 is not very well defined in most cases. 
The interval between T1 and T2 increases with polymer concentration/chain length. 
T3 denotes the ‗normal‘ cmc, at which time normal surfactant micelles are formed 
after saturation of the polymer chains with surfactant (Bell et al, 2007, 2010; Taylor 
et al, 2007).  
 





Figure 1.27: Variation in the surface tension of an anionic surfactant solution with 
surfactant concentration in absence (
__
) and presence (---) of a weakly interacting 
neutral polymer (Bell et al, 2007). 
 
Anionic surfactant-neutral polymer systems have been widely investigated in 
literature by a number of authors including Chari et al (1991) and Sesta et al (1997) 
who investigated the anionic surfactant, sodium dodecyl sulphate (SDS) and the non-
ionic polymer, polyvinylpyrrolidone (PVP); Hou et al (1999) and Bahadur et al 
(1995) who studied the anionic surfactant, sodium dodecyl sulphate (SDS) and the 
non-ionic polymer, polyethylene oxide (PEO). Less literature is available on 
interactions in mixed cationic surfactant and neutral polymer systems. 
 
Strongly interacting systems 
Strong electrostatic interactions are observed between oppositely charged ionic 








). Surface tension curves of these systems may 
show a peak due to competition between the bulk polymer-micelle complex and the 
polymer-surfactant monomer complex (Taylor et al, 2007). Five surface active 
species namely; surfactant monomer, free surfactant micelle, free polymer chain, 
polymer-surfactant monomer complex and polymer-surfactant micelle complex, are 
all involved in determining surface activity. In the literature concerning weakly 
interacting polymer-surfactant systems, there is less mention of the polymer-
surfactant monomer complex with focus being on the polymer-surfactant micelle 
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The surface tension curve of the cationic surfactant, tetradecyltrimethylammonium 
bromide (C14TAB), and the anionic polymer, sodium poly(styrene sulfonate), 
exhibits four break points, namely T1-T4 (Figure 1.28).  
 
 
Figure 1.28: Schematic diagram showing the changes in surface tension with 
changing surfactant concentration in a strongly interacting cationic polymer-anionic 
surfactant system (Bell et al, 2010). 
 
T1 corresponds to the saturation of the polymer-monomer complex at the surface, T2 
and T3 to the formation and saturation of the polymer-micelle complex in the bulk 
(and corresponding dissolution of the polymer-monomer complex at the surface), 
respectively while T4 corresponds to the formation of free surfactant micelles in the 
bulk (Bell et al, 2007; 2010; Taylor et al, 2007). Reports of strongly interacting 
systems in the literature include; the anionic surfactant, SDS, and the cationic 
polymer, polydimethyldiallylammonium chloride (Staples et al, 2002), the cationic 
surfactant, C14TAB, and the anionic polymer, NaPSS (Bell et al, 2010), the cationic 
polymer polyvinylpyridium chloride (PVPmCl) and the anionic surfactant, SDS, 
(Taylor et al, 2002) among others. 
The peak (T3) in surface tension is not observed with all strongly interacting 
systems. The appearance of a peak is dependent on the stability of the polymer-
monomer and the polymer micelle complexes, the polymer concentration as well as 
the surface active parameters of the surfactant and the polymer-monomer complex 
(Bell et al, 2010). 
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1.8.3 Polymer-surfactant adsorption at the liquid-solid interface 
Polymer/surfactant adsorption onto solid surfaces has been studied using various 
experimental techniques including neutron scattering, nuclear magnetic resonance, 
photon correlation spectroscopy, fluorescence spectroscopy, atomic force 
microscopy, microscopy among others (Goddard 2002). 
Adsorption kinetics of polymer/surfactant mixtures at the liquid/solid interface 
largely depends on the interplay of polymer-surfactant-substrate interactions, their 
concentration in the bulk solution as well as the order of addition of the various 
components (Claesson et al, 2003). Cooperative or/and competitive polymer-
surfactant adsorption may occur in any particular system.  
 
Order of addition 
Two distinct scenarios can be envisaged; one in which surfactant/polymer is pre-
adsorbed onto substrate before the addition of the second component and the other in 
which polymer-surfactant complexes are preformed in bulk solution before 
introduction of a substrate.  
Interesting surface modifying effects have been observed with polymer/surfactant 
mixtures whereby one entity is preadsorbed. Preadsorbtion of a polymer/surfactant 
on a solid surface may lead to co-adsorption of the corresponding entity, even when 
the latter does not usually adsorb on that surface. For example non-ionic polymer 
PEO does not usually adsorb on alumina but in presence of pre-adsorbed SDS it 
does. Similarly SDS does not adsorb on silica, however if the non-ionic polymer, 
polyethylene oxide, is pre-adsorbed on silica, SDS will subsequently be adsorbed 
(Maltesh et al, 1992). 
In cases where the polymer and surfactant are premixed and their complexation 
occurs in bulk solution, their adsorption onto the solid depends on the competition 
between the formation of the polymer/surfactant complexes in the bulk and on the 
nature of the solid surface. Kronberg et al (1986) observed that low amounts of 
polyacrylic acid inhibited the adsorption of polyethylene oxide onto kaolinite, while 
higher amounts of the polymer enhanced surfactant adsorption. In a different study, 
Otsuka et al (1994) observed the opposite effect. The adsorption of the non-ionic 
polymer, PVP, in the presence of the anionic surfactant, lithium dodecyl sulphate 
(LiDS) on alumina was enhanced at low LiDS concentrations and decreased at 
higher surfactant concentrations. This observation was attributed to the preferential 
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formation, at higher surfactant concentrations, of LiDS-PVP complexes in the bulk 
solution as opposed to on the solid surface. 
 
Polymer-surfactant interactions 
Polymer-surfactant combinations, which exhibit weak interactions in bulk, may 
compete for adsorption e.g. the competitive adsorption of the non-ionic polymer, 
polyethylene oxide, and the cationic surfactants, dodecyltrimethylammonium 
bromide and 1,2-bis(dodecyltrimethyl ammonio) ethane dibromide, on silica studied 
by Esumi et al (1998). On the other hand, if the polymer-surfactant combinations 
interact strongly in the bulk, the simultaneous adsorption of polymer and surfactant 
will be favoured e.g. the system consisting of the non-ionic polymer, PVP, and the 




Particle size analysis 
Particle size is the most fundamental property used to describe any nanosized 
formulation. If defined as a ‗characteristic linear dimension‘, it is largely an 
ambiguous quantity for non-spherical particles, as size obtained depends on the 
physical response of the instrument used to measure particle size in relation to the 
size and shape of the particles (Shekunov et al, 2006). Huge discrepancies in the 
particle sizes obtained are often observed among different techniques or instruments. 
 The concept of equivalent particle diameters was therefore evolved to try and solve 
this challenge. Equivalent particle diameters are diameters of calibrated spheres that 
yield the same size when analysed under the same conditions as the irregularly sized 
particles. Equivalent particle diameters may be geometrical e.g. surface area, volume 
or behavioural e.g. sedimentation, inertia (Figure 1.29). 
 





Figure 1.29: Figure illustrating a range of equivalent particle diameters from Rawle 
(2002). 
 
With the exception of microscopy, which is a direct measure of size, a variety of 
indirect techniques utilising the concept equivalent diameters are available for 
particle sizing (Table 1.6). When measuring particle size it is usually advisable to 
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Table 1.6: Characteristics of some commonly used particle sizing techniques from 
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0.5-10 Mass -weighted 
a: particle size distribution. 
 
1.9.1 Photon correlation spectroscopy  
Photon correlation spectroscopy (PCS) is also known as dynamic light scattering or 
quasi-elastic light scattering. Colloidal particles in solution undergo random 
‗Brownian‘ motion due to constant bombardment by the solvent molecules 
surrounding them. The motion of particles is inversely proportional to particle size 
with small particles moving faster and further than large particles in the same time 
period. The velocity of Brownian motion is defined as the translational diffusion 





)(                                                     (Equation 1.9)                                                                                                




where d(H) is the hydrodynamic diameter, D is the translational diffusion 
coefficient, kB is the Boltzmann‘s constant, T is the absolute temperature in degrees 
Kelvin and η is the liquid viscosity. 
 
PCS measures the apparent hydrodynamic radius of the particles dispersed in 
solution, by assessing the variation in the intensity of light scattering with time using 
an auto correlator. For large particles, which result in slow fluctuations in the 
intensity of the scattered light, the correlation persists longer than that of smaller 
particles, which result in rapid intensity fluctuations of the scattered light. A 
monodisperse population of particles produces an autocorrelation function in the 
form of a single exponential decay. Mixtures of particles of more than one size 
population produce an autocorrelation function that is the sum of exponentials. 
Algorithms, e.g. non-negatively constrained least squares (NNLS) and CONTIN 
(Tscharnuter 2000), are available to extract the "true" size distribution from complex 
samples. 
 
BAeC t  2)(                                         (Equation 1.10) 
 
where C ( ) is the autocorrelation function, and A, B are instrumental constants. 
  
Dq 2                                                      (Equation 1.11) 
 













q                                          (Equation 1.12) 
 
where n is the refractive index, θ is the scattering angle and λ is the laser wavelength. 
 
The main components of a PCS instrument include the laser, which provides the 
light source, a cell in which the sample is placed, a detector to measure the 
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fluctuations in scattered light, an attenuator to reduce the intensity of light scattering 
with concentrated samples, an autocorrelator for digital processing of the scattered 
light signal and finally a computer software package to analyze this data and derive 
particle size (Figure 1.30). 
 
 
Figure 1.30: Main components of a photon correlation spectrometer. 
 
PCS is widely used for particle sizing because it is rapid and requires a (relatively) 
small amount of sample. Furthermore it is an absolute method were size is obtained 
from first principles and can be performed in a variety of suspending liquids. 
Drawbacks are that the technique does not typically provide any particle shape 
information, nor does it produce a high resolution histogram of size distribution, 
while small quantities of dust can make measurements and interpretation difficult 
(Tscharnuter 2000). In addition, the particle size obtained by PCS is affected by 
factors such as temperature, viscosity, and the ionic strength of media, all of which 
must be taken into account during the measurement and subsequent analysis.  
 
 
   Chapter 1 Introduction 
86 
 
1.9.2 Scanning electron microscopy  
Microscopy is the only particle sizing method that allows for the direct observation 
of particle size, shape and surface. Scanning electron microscopy (SEM) employs a 
high energy beam of electrons under vacuum conditions thereby allowing for very 
high magnification and image resolution. It can efficiently detect clusters and 
agglomerates of particles in a sample. 
SEM can be used to scan large areas of sample using magnification ranges that can 
be changed rapidly. It also has the advantage of possessing a large depth of focus due 
to small probe aperture and can utilise various contrast mechanisms e.g. magnetic or 
voltage contrasts (Newbury et al, 2000).  
Drawbacks of SEM include errors due to insufficient particles being measured to 
give a representative size and possible sample artefacts due to the vacuum 
conditions.  
 
1.9.3 X-ray powder diffraction  
X-ray diffraction (XRD) is a non-destructive technique that is used for 
characterisation, quantification and identification of crystalline substances. 
Crystalline substances comprise an orderly periodic arrangement of atoms, with a 
unit cell being the basic repeating unit. 
When X-rays come in contact with a substance, they may be reflected, transmitted, 
absorbed, scattered or diffracted. Diffraction is defined as the constructive 
interference of coherent scattering and occurs when Bragg‘s law (Equation 1.13) is 
satisfied (Figure 1.31).  
 
 sin2dn                                                    (Equation 1.13) 
 
where n is an integer number, λ is the wavelength of the electromagnetic radiation, d 
is the distance between the atomic layers in the crystal (d-spacings) and θ is the 
angle of incidence. 
 





Figure 1.31: Geometric derivation of Bragg‘s law: Constructive interference occurs 
when the delay between waves scattered from adjacent lattice planes given by a1 + 
a2 is an integer multiple of the wavelength λ (Stanjek et al, 2004). 
 
Crystalline substances act as three-dimensional diffraction gratings for X-ray 
wavelengths similar to the spacing of planes in a crystal lattice. The characteristic d-
spacings and their intensity provides a ‗fingerprint‘ for crystalline substances, while 
the presence of non crystalline (disordered nanocrystalline, glassy or amorphous) 
material is observed as a specific wide ‗halo‘ on the diffraction pattern.  
The occurrence, in the diffraction pattern, of peak broadening without a change in 
peak position or intensity is characteristic of a disordered nanocrystalline material 
and is related to loss of long range order in a crystalline microstructure. With glassy 
materials, the position of the diffuse halo moves in respect to its parent crystalline 
peaks although the overall intensity envelope is maintained. Amorphous materials 
present as broad diffuse halos, which are not correlated in position or intensity 
envelope to the parent crystalline peaks (Bates et al, 2006). 
A diffractometer consists of an x-ray beam source, sample holder, and an x-ray 
detector. X rays are typically generated by heating a filament in a cathode ray tube in 
order to produce electrons of high energy which are then accelerated to a target 
material. The specific wavelengths of x-rays produced are characteristic of the target 
material (Cu, Fe, Mo, Cr). Beam optics are then used to filter, collimate and direct 
the monochromatic x-rays to the sample. A goniometer is used to rotate the sample 
and detector through a range of 2 θ angles such that all possible diffraction directions 
are attained. The detector then records the x-ray signal, which is then processed as a 
count rate. 
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1.9.4 Viscosity  
Viscosity is the resistance of a fluid to flow. It is normally determined by measuring 
the time taken for a liquid to flow through a capillary of a defined length and width 
at a specific temperature relative to a standard solution, frequently water. 





rel                  (Equation 1.14) 
 






relsp                                                (Equation 1.15) 
 
Reduced viscosity is given by the Huggins equation 
 














                                          (Equation 1.16) 
where kH is Huggins constant, c is concentration and (
c
sp
) is reduced viscosity. 
 
Inherent viscosity is calculated using the Kraemer equation:  
 













                                    (Equation 1.17) 
 
where kK is Kraemer constant, c is concentration and (
c
relln ) is inherent viscosity. 
 














                               (Equation 1.18) 
 




Intrinsic viscosity is related to polymer molecular weight by the Mark Houwink 
equation (Mc Crackin 1987):  
 
 km                                                                               
(Equation 1.19) 
 
where η is intrinsic viscosity, m is the polymer molecular weight and k, α are 
polymer dependent constants. 
 
1.9.5 Surface tension 
Liquid molecules near the air surface interact with fewer liquid molecules as 
compared to those in bulk. As a consequence molecules at the interface of a liquid 
tend to experience an inward force resulting in the spontaneous curvature of the 
surface. This inward force corresponds to surface tension and is determined by the 
amount of work needed to increase the surface area by one m
2
. 
Surfactants reduce the surface tension of liquids by adsorbing at the air-liquid 




dd                                                  (Equation 1.20) 
 
where d is the change in surface tension, i  is surface excess concentration of i, 
and id is change in chemical potential of i. 
 
At equilibrium:  
 
ii aRTdd ln                                                        (Equation 1.21) 
 
where ai is the activity of i in the bulk phase given by the molar concentration of the 












ln                                                (Equation 1.22) 
 
where C is molar concentration of the surfactant 
 
The slope of surface tension against surfactant concentration can be used to 















                             (Equation 1.23) 
 





is the slope of surface 
tension reduction versus log surfactant concentration in premicellar region, R is the 
gas constant (8.314 J/Kmol) and T is temperature in K. 
 







A                                                           (Equation 1.24) 
 
where A is the area per surfactant molecule in Å
2, Γ is surface excess concentration 
(mol m
-2






The area per surfactant molecule provides information about the degree of packing 
and orientation of the adsorbed surfactant molecules. 
 
1.9.6 Optical rotatory dispersion 
Chiral substances rotate the plane of polarized light due to different refractive 
indexes for left and right handed circularly polarized light. Optical rotatory 
dispersion (ORD) is defined as the rate of change in optical rotation with the 
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wavelength of light. The angle of rotation is dependent on the nature of substance, 
the thickness of sample, sample concentration, temperature and wavelength. This 
rotation may be clockwise (dextrorotary) or anti clockwise (levorotatory). 
The specific rotation of a compound is given by: 
 






                                          (Equation 1.25) 
 
where α is rotation in degrees, c is concentration in g/mL, l is pathlength in dm, T is 
temperature in °C and λ is wavelength in nm. 
 
Optical rotation of chiral substance in solution depends linearly on the pathlength 
and its concentration at low concentrations making it ideal for quantification. 
However, at high concentrations this linearity is lost due to intermolecular 
interactions such as association or dimerization. Molecular rotation is used to 
compare optical activity of different substances (Schreier et al, 1995).  
The molecular rotation of a compound is given by: 
 
   
100
M
M TT                                      (Equation 1.26) 
 
where α is the rotation in degrees, M is the molecular weight of compound, T is the 
temperature in °C and λ is the wavelength in nm. 
 
The basic set up of a polarimeter is shown in Figure 1.32. Major components include 
a monochromator, two polarizers (a fixed one before the sample and another after the 
sample which can be rotated relative to the first), a sample holder and a detector. The 
angle between the two polarizers is measured. 
 





Figure 1.32: Basic set up of a polarimeter. 
 
1.9.7 Zeta potential 
When an electric field is applied across an electrolyte, any charged particles 
suspended in the electrolyte are attracted towards the electrode of opposite charge. 
Viscous forces acting on the particles tend to oppose this movement. When 
equilibrium is reached between these two opposing forces, the particles move with 
constant velocity. The velocity of a particle in a unit electric field (referred to as its 
electrophoretic mobility) is dependent upon the strength of the electric field or 
voltage gradient, the dielectric constant of the medium, the viscosity of the medium 
and the zeta potential (Li et al, 2007). 
 
 Zeta potential is related to the electrophoretic mobility by the Henry equation:  
 






U E                                               (Equation 1.27) 
 
where UE is the electrophoretic mobility, z is the zeta potential, ε is the dielectric 
constant, η is viscosity, κ is the Debye length (often taken as a measure of the 
―thickness‖ of the electrical double layer), a is the particle radius and f(κa) is 
Henry‘s function. 
 
Electrophoretic determinations of zeta potential are most commonly made in 
aqueous media and at moderate electrolyte concentration. If f(κa) is 1.5, as with 
particles (> 200 nm) dispersed in moderate electrolytes (> 10
-3
 molar salt), 
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calculation of zeta potential from the mobility is carried out using the Smoluchowski 
model. For small particles in low dielectric constant media (e.g. non-aqueous media), 
f(κa) becomes 1.0 and the Huckel approximation is used to calculate zeta potential. 
Equipment for measuring zeta potential comprises of six main components, namely 
the laser which provides the light source, a cell in which the sample is placed, a 
detector to measure the scattered light, an attenuator to reduce the scattered light 
intensity when measuring concentrated samples, a digital processor to compile the 
scattered light signals and finally computer software to analyze fluctuations of 
scattered light from which electrophoretic mobility and hence zeta potential are 
calculated. 
 
1.9.8 Contact angle 
The surface energetics of a solid is related to its wettability via the Young‘s 
equation. Wetting of a solid surface involves the replacement of corresponding 
liquid-vapour and solid-vapour interfaces by a liquid-solid interface. The contact 
angle formed by a drop of liquid on a horizontonally positioned, planar, chemically 
inert, homogeneous solid surface represents an equilibrium between the solid vapour 
interfacial tension (γ SV) favouring wetting, alongside the solid liquid (γ SL) and the 





Figure 1.33:  Schematic diagram of drops of liquid (L), with increasing contact 
angles (Θ), on a solid surface (S) showing the solid vapour (γ SV), solid-liquid (γ SL) 
and liquid-vapour (γ LV) interfacial tensions acting on them (Wong et al, 2009).  
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Complete wetting is observed at a contact angle of 0
°
, while complete non-wetting 
occurs at an angle of 180
°
. The rate/speed of wetting is dependent on factors such as 
capillary forces, the viscosity of the liquid, thermal conditions of the system and 
reactions occurring at the liquid-solid interface (Attwood et al, 1983). 
Young‘s Equation represents the condition at equilibrium when no further spreading 
occurs: 
 
 cosLVSVSL             (Equation 1.28)  
where γ SV, γ SL and γ LV are respectively, the solid vapour, solid-liquid and liquid-
vapour interfacial tensions and θ is the contact angle. 
 
The contact angle and γ LV can easily be determined, leaving two unknown 
parameters in Equation 1.28, that is γ SL and γ SV. Surface tension is postulated to be 
composed of two components namely dispersive and polar interactions (Kwok et al, 
















 are the dispersive and polar components of the solid surface 
energy and liquid surface energy respectively. 
 
Combining equations 1.28 and 1.29 gives the Owens-Wendt equation (Owens et al, 
1969) below:  
 






SLV  22cos1          (Equation 1.30) 
 




 by measuring the contact angles of 
two or more different liquids (with known γL
d, γL
p
) on the same solid and solving the 
equations simulatenously. 
The sessile drop technique allows the direct measurement of contact angle. Basic 
equipment includes a light source, sample stage, lens and image capture device. A 
‗back-lit‘ drop of liquid deposited on a solid is imaged and the angle formed at solid-
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liquid interface estimated either manually or by computerized image analysis. The 
sessile drop method has been widely used in pharmaceutical wetting studies. Its 
advantages include minimal sample requirements (both liquid and solid), versatility 
and ease. 
The main setback when attempting to measure contact angle is encountered when the 
drop is absorbed by porous substrates leading to erroneous results. Saturation of the 
solid phase with the wetting liquid has been used to try and counteract this 
absorption, although its success is debatable. 
 
1.9.9 X-ray photoelectron spectroscopy 
X-ray photoelectron spectroscopy (XPS) is a surface chemical analysis technique in 
which the surface of a solid sample is bombarded with high energy X-ray photons in 
ultra high vacuum, resulting in the photoemission of core level electrons. Core level 
electrons are those electrons close to the nucleus that have binding energies 
characteristic of a particular element. The kinetic energy of the ejected electrons is 
analysed by an electron detector, allowing their binding energies to be calculated 
according to the following equation: 
 
 KEpBE EvhE                                                (Equation 1.31) 
where EKE is the kinetic energy of the ejected electrons, EBE is the binding energy of 





 kg/s) and v is the frequency of the electromagnetic radiation. 
XPS data is presented as a graph of electron current (intensity) against electron 
binding energy to give an X-ray induced photoelectron spectra. Electrons that are 
ejected without energy loss contribute to the characteristic peaks in the spectrum, 
whereas those that undergo inelastic scattering or energy loss form the background 
of the spectra. Since the binding energies of core level electrons are unique to 
elements present in a sample, XPS can detect chemical functionalities with extreme 
sensitivity (Tougaard 2005). Though X-rays may penetrate bulk, the ejected 
electrons cannot escape from within a few nanometres of the surface, limiting XPS 
to surface characterisation (to a depth of ~1-10 nm). 
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The binding energies of core level electrons for organic compounds are typically 
between 200-700 eV. These core level electrons have specific binding energies 
depending on their chemical state. For instance while the binding energy of 
unfunctionalised carbon in an aliphatic hydrocarbon is 285.00 eV, a chemical shift 
occurs in presence of adjoining functionalities to the main carbon such as in amines, 
alcohols or carbonyls to give higher binding energy values of 285.94, 286.55 and 
287.90 eV respectively. 
X-ray photoelectron spectrometers consist of a moderate vacuum sample 
introduction chamber, an ultra-high vacuum measurement chamber, the specimen 
holder, specimen manipulators, a source of X-rays or electron beam as well as an 




Figure 1.34:  Schematic diagram of an X-ray photoelectron spectrometer. 
 
1.10 Work plan 
 
1.10.1 Current problem 
Formulation of poorly water-soluble drugs poses a significant challenge to the 
pharmaceutical industry. These drugs often have sub-optimal clinical outcome due to 
poor dissolution and bioavailability, high fed to fasted variability as well as high 
inter patient variability. Over the years many methods including micronisation, 
complexation and solubilisation have been used in an attempt to increase their 
dissolution rate and consequently their bioavailability.  
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Recent technological advancements and understanding of colloidal systems has 
enabled the formulation of poorly water-soluble drugs as nanoparticles. Various 
techniques such as media milling, homogenization, precipitation and supercritical 
fluid processing have been employed to obtain drug nanoparticles. Media milling has 
had the most favourable outcome with five drugs formulated in this way reaching the 
market (van Eeerdenburgh et al, 2008; FDA 2009). Media milling is a relatively 
simple technique that can be conveniently employed for screening purposes by the 
researcher. Wet-bead milling achieves particle size reductions of drug to within the 
nanometer size range using a high impact bead mill to fracture drug particles 
dispersed in a crude concentrated suspension in presence of stabilisers (Kipp 2004 
and Merisko-Liversidge et al, 2003; 2008). 
Despite its success, mastery of the mechanism behind nanoparticle stabilization is 
lacking. Selection of stabilisers for a particular formulation is an empirical process 
involving a lot of trial and error. This is compounded by the fact that each drug 
demonstrates a unique stabilisation profile, which may vary according to the 
production process employed (Verma et al, 2009).  Previous attempts to relate drug-
stabilizer interactions to stabiliser surface tension and viscosity or drug log P, 
solubility and density have not been successful (van de Eerdenburgh et al, 2009). 
The current research aims to elucidate the mechanism of nanoparticle stabilisation 
and enable prediction of suitable stabilisers for drug formulation by wet bead 
milling. Eight, structurally disimilar, low water solubility drugs and a range of ionic, 
non-ionic polymers and surfactants were used to investigate the relationship between 
the drug and the stabilizer. Furthermore, the effect of stabilizer concentrations on 
nanoparticle production, stability and adsorption kinetics were determined. 
 
1.10.2 Drug selection 
Screening drug-stabiliser relationships for nanoparticle production via wet bead 
milling was carried out using eight poorly water-soluble drugs namely; albendazole, 
carbamazepine, frusemide, griseofulvin, halofantrine, indomethacin, nabumetone 
and phenytoin (Table 1.7). The majority of these drugs exhibit poor water-solubility 
but high permeability (BCS ІІ), except frusemide, which displays both low water-
solubility and permeability (BCS ІV). The selected drugs are structurally different 
and include acids (indomethacin, phenytoin), bases (albendazole, frusemide, 
halofantrine) and neutral compounds (carbamazepine, griseofulvin, nabumetone). 
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Pharmaceutically acceptable stabilisers employed in this screen included anionic, 
cationic, non-ionic polymers and surfactants. 
Albendazole is a broad spectrum antihelminthic, carbamazepine and phenytoin are 
both anticonvulsants, frusemide is a diuretic, griseofulvin an antifungal, halofantrine 
an antimalarial while indomethacin and nabumetone are both non steroidal anti-
inflammatory drugs. These drugs undergo slow and erratic dissolution leading to 
unpredictable performance, thereby necessitating high drug dosing which increases 
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Table 1.7: Chemical structure and properties of selected drugs. Table continued on 
next page. 
 



























236.28 190-192 18 μg/mL 
at 25°C 















330.74 295 70 μg/mL 
at 30°C 











352.77 220 64 μg/mL 
at 25°C 
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536.9 199-202 < 1.0 
μg/mL at 
25°C 









357.79 151-155 0.94 
μg/mL at 
25°C 




   
O
O  
228.3 78-83 4.7 
μg/mL at 
25°C 
  ІІ 
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Table 1.7: Chemical structure and properties of selected drugs. Table continued 
from previous page. 
 
 
The majority of the work outlined in this thesis was carried out using griseofulvin, 
which was found to only be stabilised in presence of either an anionic polymer or 
surfactant. The major indication for griseofulvin is in treatment of various 
dermatomycosis. It has been the choice agent in stubborn fungal infections for many 
years. Interest in this drug is re-emerging due to reports of anti-inflammatory activity 
and synergy with some chemotherapeutic agents. Griseofulvin is available in tablets 
of 500 mg, 250 mg, 125 mg and in the form of a paediatric suspension. Previous 
research demonstrated that micronization of griseofulvin led to a 50% reduction in 
dose (Atkinson 1962). All griseofulvin formulations have since been micronized. 
Recent attempts to improve the formulation of griseofulvin have included use of self 
micro-emulsifying drug delivery systems (Ofokanski et al, 2009), solid dispersions 
(Stachurek et al, 2009), micellar solubilisation (Pierri et al, 2005), complexation with 
cyclodextrins (Kata et al, 1998) and supercritical fluid nanoparticle production 
(Thakur et al, 2005). None of these products have reached the market. 
 
1.10.3 Aims 
1. To understand the relationship between surfactant/polymer and drug 
structure on the formation of nanoparticles by wet bead milling. 
Screening for drug-stabiliser relationships was carried out using eight poorly water-
soluble drugs namely; albendazole, carbamazepine, frusemide, griseofulvin, 
halofantrine, indomethacin, nabumetone and phenytoin. Using pre-defined 














252.27 294 32 μg/mL 
at 22°C 
   ІІ 
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experimental parameters (Goodwin, 2006) a range of ionic and non-ionic polymers 
and/or surfactants were used to determine stabiliser efficacy for nanoparticle 
formation. The stabilisers used in the screen included aerosol-OT (AOT), sodium 
dodecylsulphate (SDS), hydroxypropylmethylcellulose acetate succinate 
(HPMCAS), hydroxypropylmethylcellulose (HPMC), hydroxypropylcellulose 
(HPC), hydroxyethylcellulose (HEC), polyvinylpyrorolidine (PVP) Pluronic F 127, 
Tween 80 and dodecyltrimethylammonium bromide (DTAB); chosen to determine 
the effect of stabiliser head group charge on nanoparticle stabilisation. An alternative 
approach would be to select a homologous series of stabilisers in order to determine 
the effect of hydrocarbon length on nanoparticle stabilisation. 
 
2. To determine the effect of polymer and/or surfactant concentration and 
polymer molecular weight on production of griseofulvin nanoparticles by wet 
bead milling. 
Griseofulvin, which could only be stabilised by either an anionic polymer or 
surfactant, was selected for all subsequent research. Unfortunately anionic stabilisers 
are unsuitable for oral delivery. Anionic surfactant/non-ionic polymer co-
stabilisation using the non-ionic polymer, HPMC, was therefore investigated with 
the view of reducing the amount of ionic surfactant required for nanoparticle 
production. Reports of polymer-surfactant synergy have been widely used in the 
cosmetology, mineral processing and other industries. The effects of varying 
surfactant/polymer concentration and polymer molecular weight on nanoparticle 
formation and stability were assessed.  
 
3. To ascertain the effect of polymer/surfactant concentration and polymer 
molecular weight on the amount of stabiliser adsorbed onto griseofulvin 
nanoparticles. 
In order to obtain an adequate understanding of stabilisation of colloidal systems it is 
imperative to quantify the stabiliser absorded onto these particles. Polymer/surfactant 
adsorption isotherms were studied by the depletion method using spectroscopic 
techniques. Adsorption was studied as a function of polymer/surfactant concentration 
and polymer molecular weight. Small angle neutron scattering was used to provide 
more detailed information on the adsorbed polymer/surfactant layer.  
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4. To investigate the crystal surface properties of the various drugs used. 
The majority of pharmaceutical drugs are crystalline solids. Each crystal face 
exhibits its own physical and chemical properties. Knowledge of surface properties 
of drug crystal faces may help predict its interaction with other molecules of interest, 
in this case polymer/surfactants used as stabilisers of drug nanoparticles. 
Macroscopic griseofulvin crystals were grown in acetone and surface energies of the 
individual crystal facets determined experimentally using contact angle 
measurements and X-ray photoelectron spectroscopy. 
Computer modelling was used to predict the morphology and facet-specific surface 
energies of the albendazole, carbamazepine, griseofulvin, indomethacin, frusemide 











































2.1.1 Wet bead milling 
Media milling has been used widely for fine and ultrafine milling of materials such 
as minerals, ceramics, paint pigments, plant products and microorganisms. Generally 
stirred media mills are preferred over tumbling and vibrating ball mills due to their 
lower energy consumption (Kwade 1999). These stirred, tumbling or vibrating media 
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mills are operated ‗wet‘ thus providing advantages of temperature regulation and 
product containment. 
Wet Bead milling (WBM) is also used in the pharmaceutical industry to formulate 
poorly water-soluble drugs as nanocrystalline particles in order to improve their 
bioavailability. Elan ‗Nanocrystal‘ technology, in which micron sized drug crystals 
are media milled in the presence of a solution of pharmaceutically acceptable 
stabilisers yielding nanometer sized drug particles, is employed. WBM efficiently 
overcomes the challenges of aggregation and powder clumping due to high van der 
Waals forces, which are associated with dry milling by incorporating stabilisers in 
the milling process. The nanoparticles are thus stabilised immediately on formation. 
The presence of effective and sufficient stabilisation is paramount for the success of 
the milling process.  
The stabiliser used should promote wetting and generate a physically stable form of 
the milled material by providing a steric or ionic barrier cancelling out the effect of 
the van der Waals forces at the surface of the particles. Stabilisers used include 
celluloses, pluronics, povidones, polysorbates, and combinations of ionic and non-
ionic surfactants. Physically stable nanocrystalline formulations have been widely 
reported to occur at within specific ranges of drug to stabilizer weight ratios, with 
lower amounts of stabiliser leading to aggregation, and higher amounts of stabiliser 
promoting Ostwald ripening (Merisko-Liversidge et al, 2003).
 
The geometrical shape 
of the resultant nanoparticles is determined by drug/stabilizer interactions, the 
morphology and the fracture plane of the drug crystals (Merisko-Liversidge et al, 
2003, 2008). 
 
2.1.2 Production of nanoparticles 
WBM is a highly versatile technique that can handle quantities of drugs from mg to 
kg, and thus can be used by the research scientist for formulation screening 
(Kesisoglou et al, 2007) as well as routine production of nanoparticles in the 
pharmaceutical industry. The studies outlined in the present study were carried out 
on a micro-scale using 10 g of drug per milling experiment. 
Operating parameters such as bead size, bead loading, drug loading and energy input 
all influence the milling efficiency (Kwade 1999; Fadhel et al, 2001). Sepassi (2003) 
in our group investigated the effect of varying these parameters. Energy input and 
drug loading were found to have the most dramatic effect on nanoparticle 
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production, with nanoparticles no longer being produced if either parameter was 
reduced. A high drug loading is critical to increase the chance of the beads impacting 
the drug particles (Rabinow 2004). 
The mixer mill used in the present study operates such that the contents of two jars 
are milled simultaneously, with the jars oscillating in the horizontal plane. During 
the milling process, the YTZ beads (milling media) bombard the drug particles from 
all directions breaking them down, mainly by impact and attrition. 
 
Milling induced disorder 
It is important to realise that the milling of pharmaceutical crystalline materials may 
introduce a degree of amorphicity into the material due to exposure to mechanical 
stresses during the processing. The physical properties of amorphous structure are 
dramatically different from those of crystalline structure in terms of flow, solubility, 
stability and bioavailability. It is therefore critical to verify if a process has 
introduced any amorphous material and, if so, to quantify the amount. Various 
analytical techniques such as powder x-ray diffraction (XRD), differential scanning 
calorimetry, isothermal microcalorimetry, solution calorimetry, solid-state nuclear 
magnetic spectroscopy, fourier transform raman spectroscopy and dynamic vapour 
sorption have all been used to quantify amorphous and crystalline content in solid 
drugs. Of these techniques, XRD is the most widely used due to its relative 
simplicity and ability to detect amorphous material down to levels of ~ 5% (Shah et 
al, 2006). Amorphous material indicates isotropic material without any translational, 
orientational or conformational characteristic of the crystalline state. Crystal defects 
on the other hand include point defects involving a few atoms, line defects 
comprising crystal lattice misalignments, planar defects characterised by change in 
crystallographic direction of the lattice and bulk defects (Chamarthy et al, 2008). 
Both the drug crystal morphology and the mill type used are known to have an effect 
on the degree of milling disorder induced (Chikhalia et al, 2005). 
 
Ostwald ripening  
Ostwald ripening occurs in polydisperse systems of particles, when smaller particles 
dissolve and recrystallize around the larger particles. As time increases, the number 
of particles decreases and the average size of the particles increases, although the 
volume fraction occupied by the particles remains constant. Ostwald ripening occurs 
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as a result of the system trying to reduce its interfacial energy by diffusion of the 
small particles to the surface of the larger ones (Yao et al, 1993). Ostwald ripening 
occurs to a higher extent when the particles have some degree of solubility in the 
disperse phase. 
Ostwald ripening is a disadvantage in nanoparticle formulations as the increase in 
particle size it causes negates the advantages conferred by particle size reduction. 
Ostwald ripening can be eliminated or reduced by the tight control of formulation 
parameters such as particle size, particle-size distribution, solids content, choice of 
stabilizer, and the use of a fluid phase with minimal solubilising potential of the 
dispersed phase (Merisko-Liversidge et al, 2008). 
Nanosuspensions of poorly water-soluble drugs (< 1 mg/mL) generated by media 
milling are generally stable on storage, although Ostwald ripening may occur over 
time or at increased temperatures, particularly when the nanosuspensions are 
prepared from more water-soluble (> 10 mg/mL) drugs (Gennaro 1995) or if excess 
stabiliser has not been removed from the nanosuspension. Ostwald ripening occurs 
as a consequence of uncontrolled precipitation or crystallization of drug leading to a 
growth in the overall particle size (Boistelle et al, 1988). 
 
2.1.3 Existing challenges 
Despite the relative success of WBM for the production of drug nanoparticle 
formulations, mastery of the stabilisation mechanism is still lacking. Selection of 
stabilisers for a particular formulation is still an empirical process entailing the use 
of time and money resources. The current chapter presents a systematic investigation 
into the effect of a range of stabilisers on the production by WBM of nanoparticles 
of eight poorly water-soluble drugs, namely albendazole, carbamazepine, frusemide, 
griseofulvin, halofantrine, indomethacin, nabumetone and phenytoin. The milling 
results are analysed for trends that would enable the prediction of stabilisers suitable 





Griseofulvin was purchased from Acros Organics (Geel, Belgium). Nabumetone was 
supplied by GlaxoSmithKline (Harlow UK) batch no. 00N60141. 
Hydroxypropylmethylcellulose (HPMC) with a nominal molecular weights of 8K 
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(Methocel E3LV (HPMC 8)) and 15K (E15 (HPMC 15000)) were obtained from 
Dow Company (Michigan, USA) and Colorcon Limited (Dartford, UK), 
respectively. Hydroxypropylmethylcellulose acetate succinate (HPMCAS), an 
anionic polymer comprising a mixture of acetic and monosuccinic acid esters of 
HPMC, was kindly donated by Shin-etsu Co. Limited (UK). It was supplied in three 
micronized grades differing in weight ratio of acetyl:succinoyl substitution, low LF 
possesses an acetyl:succinoyl weight ratio substitution of 8:15, medium MF, a 
weight ratio of 9:11 and high HF, a weight ratio of 12:7. Regardless of the weight 
ratio of acetyl:succinoyl, HPMCAS, whose trade name is AQOAT, had a weight-
average molecular weight of 18000 daltons. All other chemicals were purchased 
from Sigma-Aldrich Co. Limited (Poole, UK).  
Yttrium zirconia (YTZ) beads of size 0.44 mm (0.35-0.5 mm range), which have 
minimal contamination levels acceptable for pharmaceuticals (Ruddy et al, 1998), 
were obtained from GlaxoSmithKline (Harlow, UK). Ultra pure water (UPW), 
obtained from a well seasoned, all glass still (D4000 Distinction, Sterling, UK) was 
used for all experiments. All chemicals were of the highest grade available and were 
used as received without further purification. 
 
2.2.2 Preparation of crude drug suspensions 
Stabiliser solutions were prepared by weighing the required amount of polymer 
and/or surfactant and making up to weight with UPW. The only exception to this 
method was when using the water insoluble HPMCAS polymers, where the polymer 
was suspended in an aqueous 10 mM sodium citrate (alkaline) solution prior to its 
use in milling. Note that the dispersed HPMCAS polymer systems were sometimes 
turbid, although in these cases caution was exercised to ensure the effective 
dispersion of the polymer before the addition of the drug so that no solid particles of 
polymer remained. Regardless of the nature of the stabiliser used, its 
dispersion/dissolution was achieved by constant magnetic stirring. The HPMC 
polymer solutions were kept in the fridge for 2 hours prior to use to aid polymer 
dissolution.  
40 g of the initial stabiliser solution was added to 10 g of drug to make up 50 g of the 
crude drug suspension or slurry, which was stirred overnight prior to milling. A 20% 
w/w drug concentration in the crude suspension increased the chances of the YTZ 
beads impacting the drug particles during milling. The amount of stabiliser is quoted 
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hereafter as a weight percentage of the initial stabiliser solution before the addition 
of drug. 
 
2.2.3 Wet bead milling 
Wet bead milling was carried out using the Retsch MM 200 mixer mill (Glen 
Creston Ltd, Stanmore UK) illustrated in Figure 2.1. The milling parameters used in 
the present study were adapted from those of Sepassi-Ashtiani (2003) and utilised 
0.44 mm YTZ beads, a frequency setting of 30 Hz, a milling time of 6 hours and a 
50:50 vol % bead:slurry loading.
 
Specifically 10 mL of YTZ beads (0.44 mm 
diameter) followed by 10 mL of slurry (crude drug suspension) were loaded into a 
milling jar (Nylube, Nylecast,UK) of 25 cm
3 
capacity. The jar was then well sealed 
with sufficient parafilm and clamped into the mixer mill and milled at room 
temperature. The temperature of the milling jar contents would rise to ~ 45 ± 0.1°C 





Figure 2.1: Retsch MM200 Mixer Mill. 
 
Milling was stopped every hour, the jar opened and two drops of suspension 
collected and diluted with UPW for particle size analysis. The jars were then 
resealed with parafilm and the milling resumed. After 6 hours the YTZ beads were 
separated from the nanosuspension using a 60 mesh sieve (0.25 mm nominal 
aperture), the nanosuspension collected and stored for further analysis. The beads 
Frequency setting 
Milling jar 
Direction of oscillation 
Time setting 
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were then cleaned with copious amounts of water, rinsed in methanol, oven dried 
and re-used.  
 
2.2.4 Particle size analysis 
Photon correlation spectroscopy (or light scattering) was performed using a 
Brookhaven ZetaPlus particle sizer v2.29 (Brookhaven instruments, UK) consisting 
of a He-Ne laser operating at 677 nm, in order to determine the apparent 
hydrodynamic size (i.e. effective diameter) and polydispersity index (i.e. width of 
the particle size distribution) of the drug nanoparticles. The particle size range 
accessible with this equipment, as quoted by the manufacturer, is 10 nm to 10 µm 
depending on the particle density. 
The experiments were performed at 25 ± 0.1°C using a light scattering detection 
angle of 90°. Values for viscosity and refractive index of aqueous media were set at 
0.89 cp and 1.33 respectively. 2-3 drops of the drug nanosuspensions were added to 
10 mL water to give a suitable count rate (i.e. 50-80 kcps). The diluted 
nanosuspensions were placed in clear, 4-sided, 10 mm path length disposable 
polystyrene cuvettes for particle size analysis. Each measurement was performed for 
30 seconds with ten repetitions. Particle size analysis was performed every hour in 
order to follow the milling kinetics. For each formulation studied, three individual 
nanosuspensions were prepared and their size measured. Therefore results are 
expressed as the mean of three individual measurements ± the standard deviation.  
 
2.2.5 Zeta potential 
Zeta potential was measured using a Zetasizer Nano ZS (Malvern instruments, UK), 
which utilises the Malvern M3-PALS (phase analysis light scattering) technology to 
give high sensitivity, accuracy and resolution of measurements. The detection angle 
was large (173º) as the Zetasizer Nano ZS is a back scattering instrument. Zeta 
potential measurements were carried out both in presence and absence of excess 
polymer/surfactant. 
Experiments were performed at 25 ± 0.1°C in water and zeta potential calculations 
carried out using the Smoluchowski theory. 2-3 drops of the crude drug 
nanosuspensions were added to 10 mL water. The samples were placed in 
disposable, folded capillary cells with gold electrodes for analysis. Each 
measurement was carried out for 30 seconds with ten repetitions.  




Viscosity measurements were carried out using the AVS 350 unit (Schott-Gerate, 
Hofheim, Germany) coupled to the AVS 20 viscodoser for automated dilutions. A 
Ubbelohde dilution vessel with a fill volume of 75 mL and capillary length 290 mm 
was used. The viscometer was cleaned with copious amounts of soap and water, 
ensuring it was dry and dust free before any measurements were made. Six dilutions 
were preselected and the time for temperature equilibration after dilution and prior to 
measurement was set at 10 minutes. The initial, concentrated solutions for viscosity 
measurement were filtered using a 0.22 micron cellulose acetate membrane filter 
prior to introduction into the viscometer. In addition, the flow time of UPW was also 
measured. Flow measurements were made in triplicate. All viscosity measurements 
were performed at 25 ± 0.1°C.  
For polymer molecular weight determination, it is important to ensure that the 
relative viscosity (i.e. the flow time of the solution relative to the flow time of the 
solvent) of the diluted polymer solutions was in the range 1.1 to 2. In this dilute 
region intermolecular interactions are not operative and there is a linear variation 
between viscosity and concentration. The intercept of the Huggins and Kraemar plots 
on the y-axis yield the intrinsic viscosity, which is then used to calculate viscosity 
average molecular weight by means of the Mark Houwink equation.  
 
2.2.7 Surface tension 
Surface tension measurements were performed by the Wilhelmy plate method using 
the automated K11 tensiometer (KRUSS GmbH Hamburg, Germany). A roughened 
platinum plate was used to allow the assumption of complete wetting (contact angle 
of zero) of the plate to be satisfied. About 3 mL of the solution whose surface 
tension was to be measured was poured into a scrupulously clean, metal vessel, 
which was then placed into a temperature controlled chamber (25 ± 0.1°C).  
All the glassware with which the solution whose surface tension was to be measured 
was to come in contact with, was soaked overnight in detergent, copiously rinsed 
initially with distilled water and then UPW and dried before use. Prior to the 
measurement of sample surface tension, the surface tension of the UPW used to 
prepare the samples was determined with a value of 72.8 ± 0.5 mN/m being deemed 
acceptable. Between measurements the platinum plate was cleaned and flamed to 
   Chapter 2 Wet bead milling 
112 
 
ensure no residual surface active material remained to interfere with the 
measurement of surface tension. 
Surface tension was measured as a function of surfactant concentration in order to 
obtain the critical micelle concentration of SDS, AOT, Tween 80 and DTAB. Stock 
solutions of 10% w/w surfactant were prepared and serially diluted in the same 
container to avoid loss of surfactant by its adsorption onto the container walls. The 
surface tension of the anionic surfactants as a function of surfactant concentration 
was also measured in the presence of the non-ionic polymer, HPMC, to determine 
the critical aggregation concentration. For the polymer/surfactant studies, 0.1% w/w 
HPMC solution was used in place of UPW as the diluent. The surface tensions of 1% 
w/w polymer (HEC, HPC, HPMC, PVP 30 and F127) solutions were also measured. 
Each measurement was performed on three individual solutions and therefore the 
results are expressed as the mean of these three measurements ± standard deviation. 
Surface tension was taken every 30 seconds until an equilibrium value was attained. 
The more dilute solutions took markedly longer times to reach equilibrium e.g. 5 and 
15 min equilibration times for 1.0% w/w and 0.01% w/w of SDS solutions 
respectively. 
 
2.2.8 Scanning electron microscopy  
Scanning electron microscopy (SEM) images of griseofulvin nanosuspensions 
prepared by 6 hours WBM in presence of 0.5% w/w SDS, 0.5% w/w AOT, 0.5% 
w/w SDS + 1.88% w/w HPMC 8000, 0.5% w/w AOT + 1.88% w/w HPMC 8000 
and 0.5% w/w HPMCAS-LF were obtained. These samples were selected to 
investigate effect of stabiliser on the morphology of resultant nanoparticles. SEM 
images of a suspension of unmilled griseofulvin stirred in UPW were also taken to 
establish griseofulvin morphology prior to milling. 
A drop of the sample to be examined was placed on the surface of a small cover 
glass (ca. 5 x 5 mm) mounted on a specimen stub and allowed to dry before being 
mounted in the electron microscope. A FEI Quanta 200 ESEM FEG scanning 
electron microscope operating at accelerating voltage of 7.5 kV under low vacuum 
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2.2.9 X-ray powder diffraction  
Griseofulvin nanosuspensions prepared by 6 hours WBM in presence of 0.5% w/w 
SDS, 0.5% w/w AOT, 0.5% w/w SDS + 1.88% w/w HPMC 8000, 0.5% w/w AOT + 
1.88% w/w HPMC 8000 and 0.5% w/w HPMCAS-LF, MF and HF were snap frozen 
using liquid nitrogen and subsequently dried using a Heto PowerDry
®
 LL3000 freeze 
dryer (Thermo Fisher Scientific, UK) operating at 55 ± 0.1°C for 24 hours. X-ray 
diffraction (XRD) patterns of the powders were obtained, alongside that of unmilled 
drug to investigate whether milling induces any changes in the crystalline nature of 
the drug. 
An X‘Pert PRO X-ray diffractometer (PANalytical B.V) with Cu-Kα targets was 
used to record the XRD patterns of the samples. The powders to be examined were 
first coarsely ground using a mortar and pestle to break any loose powder clumps. 
About 50 mg of powder was then loaded into the sample holder before mounting it 
into the machine. XRD measurements were then carried out from 5 to 60 2θ degrees 
using a step size of 0.1 2θ degrees and a dwell time of 10 s at each step. 
 
2.2.10 Time stability studies 
Griseofulvin nanosuspensions prepared in sections 2.3.3-2.3.5 were stored in their 
original milled state, i.e. in presence of excess polymer/surfactant, at room 
temperature for 1 year and particle size periodically monitored. 
 
2.2.11 pH stability studies 
pH stability studies were carried out to understand the effect of pH changes on the 
nanoparticle size during transit through the gastrointestinal tract. The sizes of 
griseofulvin nanoparticles prepared in sections 2.3.3 and 2.3.5 were measured by 
PCS immediately after dilution in hydrochloric acid (pH 1-6) or water (pH 7) at 25 ± 
0.1°C and 37 ± 0.1°C. Of particular interest was the effect of inclusion of the non-





2.3.1 Stabiliser screen 
Selection of stabilisers for the production of drug nanoparticles is an empirical 
process involving trial and error. Difficulty in the selection process is compounded 
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by the fact that each drug demonstrates a unique stabilisation profile, which may 
vary according to the production process employed to produce the nanoparticles 
(Verma et al, 2009).   
Eight structurally different, poorly water-soluble drugs namely; albendazole, 
carbamazepine, frusemide, griseofulvin, halofantrine, indomethacin, nabumetone 
and phenytoin (Table 1.7) with varying physical properties (molecular weights, 
melting points, aqueous solubility‘s) were studied for their ability to be formulated 
into nanoparticles using a range of stabilisers. The selected drugs included acids 
(indomethacin, phenytoin), bases (albendazole, frusemide, halofantrine) and neutral 
compounds (carbamazepine, griseofulvin, nabumetone). All drugs had a mean 
particle size of above 10 microns prior to milling. 
Appropriate amounts of stabiliser, sufficient to prepare a 1.5% w/w aqueous solution 
were weighed and mixed with the required amount of water. Wet bead milling of the 
crude drug solutions was performed as outlined in sections 2.2.2-2.2.3 and resultant 
particle size determined. The stabilisers investigated were the non-ionic polymers - 
hydroxylpropylmethylcellulose (HPMC), hydroxylpropylcellulose (HPC), 
hydroxylethylcellulose (HEC) and polyvinylpyrolidine (PVP); the polymer non-ionic 
surfactant - Pluronic 127 (F127); and the low molecular weight surfactants - sodium 
dodecyl suphate (SDS), dodecyl trimethylammonium bromide (DTAB) and Tween 
80. The structures and molecular weights of the stabilisers used are shown in Table 
2.1. The stabiliser concentration of 1.5% w/w was chosen after preliminary studies 
deemed it to be a sufficiently high concentration to provide sufficient coverage of the 
nanoparticles while at the same time not producing too viscous a solution as to 
impede the collision of the drug particles and beads. The screen was adapted from 
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Table 2.1: Chemical structures and physicochemical properties of stabilisers 
investigated. Table continued on next page. 
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Table 2.1: Chemical structures and physicochemical properties of stabilisers 
investigated. Table continued on next page. 
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Table 2.1: Chemical structures and physicochemical properties of stabilisers 
investigated. Table continued from previous page. 
 























10.  Pluronic F 127  
OH O O OH
CH3







Table 2.2 shows the results obtained after 6 hours wet bead milling of the eight drugs 
studied with the various drug-stabiliser combinations tested. The milled 
nanoparticles generally exhibited a relatively narrow polydispersity (PI of less than 
0.2), except when the particle size was above 400 nm. Formulations denoted ‗M‘ 
indicate those in which stabilisation was ineffective producing micron sized particles 
after the 6 hours of milling. In some of these cases, formulations solidified in the jars 
e.g. with halofantrine-SDS – the occurrence of solidification is not specifically 
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indicated in the table. Milling of halofantrine was only carried out in presence of 4 
stabilisers, namely HPMC, PVP 30, SDS and DTAB, due to a shortage of drug.   
Unfortunately no apparent trend was visible from the milling results. As can be seen 
most of the drugs displayed different stabilisation profiles. Indeed only the non-ionic 
drugs, nabumetone and carbamazepine had similar stabilisation profiles, despite the 
fact that they are structurally quite distinct (Table 1.7). 
 
Table 2.2: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of 8 structurally different drugs in presence of a range of 















Albendazole 513.4 316.2 406.8 440 M M 309.4 463.5 
Carbamazepine 482.9 730.0 M M M M M M 
Frusemide 246.4 199.6 380 234.9 347.8 417.3 M M 
Griseofulvin M M M M M M 276.0 M 
Halofantrine 522.7 ND ND 501.4 ND ND M 407.8 
Indomethacin 237 210 320 260 640 308.9     M M 
Nabumetone 388.3 359.1 M M M M M M 
Phenytoin 355 218 309 234 641 M M M 
  M: micron sized particles thus stabiliser not effective.  ND: not determined 
 
The drug-stabiliser relationships will be discussed further as a function of stabiliser 
and drug properties: 
 
Stabiliser properties 
The screen revealed that the non-ionic polymers, particularly the cellulosics, HPMC 
and HPC, were the most efficient stabilisers forming nanoparticles with all drugs 
tested, except griseofulvin (Table 2.2). The non-ionic polymers, HEC and PVP 30, 
were also successful stabilisers, stabilising all but 3 of the drugs tested while 
Pluronic F 127 stabilised 3 drugs out of the 7 drugs it was tested with. The low 
molecular weight surfactants stabilised a narrower range of drugs in comparison to 
the non-ionic polymers and polymeric surfactants, with Tween 80, SDS and DTAB 
stabilising only 2 drugs each. The observed differences in resultant particle size of 
the nanoparticles obtained with the various drugs are probably a result of the 
difference in the hardness of the drugs and drug/stabiliser interactions. It is important 
to note that in the present study because one representative stabiliser concentration 
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was tested, the differences in sizes obtained for the drugs with the various stabilisers 
may be, in part, a consequence of the use of a sub-optimal amount of stabiliser.   
 
Drug properties 
Most of the drugs examined displayed unique stabilisation profiles that were not 
obviously possible to predict. For example although the non-ionic drugs, 
carbamazepine and nabumetone could both be stabilised by the non-ionic polymers, 
HPMC and HPC, the drugs exhibited widely varying structures and physical 
properties, in particular different solubilities and lipophilicites. Frusemide and 
indomethacin formed the smallest nanoparticles of about 200 nm, probably 
indicating these drugs were easily fractured. It must be noted however that the one 
representative concentration of stabiliser used for the screen, possibly explaining the 
variation in the size of the nanoparticles obtained with the different stabilisers. 
Interestingly griseofulvin only formed nanoparticles with one of the stabilisers 
examined, namely the anionic surfactant, SDS.  
The number of successful stabilisers for each drug was plotted against the physico-
chemical properties of the drugs examined, namely molecular weight, solubility, 
melting point, surface tension and functional groups (groups containing nitogen, 
oxygen, sulpur or halogens) to see if any trends were visible (Figures 2.2 to 2.6). 
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Figure 2.2: Plot of number of effective stabilisers against drug molecular weight. 
 

















































   Chapter 2 Wet bead milling 
121 
 
































Drug melting point (C)
 
 
Figure 2.4: Plot of number of effective stabilisers against drug melting point. 
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Figure 2.6: Plot of number of effective stabilisers against drug functional groups. 
  
With the exception of one outlier, a relationship was observed in the plots of the 
number of effective stabilisers against drug molecular weight and functional groups 
(Figures 2.2 and 2.6). In general, the number of effective stabilisers and thus ease of 
stabiliser selection was found to increase with both the drug‘s molecular weight and 
the number of functional groups it contains. Interestingly, despite griseofulvin‘s high 
molecular weight and number of functional groups, it did not follow the observed 
trends and was the noticeable outlier in both Figures 2.2 and 2.6.  
As the number of effective stabilisers tended to be higher for the less water-soluble 
drugs (Figure 2.3), this suggests that it should be relatively easier to select stabilisers 
for very poorly water-soluble drugs. No relationship between the melting point or 
surface tension of a drug and the number of effective stabilisers was clear (Figure 
2.4, 2.5). Lee et al (2008) performed drug-stabiliser studies using 11 drugs and 5 
polymers and 2 surfactants and observed an increase in number of successful 
stabilisers with increasing drug molecular weight and melting point and decreasing 
water solubility. Using the results obtained from milling 9 structurally different 
drugs using 13 stabilisers, van de Eerdenburgh et al (2009) attempted to relate drug-
stabilizer interactions using the surface tension and viscosity of the stabiliser 
solution, and the log P, solubility and density of the drug. Recently Liu et al (2011) 
also carried out a similar screen on 2 drugs namely indomethacin and itraconazole 
using 4 different stabilisers at 4 different concentrations. In neither of the latter 
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studies did a pattern emerge for the prediction of which stabilisers were suitable for 
production of nanoparticles using a particular drug. 
 
Griseofulvin nanoparticles 
All subsequent milling experiments in the present study were performed using 
griseofulvin. Although griseofulvin is a neutral drug, possessing no charged groups, 
during the stabiliser screen, it was only stabilised by the anionic surfactant, SDS. To 
this end, other anionic molecules, namely aerosol-OT (AOT) and hypromellose 
acetate succinate (HPMCAS), were also investigated for their ability to produce 
griseofulvin nanoparticles. The molecular structure of AOT and HPMCAS are 
shown in Table 2.1. 
SDS is a monoalkyl surfactant with a sulphate head group. It is very hydrophilic 
(HLB 40) and dissolves rapidly in water to form micelles. AOT on the other hand is 
a dialkyl surfactant with a sulfo-succinate head group. It is hydrophobic and requires 
sonication to disperse it in water. On dispersion in water, it forms a lamellar phase. 
HPMCAS is an anionic polymer with a hypromellose backbone and acetate and 
succinate ester side groups. Various grades of HPMCAS are available differing in 
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≥ 5.5 8 / 15 5 μm Micronized grades or 
aqueous and dry coating. 
Aqoat AS-MF  ≥ 6.0 9 / 11 
Aqoat AS-HF  ≥ 6.5 12 / 7  




≥ 6.0 9 / 11 
Aqoat AS-HG  ≥ 6.5 12 / 7 
* In Mcllvaine's buffer (citric acid‐Na2HPO4) and USP Phosphate Buffer (NaOH‐KH2PO4) 
 
A preliminary milling of griseofulvin in the presence of either 1.5% w/w AOT or 
HPMCAS led to the production of nanoparticles, further confirming that the 
presence of anionic groups was paramount for the stabilisation of griseofulvin 
nanoparticles. The size of the griseofulvin nanoparticles produced in presence of 
AOT and HPMCAS will be presented and discussed in a latter section, namely 2.3.3. 
 
2.3.2 Characterisation of polymers/surfactants 
2.3.2.1 Viscosity measurements 
Capillary viscometry measurements of dilute polymer solutions of HPC, HEC, 
HPMC or PVP 30 were used to obtain their intrinsic viscosity in order to calculate 
polymer viscosity averaged molecular weight. The Mark Houwink parameters ‗k‘ 
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HPMC  20 3.39 * 10
-4
 0.88 Dow chemical 1975 
HPC  25 6.25 * 10
-5 
0.84 Law et al, 1983 
HEC 25 9.49 * 10
-5 
0.87 Brown et al, 1963 
PVP 30 25 6.76 * 10
-4 
0.55 Ahmad et al, 1990 
 
The Huggins and Kraemer plots of the polymers studied intercepted on or close to 
the y-axis (Figure 2.7 to 2.12), thereby enabling an accurate determination of the 
intrinsic viscosities of the polymer solutions. Table 2.5 gives the intrinsic viscosity 
and viscosity averaged molecular weights calculated in this manner. As can be seen 
from the Table there was good agreement between the nominal molecular weight 
(Mn) quoted by the manufacturer and the experimentally determined value (Mv), with 
the exception of HPMC 8000 and PVP 30 whose experimentally determined 
molecular weight was much lower than that quoted by the manufacturer.  
 
Table 2.5: Polymer intrinsic viscosities (η) and viscosity averaged molecular 













HPMC 8000 8000 52.7 ± 1.4 4200 ± 110 
HPMC 15000 15000 153.1± 2.1  14000 ± 190 
HPMC 86000 86000 770.5 ± 1.2 89000 ± 140 
HEC 33000 33000  90.7 ± 2.3 38000 ± 220 
HPC-SSL 34000 34000  44.1 ± 1.2 38000 ± 110 

















































Concentration of HPC-SSL 34000 (g/mL)
 
Figure 2.7: Huggins/Kraemer plots for aqueous solutions of HPC-SSL 34000 at 25 ± 
0.1°C (n = 3 ± s.d.). Error from measurements on three separate solutions.  
 




























Figure 2.8: Huggins/Kraemer plots for aqueous solutions of HEC 33000 at 25 ± 









































Figure 2.9: Huggins/Kraemer plots for aqueous solutions of PVP 30 42000 at 25 ± 
0.1°C (n = 3 ± s.d.). Error from measurements on three separate solutions. 
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Figure 2.10: Huggins/Kraemer plots for aqueous solutions of HPMC 8000 at 25 ± 

















































Figure 2.11: Huggins/Kraemer plots for aqueous solutions of HPMC 15000 at 25 ± 
0.1°C (n = 3 ± s.d.). Error from measurements on three separate solutions. 
 

































Figure 2.12: Huggins/Kraemer plots for aqueous solutions of HPMC 86000 at 25 ± 
0.1°C (n = 3 ± s.d.). Error from measurements on three separate solutions. 
 
2.3.2.2 Surface tension  
 
Surfactants 
The surface tension of SDS, AOT, DTAB and Tween 80 in water was measured as a 
function of surfactant concentration in order to obtain the various surfactants‘ critical 
micelle concentration (cmc), i.e. the concentration at which surfactant micelles are 
formed in the bulk solution. Characteristic surface tension isotherms (where surface 
tension reduced monotonically with increasing surfactant concentration up to a 
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certain concentration beyond which there was no appreciable change in surface 
tension) were obtained for each of the surfactants (Figures 2.13 to 2.16). The break 
in surface tension corresponds to the critical micelle concentration of the surfactant. 
Surface excess and area per molecule were calculated to obtain an understanding of 
surfactant packing at the air-water interface (Table 2.6). 
As can be seen from Table 2.6, the dichain, anionic surfactant, AOT is more surface 
active than its single chain counterpart, SDS, displaying both a lower cmc and a 
lower surface tension at the cmc. This result was expected due the higher ionisation 
potential of the sulphate head group relative to the sulfosuccinate (Attwood et al, 
1983; Chatterjee et al, 2001), coupled with the larger/more hydrophobic chain region 
present in AOT compared to SDS. Secondly, AOT occupies a larger area per 
molecule at the air-water interface in comparison to SDS, which again is predictable 
from a consideration of their respective molecular structures.  
The cationic surfactant, DTAB, exhibited a cmc value similar to that of SDS (Table 
2.6), which is perhaps not unexpected considering that these two surfactants have a 
similar hydrophobic chain length, differing only in their head group - SDS possess a 
sulphate group and DTAB a trimethylammonium group. The DTAB surfactant 
exhibited a larger area per molecule than SDS, which is expected from a 
consideration of their respective head groups. The non-ionic surfactant, Tween 80, 
possessed a lower cmc than any of the ionic surfactants (Table 2.6). This observation 
was as expected since non-ionic surfactants tend to possess a lower cmc than ionic 
surfactants, because of the lower nature of the repulsive forces between the non-ionic 
head groups. Perhaps surprisingly, because of the polymeric nature of its head group, 













































Log concentration of SDS (g/mL)
 
 
Figure 2.13: Variation in surface tension against log concentration for SDS (■) in 
water at 25 ± 0.1°C (n = 3 ± s.d.). Error from measurements on three separate 
solutions.  
 























Log concentration AOT (g/mL)
 
 
Figure 2.14: Variation in surface tension against log concentration for AOT (■) in 













































Figure 2.15: Variation in surface tension against log concentration for DTAB (■) in 
water at 25 ± 0.1°C (n = 3 ± s.d.). Error from measurements on three separate 
solutions. 
 























Log concentration Tween 80 (g/mL)
 
 
Figure 2.16: Variation in surface tension against log concentration of Tween 80 (■) 
in water at 25 ± 0.1°C (n = 3 ± s.d.). Error from measurements on three separate 
solutions. 
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Table 2.6: Surface parameters of SDS, AOT, DTAB and Tween 80 in water at 25 ± 0.1°C (n = 3 ± s.d.). 
 

















AOT  0.107 ± 0.02 2.418 ± 0.04 29 ± 0.3 1.845 * 10
-6 
± 0.01 89 ± 0.6 
SDS  0.128 ± 0.03 4.425 ± 0.05  38.7 ± 0.2 3.082 *10
-6
± 0.03  53.9 ± 0.7 
DTAB  0.128 ± 0.03 4.145 ± 0.04 36.4 ± 0.2 3.489 * 10
-6
± 0.04  47.6 ± 0.5 
Tween 80  0.004 ± 0.00 0.028 ± 0.00 34.9 ± 0.4 4.512 * 10
-6
± 0.03 36.8 ± 0.8 




As outlined in section 1.7.2, some of the hydrophilic polymers used in the present 
study are surface active, consequently the surface tension of the aqueous polymer 
solutions of HPMC, HEC, HPC, PVP 30 and F127 were measured at a concentration 
of 1% w/w (Table 2.7). The results in Table 2.7 indicate that all polymers used as 
stabilisers in the present study were surface active. The cellulosics, HPMC, HPC, 
and HEC, all exhibited similar surface tension values of ~ 44-45 mN/m. PVP 30 was 
the least surface active polymer, with F127 being the most surface active, which is 
perhaps not surprising as F127 is a non-ionic, polymeric surfactant. 
 
Table 2.7: Surface tension of 1% w/w polymer solutions in water at 25 ± 0.1°C (n = 
3 ± s.d.). 
 
Formulation Surface tension 
(mN/m) 
HPMC 8000 45.5 ± 0.3 
HPMC 15000 45.6 ± 0.2 
HPMC 86000 45.7 ± 0.4 
HEC 33000 44.5 ± 0.5 
HPC 34000 44.0 ± 0.4 
PVP 30 56.3 ± 0.3 
F127 36.8 ± 0.3 
 
Polymer-surfactant mixtures 
The surface tension of SDS and AOT in the presence of 0.1% w/w HPMC (nominal 
molecular weight either 8000, 15000 or 86000) was measured as a function of 
surfactant concentration in order to elucidate any polymer-surfactant interactions. In 
presence of polymer, two transition points, namely a cmc and cac, were observed, 
indicative of weak interactions between the non-ionic polymer and anionic surfactant 
(Figures 2.17 and 2.18). As anticipated, the cac occurred at a lower concentration 
than the cmc, this is because the complexation between the polymer and surfactant is 
more energetically favourable than the micellisation of the surfactant. The cac/cmc 
ratio is inversely proportional to the strength of the polymer-surfactant interactions 
(Yan et al, 2004).  
From the experimentally determined values listed in Table 2.8, it can be deduced that 
the complexation between SDS and the HPMC polymer is stronger relative to the 
interaction of the polymer with AOT. Notable differences between the results shown 
in Figures 2.17 and 2.18, suggests differences in the mechanism of polymer 
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complexation between the two surfactants. Interestingly polymer molecular weight 
did not appear to have an effect on the mechanism of polymer complexation with the 
anionic surfactant, with the cac varying only slightly with polymer molecular 
weight- F (2, 6) = 2.362, p = 0.175. 
The surface tension of neutral polymer-ionic surfactant systems at the air-water 
interface have recently been studied by other workers who also reported the presence 
of both cac and cmc transition points (Bell et al, 2007; Taylor et al, 2007; Touhami 
et al, 2001). 
 
Table 2.8: Surface parameters of AOT and SDS in the presence of 0.1% w/w HPMC 













AOT/HPMC 8000  0.093 ± 0.00 2.083 ± 0.03 0.862 ± 0.02 29.68 ± 0.4 
SDS/HPMC 8000  0.096 ± 0.00 3.319 ± 0.05 0.75 ± 0.0 37.29 ± 0.3 
AOT/HPMC 15000 0.097 ± 0.00 2.172 ± 0.04  0.898 ± 0.03 30.45 ± 0.2 
SDS/HPMC 15000  0.101 ± 0.01 3.491 ± 0.04 0.789 ± 0.02 36.86 ± 0.3 
AOT/HPMC 86000 0.090 ± 0.00 2.016 ± 0.05 0.834 ± 0.01 29.21 ± 0.5 
SDS/HPMC 86000 0.105 ± 0.00 3.630 ± 0.02 0.82 ± 0.02 37.43 ± 0.5 
cmc data shown in Table 2.6 
 


























Figure 2.17: Variation in surface tension against log concentration of SDS in water 
(■) and in 0.1% HPMC 8000 (●), HPMC 15000 (▲), and HPMC 86000 (▼) at 25 ± 




































Log concentration AOT (g/mL)
 
 
Figure 2.18: Variation in surface tension against log concentration of AOT in water 
(■) and in 0.1% HPMC 8000 (●), HPMC 15000 (▲), and HPMC 86000 (▼) at 25 ± 
0.1°C (n = 3 ± s.d.). Error from measurements on three separate solutions. 
 
2.3.3 Effect of anionic surfactant/polymer concentration on griseofulvin 
nanoparticle production 
The stabiliser screen in section 2.3.1 revealed that griseofulvin nanoparticles could 
only be produced in presence of SDS, AOT or HPMCAS. It is apparent that anionic 
stabilisation is necessary for WBM production of griseofulvin nanoparticles. The 
cationic surfactant, DTAB, differs from SDS only in its head group. In this case, 
replacement of the anionic sulphate group with a cationic trimethylammonium group 
leads to the loss of stabilisation efficacy. Interestingly, none of the non-ionic 
polymers or surfactants provided effective stabilisation of griseofulvin nanoparticles.  
The effect of varying concentration (0.1-10 %w/w) of AOT, SDS and HPMCAS on 
the production of griseofulvin nanoparticles by WBM is reported in Table 2.9. The 
WBM of griseofulvin using crude drug suspension was performed as outlined in 
sections 2.2.2-2.2.3 and resultant particle size determined by laser light scattering. 
Zeta potential measurement was performed simultaneously, on the same suspensions 
as used for PCS, as described in section 2.2.5. Any interference in zeta potential 
measurement from the excess surfactant/polymer was investigated by centrifuging 
the milled nanosuspensions, removal of the supernatant containing excess 
surfactant/polymer and resuspending the nanoparticles with an equivalent volume of 
cmc 
cac 
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UPW prior to measurement. In no case was any marked difference observed between 
the zeta potential obtained for the nanosuspensions in the absence and presence of 
excess stabiliser. This is probably because, although the surfactant micelles were 
negatively charged (-78.3 mV and -105.7 mV for 0.5% w/w SDS and AOT solutions 
respectively), the copious dilution of nanosuspensions prior to zeta potential 
measurement negated any interference from any surfactant micelles or excess 
monomeric surfactant present. 
 
Table 2.9: Effect of concentration of anionic surfactant/polymer on griseofulvin 
particle size after 6 h milling (n = 3 ± s.d.). Concentrations expressed in % w/w. 
Table continued on next page.  
 
















(mV) at pH 
7 
SDS  
10.0% SDS 2.5:1 425.3 ± 9.8 - 42.2 ± 0.4 
5.0% SDS 5:1 320.9 ± 7.5 - 38.0 ± 0.5 
2.0% SDS 12.5:1 275.9 ± 4.8 - 31.8 ± 0.8 
1.5% SDS 16.7:1 276.0 ± 4.3 - 30.9 ± 0.4 
1.0% SDS 25:1 264.6 ± 3.4 - 28.3 ± 0.3 
0.5% SDS 50:1  269.2 ± 4.3    - 27.6 ± 0.4 
0.25% SDS 100:1  304.3 ± 4.2    - 25.1 ± 0.3 
0.1% SDS 250:1     > 1000     ND 
AOT  
10.0% AOT 2.5:1 ND ND 
5.0% AOT 5:1 324.5 ± 8.2 - 48.3 ± 0.3 
2.0% AOT 12.5:1 270.3 ± 4.2 - 46.1 ± 0.4 
1.5% AOT 16.7:1 266.7 ± 5.7 - 45.7 ± 0.3 
1.0% AOT 25:1 265.8 ± 6.1 - 44.4 ± 0.5 
0.5% AOT 50:1  254.4 ± 3.3 - 37.6 ± 0.4 
0.25% AOT 100:1  290.5 ± 2.6 - 34.8 ± 0.5 
0.1% AOT 125:1      > 1000      ND 
HPMCAS-LF  
10.0% HPMCAS-LF 2.5:1 434.7 ± 8.8 - 43.8 ± 0.8 
5.0% HPMCAS-LF 5:1 328.8 ± 6.5 - 42.4 ± 1.2 
2.0% HPMCAS-LF 12.5:1 321.9 ± 4.9 - 38.8 ± 0.8 
1.5% HPMCAS-LF 16.7:1 326.3 ± 3.0 - 37.1 ± 0.9 
1.0% HPMCAS-LF 25:1 300.0 ± 3.0 - 35.8 ± 1.3 
0.5%HPMCAS-LF 50:1 274.4 ± 3.0 - 31.1 ± 1.6 
0.25%HPMCAS-LF 100:1 310.8 ± 3.0 - 32.2 ± 0.9 
0.1 %HPMCAS-LF 125:1             >1000 ND 
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Table 2.9: Effect of concentration of anionic surfactant/polymer on griseofulvin 
particle size after 6 h milling (n = 3 ± s.d.). Concentrations expressed in % w/w.  
Table continued from previous page. 
 
ND = not determined 
 
As can be seen from Table 2.9, the surfactants SDS and AOT displayed a similar 
trend in nanoparticle production with surfactant concentration. For example for both 
surfactants, there was a minimum starting surfactant concentration of 0.25% w/w 
below which nanoparticles could not be produced. This was due to insufficient 
amount of surfactant being present to coat the particle surfaces leading to particle 
aggregation during milling. Increasing surfactant starting concentration to a level 
within the range 0.5-2.0% w/w lead to the production of the smallest nanoparticles. 
A simultaneous increase in the zeta potential of the nanoparticles suggests an 
increase in the amount of surfactant adsorbing onto their surface. The highly 
negative zeta potential of the nanoparticles suggests that they should be highly stable 
on storage, assuming that the pH (or electrolyte concentration) of the system does 
not change.  
Any further increase in surfactant concentration led to an increase in particle size 














(mV) at pH 
7 
HPMCAS-MF  
10.0% HPMCAS-MF 2.5:1 416.5 ± 9.7 - 44.9 ± 1.4 
5.0% HPMCAS-MF 5:1 328.6 ± 5.8 - 41.6 ± 1.3 
2.0% HPMCAS-MF 12.5:1 273.8 ± 3.2 - 38.2 ± 1.1 
1.5% HPMCAS-MF 16.7:1 288.9 ± 4.1 - 36.4 ± 0.8 
1.0% HPMCAS-MF 25:1 304.5 ± 3.0 - 35.2 ± 0.9 
0.5% HPMCAS-MF 50:1 284.6 ± 3.0 - 32.8 ± 1.4 
0.25% HPMCAS-MF 100:1 274.5 ± 3.0 - 32.7 ± 0.7 
0.1 % HPMCAS-MF 125:1 430.4 ± 3.0 - 30.4 ± 0.8 
HPMCAS-HF  
10.0% HPMCAS-HF 2.5:1 489.6 ± 9.8 - 42.6 ± 1.1 
5.0% HPMCAS-HF 5:1        472.2 ± 10.1 - 40.1 ± 0.5 
2.0% HPMCAS-HF 12.5:1 464.5 ± 8.3 - 37.7 ± 1.3 
1.5% HPMCAS-HF 16.7:1 496.8 ± 9.2 - 35.8 ± 0.9 
1.0 % HPMCAS-HF 25:1 415.4 ± 3.0 - 34.7 ± 1.5 
0.5%HPMCAS-HF  50:1 413.0 ± 3.0 - 32.6 ± 1.1 
0.25%HPMCAS-HF 100:1 484.3 ± 3.0 - 33.0 ± 0.8 
0.1 %HPMCAS-HF 125:1 >1000 ND 
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consumptions (Kwade 1999). The highest concentration of AOT studied was 5% 
w/w, above which a highly viscous initial stabiliser solution, unsuitable for milling, 
was formed. Bilgili et al (2004) studied the effect of varying the concentration of the 
anionic surfactant, sodium N-methyl N-oleyl taurate, on the production of pigment 
nanoparticles by WBM and obtained similar results in that intermediate surfactant 
concentrations produced the smallest nanoparticles. 
As with SDS and AOT, when WBM griseofulvin in the presence of HPMCAS, there 
was a minimum starting concentration of HPMCAS, i.e. 0.25% w/w for HPMCAS-
HF, LF and 0.1% w/w for HPMCAS-MF, below which nanoparticles could not be 
produced (Table 2.9). This was due to insufficient amounts of polymer being present 
on the nanoparticle surfaces leading to particle aggregation during milling. In 
addition, there were notable differences in the nanoparticle stabilisation profiles 
obtained with the three HPMCAS grades. HPMCAS-MF with the intermediate 
acetyl/succinoyl substitution was the most efficient at stabilising the griseofulvin 
nanoparticles. This grade produced the smallest nanoparticle sizes across the whole 
concentration range studied. In contrast, the polymers, HPMCAS-LF and HF were 
not effective at producing nanoparticles across the whole concentration range with 
HPMCAS-HF producing the largest griseofulvin nanoparticles. The zeta potential of 
the resultant nanoparticles increased with an increase in starting HPMCAS 
concentration suggesting that more polymer was adsorbed onto the nanoparticle 
surfaces. Interestingly there was no effect of polymer grade i.e HPMCAS LF, MF or 
HF on the zeta potential of nanoparticles produced at any given polymer 
concentration. The milled nanoparticles generally exhibited a relatively narrow 
polydispersity (PI of less than 0.2), except when the particle size was above 400 nm. 
The weight ratio of drug to stabiliser is given in Table 2.9 due to reports of optimal 
drug:stabiliser weight ratios of 10:1 or lower quoted by Mersiko-Liversidge et al 
(2008), although in the present study nanoparticles are produced at higher 
drug:stabiliser weight ratios of up to 100:1. In fact the drug:stabiliser weight ratio is 
not felt to be a useful parameter in either predicting or understanding nanoparticle 
production.  
Figures 2.19-2.21 show the kinetics of the milling process over time. The initial 
particle size of the drug in the crude initial suspension was in the micron size range. 
It is clear that the majority of the particle size reduction occurred within the first 2 
hours of milling when the particles where reduced to the nanometre size range, 
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thereafter the reduction in size tapered off. No marked difference in the size 
reduction profile was seen with the different surfactant concentrations tested (Figure 
2.19-2.20). However, with the HPMCAS-LF formulations, the size reduction was 
notably slower when the higher polymer concentrations, which were more viscous, 
were used (Figure 2.21). The effects on suspension viscosity on the milling process 
will be discussed in detail in section 2.3.4. 


























Figure 2.19: Particle size reduction of griseofulvin milled for 6 h in the presence of 
0.25% w/w SDS (■), 0.5% w/w SDS (●), 1.0% w/w SDS (▼), 1.5% w/w SDS (▲), 
and 2.0% w/w SDS (◄) (n = 3 ± s.d.). Error from light scattering measurements on 
one nanosuspension.  


























Figure 2.20: Particle size reduction of griseofulvin milled for 6 h in the presence of 
0.25% w/w AOT (■), 0.5% w/w AOT (●), 1.0% w/w AOT (▼), 1.5% w/w AOT 
(▲), and 2.0% w/w AOT (◄) (n = 3 ± s.d.). Error from light scattering 
measurements on one nanosuspension.  
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Figure 2.21: Particle size reduction of griseofulvin milled for 6 h in the presence of 
0.25% w/w HPMCAS-LF (◄), 0.5% w/w HPMCAS-LF (▼), 1.0% w/w HPMCAS-
LF (▲), 1.5% w/w HPMCAS-LF (●), and 2.0% w/w HPMCAS-LF (■)(n = 3 ± s.d.). 
Error from light scattering measurements on one nanosuspension.  
 
Polymer-surfactant systems 
The use of ionic surfactants in oral drug formulations presents challenges such as 
incompatibilities with other ionic molecules, sensitivity to pH, salt or temperature 
changes, GIT irritation and toxicity (Attwood et al, 1983). Despite a knowledge of 
the synergy which can be achieved when using polymers and surfactants, this 
synergism has not been widely utilised in pharmaceutical nanotechnology. Only a 
few literature reports exist employing polymer-surfactant combinations for the 
stabilisation of drug nanoparticles including albendazole, buparvaquone, cilostazol 
and other undisclosed drug moieties (van Eerdenbrugh et al, 2008).  
In the present study, electrosteric stabilisation, tailored to take advantage of pH 
stability associated with steric stabilisers, has been investigated. Polymer-surfactant 
mixtures comprising of the non-ionic polymer, HPMC, and an anionic surfactant, 
either SDS or AOT, were employed. In this part of the study, HPMC of different 
molecular weights, namely 8000, 15000 and 86000, were studied. As reported 
previously screening experiments revealed that the use of HPMC as sole stabilising 









2.3.4 Effect of non-ionic polymer molecular weight and concentration on 
griseofulvin nanoparticle production in presence of anionic surfactant 
Keeping the surfactant concentration constant at 0.5% w/w SDS, the effect of 
varying polymer molecular weights and concentration on the size of the griseofulvin 
particles obtained by WBM was determined (Table 2.10). Note that the polymer 
molecular weights quoted are those given by the manufacturer. 
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Table 2.10: Effect of varying HPMC concentration in presence of constant surfactant concentration (0.5% w/w SDS) on griseofulvin particle 
size after 6 h milling (n = 3 ± s.d.). Concentrations expressed in % w/w. 
 
Formulation and 






















(mV) at pH 7 
0.5% SDS + 10.0% HPMC 2:1  > 1000 ND NF ND NF ND 
0.5% SDS + 5.0% HPMC 4:1 460.7 ± 9.6 - 26.9 ± 0.5 NF ND NF ND 
0.5% SDS + 2.5% HPMC 8:1 306.5 ± 2.4 - 27.0 ± 0.6 NF ND NF ND 
0.5% SDS + 1.88% HPMC 11:1 250.4 ± 2.3 - 26.7 ± 0.7 > 1000 ND NF ND 
0.5% SDS + 1.5% HPMC 13:1 245.7 ± 2.1 - 27.3 ± 0.9 471.1± 8.8 - 22.1 ± 0.6 NF ND 
0.5% SDS + 1.0% HPMC 17:1 239.0 ± 1.9 - 27.4 ± 0.4 326.0 ± 4.3 - 22.1 ± 1.1 NF ND 
0.5% SDS + 0.5% HPMC 25:1 232.4 ± 2.9 - 27.6 ± 0.5 247.3 ± 3.4 - 25.9 ± 0.7 NF ND 
0.5% SDS + 0.1% HPMC 42:1 258.4 ± 3.0 - 27.7 ± 0.7 262.2 ± 1.3    - 27.5 ± 0.5 > 1000 ND 
0.5% SDS 50:1 265.8 ± 4.2 - 27.6 ± 0.4 265.8 ± 4.2               - 27.6 ± 0.4      265.8 ± 4.2 - 27.6 ± 0.4 
 ND = not determined, NF = not formed – nanoparticles not produced
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As seen with the surfactant only formulations in section 2.3.3, nanoparticles could be 
produced outside the optimal drug:stabiliser weight ratio of 10:1 quoted by Merisko-
Liversidge et al (2008). Indeed nanoparticles could be formulated at drug:stabiliser 
weight ratios of up to 42:1, depending on the molecular weight of the non-ionic 
polymer used. This observation illustrates the uselessness of using a drug:stabliliser 
weight ratio to predict nanoparticle formation.  
For both HPMC 8000 and 15000, the smallest particle size was produced when 0.5% 
w/w of both surfactant and polymer was used. Thereafter, an increase in polymer 
concentration led to a gradual increase in particle size and a corresponding slower 
rate of nanoparticle production. In addition, regardless of the polymer molecular 
weight, there was a maximum polymer concentration above which nanoparticles 
could not be produced. This maximum concentration reduced with increasing 
polymer molecular weight, such that the range over which nanoparticles could be 
produced narrowed with increasing polymer molecular weight. As seen in Table 
2.10, the maximum effective concentration of HPMC 8000 was 5% w/w, while for 
HPMC 15000 the maximum was 1.5% w/w – in both cases the minimum HPMC 
concentration was 0.1% w/w. It is of note that nanoparticles were not produced in 
presence of HPMC 86000, even at polymer concentrations as low as 0.1% w/w. 
Similar polymer molecular weight effects were recorded by Sepassi (2003) and 
Goodwin (2006) who investigated stabilisation of nabumetone nanoparticles, using 
HPMC and HEC, respectively. 
These observations can be partly attributed to the increasing viscosity of the initial 
crude suspensions with increasing polymer molecular and/or concentration. The 
increase in viscosity of crude suspension leads to a cushioning of drug particles from 
impact by YTZ beads thereby decreasing milling efficiency (Kwade 1999; 
Yokohama et al, 1996). Secondly, in order to stabilise the drug nanoparticles, the 
stabiliser must undergo migration to the freshly exposed drug surface. Higher 
molecular weight polymers tend to undergo slower diffusion to the freshly cleaved 
drug surfaces during milling than their lower molecular weight equivalents.  
Figures 2.22 and 2.23 show the change in particle size with WBM in the presence of 
0.5% w/w SDS and varying concentrations of HPMC polymer of molecular weights 
of 8000 and 15000 respectively. As can be seen a dramatic reduction of particle size 
was observed within the first 2 hours of milling, with a reduction in particle size 
from microns to nanometers. Furthermore, regardless of molecular weight, an 
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increase of polymer concentration in the initial crude suspension resulted in a slower 
production of nanoparticles, attributable to an increased suspension viscosity.  
There was no marked difference in the zeta potential of the nanoparticles produced 
with 0.5% w/w SDS either in the absence or the presence of either HPMC 8000 or 
low HPMC 15000 concentrations (i.e. < 1.0% w/w). However, the nanoparticles 
prepared in the presence of high concentrations (> 1.0% w/w) of HPMC 15000 and 
0.5% w/w SDS exhibited a zeta potential that was 5 mV lower than that of 
nanoparticles prepared in absence of polymer (Table 2.10). This zeta potential 
reduction could be due to a thicker co-adsorbing HPMC 15000 layer partially 
masking the charge due to SDS. The milled nanoparticles generally exhibited a 
relatively narrow polydispersity (PI of less than 0.2), except when the particle size 
was above 400 nm. 


























Figure 2.22: Effect of varying HPMC 8000 concentration in presence of 0.5% w/w 
SDS on size reduction profile of griseofulvin milled for 6 h: 0.5% w/w SDS (■), 
0.5% w/w SDS + 0.1% w/w HPMC 8000 (♦), 0.5% w/w SDS + 0.5% w/w HPMC 
8000 (●), 0.5% w/w SDS + 1.0% w/w HPMC 8000 (▲), 0.5% w/w SDS + 1.5% 
w/w HPMC 8000 (◄), 0.5% w/w SDS + 1.88% w/w HPMC 8000 (►), 0.5% w/w 
SDS + 2.5% w/w HPMC 8000 (▼)(n = 3 ± s.d.). Error from light scattering 









































Figure 2.23: Effect of varying HPMC 15000 concentration in presence of 0.5% w/w 
SDS on size reduction profile of griseofulvin milled for 6 h: 0.5% w/w SDS (■), 
0.5% w/w SDS + 0.1% w/w HPMC 15000 (●), 0.5% w/w SDS + 0.5% w/w HPMC 
15000 (▲), 0.5% w/w SDS + 1.0% w/w HPMC 15000 (◄)(n = 3 ± s.d.). Error from 
light scattering measurements on one nanosuspension.  
 
2.3.5 Effect of anionic surfactant concentration on griseofulvin nanoparticle 
production in presence of non-ionic polymer 
Using the previously determined highest optimal concentration of 1.88% w/w 
HPMC 8000 (Table 2.10), the effect of varying surfactant concentration at constant 
polymer concentration was studied (Table 2.11). As can be seen, the inclusion of 
HPMC 8000 in the milling suspension allowed a reduction in the amount of 
surfactant required for effective stabilisation. Whereas in presence of either SDS or 
AOT alone, nanoparticles could only be produced above a surfactant concentration 
of 0.25% w/w (section 2.3.3), in the presence of HPMC, lower surfactant 
concentrations were effective. There was a reduction in the minimum SDS 
concentration required to 0.05% w/w and that of AOT to 0.1% w/w. This 
potentiation of stabilisation efficiency in presence of HPMC is thought to be the 
result of the formation of polymer surfactant complexes at the nanoparticle surfaces. 
Surface tension measurements (section 2.3.2) have confirmed the interaction 
between the anionic surfactants and HPMC of varying molecular weight in bulk 
solution. On the basis of these results, it can be postulated that polymer-surfactant 
interactions also occur at the solid-liquid interface. Interestingly, in the presence of 
HPMC, the smallest nanoparticles were produced using a surfactant concentration of 
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0.5% w/w, thereafter an increase in nanoparticle size occurred with an increase or 
decrease in surfactant concentration. This result possibly suggests that polymer-
surfactant surface interactions were optimal at this surfactant concentration. The 
milled nanoparticles generally exhibited a relatively narrow polydispersity (PI of less 
than 0.2), except when the particle size was above 400 nm. 
 
Table 2.11: Effect of anionic surfactant concentration on griseofulvin particle size 
after 6 h milling in the presence of various concentrations of surfactant + 1.88% w/w 
HPMC 8000  (n = 3 ± s.d.). Concentrations expressed in % w/w. 
 
Polymer/ Surfactant 
combination and concentration 







6 h milling 
Zeta 
potential 
(mV) at pH 
7 
SDS/HPMC 
1.88% HPMC 8000 + 10.0%SDS 2.1:1     433.4 ± 8.3 -32 ± 1.1 
1.88% HPMC 8000 + 5.0%SDS 3.6:1     298.7 ± 3.6 -27.7 ± 0.8 
1.88% HPMC 8000 + 2.0%SDS 6.4:1     297.4 ± 3.1 - 28.7 ± 0.5 
1.88% HPMC 8000 + 1.5%SDS 7.4:1     296.7 ± 3.3 - 28.7 ± 0.3 
1.88% HPMC 8000 + 1.0%SDS 8.7:1      282.0 ± 2.7 - 28.3 ± 0.9 
1.88% HPMC 8000 + 0.5%SDS 11:1 250.4 ± 2.3 - 26.7 ± 0.6 
1.88% HPMC 8000 + 0.25%SDS 12:1 306.1 ± 4.7 - 25.5 ± 0.5 
1.88% HPMC 8000 + 0.1%SDS 13:1 321.4 ± 4.3 - 24.6 ± 0.7 
1.88% HPMC 8000 + 0.05%SDS 13:1 330.5 ± 3.6 - 23 ± 0.9 
1.88% HPMC 8000 + 0.025%SDS      13:1 > 1000 ND 
AOT/HPMC 
1.88% HPMC 8000 + 10.0% AOT 2.1:1 ND ND 
1.88% HPMC 8000 + 5.0% AOT 3.6:1 389.4 ± 7.8 -37.8 ± 1.4 
1.88% HPMC 8000 + 2.0% AOT 6.4:1 350.3 ± 5.3 - 35.5 ± 0.5 
1.88% HPMC 8000 + 1.5% AOT 7.4:1 332.9 ± 6.1 - 35.4 ± 0.7 
1.88% HPMC 8000 + 1.0% AOT 8.7:1 308.6 ± 5.6 - 29.9 ± 1.3 
1.88% HPMC 8000 + 0.5% AOT      11:1 274.1 ± 4.8 - 27.1 ± 0.3 
1.88% HPMC 8000 + 0.25% AOT      12:1 301.9 ± 3.3 - 26.4 ± 0.8 
1.88% HPMC 8000 + 0.1% AOT      13:1 335.8 ± 3.2 - 25.9 ± 0.4 
1.88% HPMC 8000 + 0.05% AOT     13:1 >1000 ND 
ND = not determined 
 
The zeta potentials of nanoparticles prepared in presence of 1.88% w/w HPMC 8000 
were lower than those prepared in absence of polymer throughout the AOT 
concentrations studied and at SDS concentrations above 1.0% w/w SDS (Table 2.9, 
2.11). The reduction of zeta potential suggests that the non-ionic polymer is co-
adsorbing onto the drug surfaces. No marked change in zeta potential was seen with 
nanoparticles prepared in absence or presence of 1.88% w/w HPMC 8000 at SDS 
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concentrations of 1.0% w/w or below, possibly due to the low amount of co-
adsorbing non-ionic polymer at the drug surface. 
Figures 2.24-2.25 show the change in particle size with milling. Again a dramatic 
reduction of particle size was observed within the first 2 hours of milling, when 
particle size decreased from microns to nanometers. However the reduction in 
particle size was slowest in formulations prepared using lower surfactant 
concentrations. This result suggests that the presence of anionic surfactant promotes 
a rapid size reduction, most probably because of its rapid diffusion to the freshly 
exposed surface of the nanoparticles. 


























Figure 2.24: Effect of varying SDS concentration in presence of 1.88% w/w HPMC 
8000 on size reduction profile of griseofulvin milled for 6 h: 0.05% w/w SDS + 
1.88% w/w HPMC 8000 (■), 0.1% w/w SDS + 1.88% w/w HPMC 8000 (●), 0.25% 
w/w SDS + 1.88% w/w HPMC 8000 (▲), 0.5% w/w SDS + 1.88% w/w HPMC 
8000 (▼), 1.0% w/w SDS + 1.88% w/w HPMC 8000 (◄), 1.5% w/w SDS + 1.88% 
w/w HPMC 8000 (►), 2.0% w/w SDS + 1.88% w/w HPMC 8000 (♦)(n = 3 ± s.d.). 
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Figure 2.25: Effect of varying AOT concentration in presence of 1.88% w/w HPMC 
8000 on size reduction profile of griseofulvin milled for 6 h: 0.1% w/w AOT + 
1.88%  w/w HPMC 8000 (■), 0.25% w/w AOT + 1.88% w/w HPMC 8000 (●), 0.5% 
w/w AOT + 1.88% w/w HPMC 8000 (▲), 1.0% w/w AOT + 1.88% w/w HPMC 
8000 (▼), 1.5% w/w AOT + 1.88% w/w HPMC 8000 (◄), 2.0% w/w AOT + 1.88% 
w/w HPMC 8000 (♦) (n = 3 ± s.d.). Error from light scattering measurements on one 
nanosuspension.  
 
2.3.6 Morphology of nanoparticles 
Scanning electron microscopy (SEM) was used to assess the morphology of the 
nanoparticles. The geometrical shape of milled nanoparticles is known to be 
dependent on various factors including drug/stabiliser interactions, the fracture plane 
of crystal and the morphology of the starting drug material (Merisko-Liversidge et 
al, 2003).  
SEM images of griseofulvin before milling and of resultant nanosuspensions after 
milling for 6 hours in presence of the various stabilisers were taken. Figure 2.26 (a-f) 
shows the images obtained. These images were very crowded with overlapping of 
some of the nanoparticles making it difficult to carry out accurate size and shape 
analysis. In retrospect, the nanoparticle samples should have been diluted prior to the 
examination by SEM. In addition, the nanoparticles appeared to ‗melt‘, an 
observation attributable to decrease of the drug melting point under experimental 
vacuum conditions. As can be seen the melting was dependent on particle size; with 
the unmilled micron sized griseofulvin particles showing no evidence of melting, 
suggesting that there is a size dependent effect of the vacuum on melting. 
Griseofulvin has a melting point of 218-222°C under ambient conditions. As a 
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consequence of this ‗melting‘, gold coating of nanoparticles could have been used to 
reduce thermal damage and preserve sample integrity.  
                               (26 a)                                                           (26b) 
                                                            
                               (26 c)                                                            (26d) 
     
 
                             (26 e)                                                              (26f) 
     
 
Figures 2.26 (a-f): Scanning electron micrographs of griseofulvin before milling (a), 
and after milling for 6 hours in presence of 0.5% w/w SDS (b), 0.5% w/w SDS + 
1.88% w/w HPMC 8000 (c), 0.5% w/w AOT (d), 0.5% w/w AOT + 1.88% w/w 
HPMC 8000 (e), and 0.5% w/w HPMCAS-LF (f).  
20 µm 2 µm 
2 µm 2 µm 
2 µm 2 µm 
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Despite these problems the SEM images of unmilled griseofulvin revealed a range of 
micron sized, irregular shaped particles (Figure 2.26 a). The unmilled particles were 
quite polydisperse with sizes ranging from ~ 5 micron to greater than 20 microns. 
The resultant milled nanoparticles (Figures 2.26 b-f) were also irregular in shape and 
exhibited a particle size in good agreement with that obtained by PCS, namely 250-
300 nm. There were no differences in the resultant nanoparticle shape attributable to 
the use of different stabilisers. In the literature, the effect of stabiliser on the resultant 
shape of the nanoparticles seems to be drug specific. For example, Sepassi et al 
(2007) observed differences in nanoparticle shape when using different stabilisers to 
produce nanoparticles of halofantrine using WBM. While Liu et al (2011) observed 
changes in the resultant nanoparticle shape with stabiliser when WBM itraconazole 
but not indomethacin. 
With regard to polydispersity, the nanoparticles produced in the presence of AOT 
appeared to be most polydisperse when examined by SEM. Although interestingly 
PCS measurements of the suspensions used for the SEM study indicated that all 
nanoparticle suspensions (including those stabilised by AOT) exhibited a relatively 
narrow polydispersity (PI of less than 0.2). The observed non-sphericity and 
polydisperse nature of the milled nanoparticles may be expected to introduce an error 
in the calculation of surface area required for adsorption isotherm determination. 
However, when Sepassi et al (2007) determined HPMC and PVP adsorption 
isotherms onto milled drug nanoparticles assuming the presence of spherical, 
cuboidal or rodlike particles, they deduced that shape differences did not impart 
much error to the adsorption calculations. 
 
2.3.7 X-ray diffraction  
X-ray diffraction (XRD) was used to determine whether WBM induced disorder into 
the griseofulvin nanoparticles. High energy milling can cause amorphous conversion 
or crystal defects in the lattice of crystalline materials (Chamarthy et al, 2008). 
Figure 2.27 (a-h) shows XRD patterns of griseofulvin obtained before milling and 
after milling in presence of the various stabilisers used to produce griseofulvin 
nanoparticles. The XRD pattern obtained before milling was that of a highly 
crystalline substance as evidenced by the presence of distinct peaks. This diffraction 
pattern was in good agreement with the griseofulvin XRD pattern obtained from the 
Cambridge structural database (Allen 2002) confirming the identity and purity of the 
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compound. Similar crystalline patterns in terms of nature and position of the peaks 
were observed before and after milling of griseofulvin confirming that crystallinity 
was largely, if not totally, maintained during milling. Furthermore, no peak 
broadening or halos were observed indicating that no significant long-range 
crystalline disorder or amorphous transformation had occurred. A slight decrease in 
the intensity of peaks 1 and 3 was, however, observed in all of the milled samples, 
regardless of the stabiliser used. As a consequence of this, after milling the intensity 
of the first three peaks was comparable, with the relative intensity of the second peak 
having appeared to increase compared to the situation prior to milling. These 
changes may indicate the formation of crystal defects. Furthermore, a reduction in 
the intensity of peak 4 was seen in samples stabilised in the presence of polymer, 
either HPMC with AOT or SDS and HPMCAS. Again this could possibly indicate 
the formation of different crystal defects in griseofulvin when milled in the presence 
of polymer. Chamarthy et al (2008) and Feng et al (2008) investigated the 
crystallinity of griseofulvin after cryrogenic milling and did not observe any features 
attributable to an amorphous transition. They did, however observe changes in the 
pattern of the XRD obtained for griseofulvin, which they deduced to be due to 
crystal defects.  
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Figure 2.27 (a-h): XRD of griseofulvin samples before milling (a), after 6 h milling 
in presence of 1.0% w/w SDS (b), 1.0% w/w AOT (c), 1.0% w/w SDS + 1.88% w/w 
HPMC 8000 (d), 1.0% w/w AOT + 1.88% w/w HPMC 8000 (e), 1.0% w/w 
HPMCAS-LF (f), 1.0% w/w HPMCAS-MF (g) and 1.0% w/w HPMCAS-HF (h). 
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2.3.8 Time stability studies 
The size of griseofulvin nanosuspensions stored in their original milled state, i.e. in 
presence of excess polymer/surfactant, at room temperature was monitored over 
time. As can be seen in Figures 2.28 to 2.33 Ostwald ripening was observed in all 
formulations, irrespective of the stabilising agent used in their preparation. 
























Figure 2.28: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of varying SDS concentrations at production (■), 1 month (●), 3 months 
(▲), 6 months (▼), 9 months (◄) and 12 months (►) (n = 3 ± s.d.). Error from 
particle sizes obtained with three separate nanosuspensions.  
























Figure 2.29: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of varying AOT concentrations at production (■), 1 month (●), 3 months 
(▲), 6 months (▼), 9 months (◄) and 12 months (►) (n = 3 ± s.d.). Error from 
particle sizes obtained with three separate nanosuspensions.  
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Figure 2.30: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of 1.88% w/w HPMC 8000 and varying SDS concentrations at production 
(■), 1 month (●), 3 months (▲), 6 months (▼), 9 months (◄) and 12 months (►)  
(n = 3 ± s.d.). Error from particle sizes obtained with three separate nanosuspensions.   


























Figure 2.31: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of 1.88% w/w HPMC 8000 and varying AOT concentrations at production 
(■), 1 month (●), 3 months (▲), 6 months (▼), 9 months (◄) and 12 months (►)  
(n = 3 ± s.d.). Error from particle sizes obtained with three separate nanosuspensions.  
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Figure 2.32: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of 0.5% w/w SDS and varying HPMC 8000 concentrations at production 
(■), 1 month (●), 3 months (▲), 6 months (▼), 9 months (◄) and 12 months (►)  
(n = 3 ± s.d.). Error from particle sizes obtained with three separate nanosuspensions.  


























Figure 2.33: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of 0.5% w/w SDS and varying HPMC 15000 concentrations at production 
(■), 1 month (●), 3 months (▲), 6 months (▼), 9 months (◄) and 12 months (►) (n 
= 3 ± s.d.). Error from particle sizes obtained with three separate nanosuspensions.  
 
Figures 2.28-2.29 show the change in particle size of nanoparticles prepared in the 
presence of SDS and AOT, respectively. In both cases, the surfactant stabilised 
nanoparticles displayed only slight increases in size over the 12 months. The 
surfactant stabilised particles were relatively stable as can be predicted by their high 
zeta potentials of between -25.1 to -42.2 mV (SDS stabilised nanoparticles) and 
between -34.8 to -48.3 mV (AOT stabilised nanoparticles) on production (Table 2.9). 
Electrostatically stabilised particles of nominal zeta potential of 30 mV are normally 
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regarded as physically stable, whereas for electrosterically stabilised particles a value 
of 20 mV is usually considered adequate for stabilisation (Jacobs et al, 2002). 
As can be seen from Figures 2.30-2.33, nanoparticle growth was much higher in the 
systems stabilised by a combination of HPMC polymer and surfactant. This 
observation could be attributed to the higher griseofulvin solubilising capacity of 
HPMC. Indeed it is clear that nanoparticle growth was greatest in the formulations 
prepared using the higher concentrations of HPMC, supporting this assumption. In 
addition, the presence of non-ionic polymer on the surface of the drug would be 
expected to reduce the amount of anionic surfactant adsorbed and thereby lower the 
particle zeta potential and decrease charge stability, although the presence of a steric 
stabilisation due to the hydrophilic polymer chains may, at least in part, be expected 
to counteract this situation.  
When a constant amount of HPMC 8000 was used to prepare the nanoparticles 
(Figures 2.30-2.31), nanoparticle size growth was highest in formulations prepared 
using the lowest surfactant concentrations (i.e. < 0.5% w/w). When a constant 
amount of surfactant was used, nanoparticle size growth was highest in those 
formulations containing either the higher molecular weight HPMC, HPMC 15000 
and/or the higher HPMC concentrations (Figures 2.32-2.33), most probably due to 
the higher solubilising capacity of the HPMC polymer. Notably nanoparticles at both 
extremes (i.e. lowest surfactant concentration or highest polymer molecular 
weight/concentration) contained the largest and most polydisperse particles, making 
Ostwald ripening more probable. The zeta potentials of the polymer/surfactant 
formulations at production were all above -20 mV and thus the value of zeta 
potential alone did not give a clear prediction to the stability of the 
polymer/surfactant stabilised nanosupensions (Tables 2.10-2.11). 
Nanoparticles prepared using HPMCAS were the least stable of all nanoparticles 
with the majority of the systems solidifying within 1-3 months of storage. These 
formulations were very viscous on preparation, a fact most likely contributing to the 
aggregation due to low interparticle distances. Zeta potentials of the HPMCAS 
nanoparticles at production were above -30 mV (Table 2.9) supporting the 
observation seen with polymer/surfactant stabilised nanoparticles that zeta potential 
alone was not a good indicator of nanoparticle stability. 
Drug aqueous solubility is a critical factor in determining the relative stability of the 
drug nanoparticles. WBM nanoparticles of nabumetone stabilized by HPMC or HPC 
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and halofantrine nanoparticles stabilised by HPMC or PVP 30 were found to be 
stable for one year under similar storage conditions (Sepassi 2003; Goodwin 2006). 
Both nabumetone (4.7 µg/mL) and halofantrine (< 1.0 µg/mL) have a much lower 
aqueous solubility at 25 ± 0.1ºC in comparison to griseofulvin (64 µg/mL) and as a 
consequence Ostwald ripening was considered less likely. 
 The solubilising effect of the disperse phase is also an important factor affecting 
stability. To investigate the effect of an excess amount of polymer/surfactant on 
stability a selection of griseofulvin nanosuspensions were centrifuged, the excess 
polymer/surfactant removed and the nanoparticles re-suspended in water before 
storage at room temperature. The nanosuspensions tested were those prepared in the 
presence of 0.5% w/w SDS, 0.5% w/w AOT, 0.5% w/w SDS + 1.88% w/w HPMC 
8000, 0.5% w/w AOT + 1.88% w/w HPMC 8000 and 0.5% w/w HPMCAS-MF. As 
can be seen in Figure 2.34, any increase in nanoparticle size with time was tended to 
be slightly lower (although not significantly so) in the formulations re-suspended in 
water compared to those stored in the presence of an excess of polymer/surfactant. 
However, interestingly the griseofulvin nanoparticles prepared in presence of 
HPMCAS aggregated (> 1000 nm) when stored both in excess polymer and when re-
suspended in water. 






















Figure 2.34: Particle size of griseofulvin nanoparticles prepared by 6 h milling in 
presence of 0.5% w/w SDS, 0.5% w/w AOT, 0.5% w/w SDS + 1.88% w/w HPMC 
8000, 0.5% w/w AOT + 1.88% w/w HPMC 8000 and 0.5% w/w HPMCAS-MF at 
production (■), after 12 months storage in excess polymer/surfactant (■) and after 12 
months storage in water after removal of excess polymer/surfactant (■) (n = 3 ± s.d.). 
Error from particle sizes obtained with three separate nanosuspensions.  
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With the exception of the HPMCAS formulation, the rest of the nanosupensions 
chosen for investigation were fairly stable upon storage in excess polymer/surfactant. 
In retrospect it may have been more beneficial to study the more unstable 
formulations in order to fully elucidate any advantage conferred by removal of 
excess polymer/surfactant.  
All griseofulvin nanoparticles, regardless of stabiliser used for production, were 
observed to sediment over the year‘s storage and had to be re-suspended by shaking 
prior to PCS measurements which could partly explain the observed increase in 
particle size. 
Rao et al (1997) determined the solubility of crystalline griseofulvin in water and in 
SDS solutions of varying concentrations at 25 ± 0.1ºC. The solubility of crystalline 
griseofulvin in water (12.1 gm/L) increased to 44.7 gm/L, 57.4 gm/L and 598.6-
2340.8 gm/L below, at and above critical micellar concentration of SDS, 
respectively. In another study Murdande et al (2011) found that the solubility of 
crystalline griseofulvin in water (8.6 gm/L) increased to 11.4 gm/L and 22.9 gm/L in 
solutions of 1% w/w HPMC (E5) and HPMCAS-HF, respectively at 25 ± 0.1ºC. The 
increased solubility of griseofulvin in SDS, HPMC and HPMCAS was therefore 
likely to be a contributing factor to the Ostwald ripening observed. 
Kumar et al (2009) studied the stability of itraconazole and odanacatib nanoparticles 
under a range of different conditions; namely temperature, nanoparticle size, drug 
solubility and nature of the stabiliser used. They found that nanoparticle size, drug 
solubility and temperature were important factors with nanoparticles stored at room 
temperature growing faster than those stored at 5 ± 0.1
o
C. These workers attributed 
an increase in formulation instability seen with polymeric surfactant stabilisers to 
solubilisation of drug within the polymeric micelles formed by these molecules.   
 
2.3.9 pH stability studies 
Simulation of the stability of a nanoparticle formulation in the gastrointestinal tract 
is critical as it may help predict whether the formulation is stable and does not 
undergo aggregation in vivo, which, if it occurred, would negate the benefits 
conferred by particle size reduction. Numerous studies of in vitro gastrointestinal 
stability of various nanoformulations using simulated gastric and intestinal fluids are 
available in literature e.g. palcitaxel lipid nanocapsules (Roger et al 2009), solid lipid 
nanoparticles (Zimmerman et al, 2001) among others. 
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The microclimate of the stomach favours particle aggregation due to its high ionic 
strength and/or acidity (Mehnert et al, 2001; Zimmerman et al, 2001). The fasted 
stomach is highly acidic with a mean pH of 1-2.5, as determined by Evans et al, 
1988. This pH may rise with food intake and in disease states such as achlorrhydia. 
The rest of the gut has a pH value ranging from 6.6 to 7.5, 6.6 for proximal ileum, 
7.5 for terminal ileum and 6.4 in the caecum (Evans et al, 1988).  
Figures 2.35-2.36 show the particle sizes of nanoparticles prepared in the presence of 
AOT and SDS respectively when suspended in solutions of pH 1-7 at 25 ± 0.1
o
C. In 
all these formulations there was a marked increase in particle size at pH 1, with 
aggregation (> 1000 nm) seen in the formulations prepared using surfactant 
concentrations of < 2.0% w/w, in keeping with their lower zeta potentials. In 
addition, some of the SDS (but none of the AOT) stabilised formulations displayed 
aggregation at pH values of 2-3. On production, SDS stabilised nanoparticles 
generally had lower zeta potentials in comparison to those stabilised by AOT (Table 
2.9). In these electrostatically stabilised particles, a high zeta potential seemed 
beneficial in preventing particle aggregation at low pH‘s of between 1-3. Similarily 
high zeta potential was predictive of the stability of these surfactant stabilised 
nanoparticles over time (section 2.3.8). 
PCS measurements of the nanoparticles measured at 37 ± 0.1
o
C (Figures 2.37-2.38) 
yielded particle sizes larger than those obtained at 25 ± 0.1
o
C due to the increased 
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Figure 2.35: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.25% w/w AOT (■), 0.5% w/w AOT (■), 1.0% w/w AOT (■), 1.5% w/w AOT (■), 
2.0% w/w AOT (■) and 5.0% w/w AOT (■) when suspended in solutions of pH 1-7 
at 25 ± 0.1
o
C (n = 3 ± s.d.). Error from particle sizes obtained with three separate 
nanosuspensions.  





















Figure 2.36: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.25% w/w SDS (■), 0.5% w/w SDS (■), 1.0% w/w SDS (■), 1.5% w/w SDS (■), 
2.0% w/w SDS (■), 5.0% w/w SDS (■) and 10.0% w/w SDS (■) when suspended in 
solutions of pH 1-7 at 25 ± 0.1
o
C (n = 3 ± s.d.). Error from particle sizes obtained 
with three separate nanosuspensions.  
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Figure 2.37: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.25% w/w AOT (■), 0.5% w/w AOT (■), 1.0% w/w AOT (■), 1.5% w/w AOT (■), 
2.0% w/w AOT (■) and 5.0% w/w AOT (■) when suspended in solutions of pH 1-7 
at 37 ± 0.1
o
C (n = 3 ± s.d.). Error from particle sizes obtained with three separate 
nanosuspensions.  





















Figure 2.38: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.25% w/w SDS (■), 0.5% w/w SDS (■), 1.0% w/w SDS (■), 1.5% w/w SDS (■), 
2.0% w/w SDS (■), 5.0% w/w SDS (■) and 10.0% w/w SDS (■) when suspended in 
solutions of pH 1-7 at 37 ± 0.1
o
C (n = 3 ± s.d.). Error from particle sizes obtained 
with three separate nanosuspensions.  
 
Figures 2.39-2.40 show particle sizes of nanoparticles prepared in the presence of 
AOT + 1.88% w/w HPMC 8000, and SDS + 1.88% w/w HPMC 8000, respectively 
when suspended in solutions of pH 1-7 at 25 ± 0.1
o
C. In all these formulations there 
was a marked increase in nanoparticle size at pH 1-2, with aggregation (> 1000 nm) 
seen in the formulations prepared using surfactant concentrations > 2.0% w/w AOT 
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and > 0.5% w/w SDS, despite their higher zeta potentials upon production. This 
contradicts the scenario with the surfactant stabilised formulations whereby the 
nanopartcles with higher zeta potential were less likely to under aggregation at low 
pH. In these polymer/surfactant formulations, the zeta potentials (Table 2.11) did not 
predict aggregation behaviour. Rather the amount of surfactant used in nanoparticle 
production was a more useful predictor, with lower starting amounts of surfactant 
appearing to be more beneficial when a polymer was present, in preventing particle 
aggregation at low pHs of between 1-3. Once again PCS measurements on 
nanoparticles stored at 37 ± 0.1
o
C (Figures 2.41-2.42) yielded particle sizes larger 
than those obtained at 25 ± 0.1
o
C.  






















Figure 2.39: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.1% w/w AOT + 1.88% w/w HPMC 8000 (■), 0.25% w/w AOT + 1.88% w/w 
HPMC 8000 (■), 0.5% w/w AOT + 1.88% w/w HPMC 8000 (■), 1.0% w/w AOT + 
1.88% w/w HPMC 8000 (■), 1.5% w/w AOT + 1.88% w/w HPMC 8000 (■), 2.0% 
w/w AOT + 1.88% w/w HPMC 8000 (■) and 5.0% w/w AOT + 1.88% w/w HPMC 
8000 (■) when suspended in solutions of pH 1-7 at 25 ± 0.1oC (n = 3 ± s.d.). Error 
from particle sizes obtained with three separate nanosuspensions.  
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Figure 2.40: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.05% w/w SDS + 1.88% w/w HPMC 8000 (■), 0.1% w/w SDS + 1.88% w/w 
HPMC 8000 (■), 0.25% w/w SDS + 1.88% w/w HPMC 8000 (■), 0.5% w/w SDS+ 
1.88% w/w HPMC 8000  (■), 1.0% w/w SDS + 1.88% w/w HPMC 8000 (■), 1.5% 
w/w SDS + 1.88% w/w HPMC 8000 (■), 2.0% w/w SDS+ 1.88% w/w HPMC 8000  
(■), 5.0% w/w SDS + 1.88% w/w HPMC 8000 (■) and 10.0% w/w SDS + 1.88% 
w/w HPMC 8000 (■) when suspended in solutions of pH 1-7 at 25 ± 0.1oC (n = 3 ± 
s.d.). Error from particle sizes obtained with three separate nanosuspensions.  






















Figure 2.41: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.1% w/w AOT + 1.88% w/w HPMC 8000 (■), 0.25% w/w AOT + 1.88% w/w 
HPMC 8000 (■), 0.5% w/w AOT + 1.88% w/w HPMC 8000 (■), 1.0% w/w AOT + 
1.88% w/w HPMC 8000 (■), 1.5% w/w AOT + 1.88% w/w HPMC 8000 (■), 2.0% 
w/w AOT + 1.88% w/w HPMC 8000 (■) and 5.0% w/w AOT + 1.88% w/w HPMC 
8000 (■) when suspended in solutions of pH 1-7 at 37 ± 0.1oC (n = 3 ± s.d.). Error 
from particle sizes obtained with three separate nanosuspensions.  
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Figure 2.42: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.05% w/w SDS + 1.88% w/w HPMC 8000 (■), 0.1% w/w SDS + 1.88% w/w 
HPMC 8000 (■), 0.25% w/w SDS + 1.88% w/w HPMC 8000 (■), 0.5% w/w SDS+ 
1.88% w/w HPMC 8000  (■), 1.0% w/w SDS + 1.88% w/w HPMC 8000 (■), 1.5% 
w/w SDS + 1.88% w/w HPMC 8000 (■), 2.0% w/w SDS+ 1.88% w/w HPMC 8000  
(■), 5.0% w/w SDS + 1.88% w/w HPMC 8000 (■) and 10.0% w/w SDS + 1.88% 
w/w HPMC 8000 (■) when suspended in solutions of pH 1-7 at 37 ± 0.1oC  (n = 3 ± 
s.d.). Error from particle sizes obtained with three separate nanosuspensions.  
 
Nanoparticles prepared in the presence of HPMCAS (one grade i.e. HPMCAS-MF 
plotted) were the least stable when suspended in solutions of pH 1-4 (Figures 2.43-
2.44). For example, when dispersed in a solution of pH 4, at either 25 ± 0.1
o
C or 37 
± 0.1
o
C, the nanoparticles aggregated, with particle sizes of > 1000 nm being 
observed. When dispersed in a solution of pH between 1-3, at either 25 ± 0.1
o
C or 37 
± 0.1
o
C, the same nanoparticles produced a visible cloudy precipitate, with particle 
sizes of greater than 10000 nm being recorded. These results predict that the 
HPMCAS would be the least suitable stabiliser for nanoparticles of griseofulvin 
intended for oral use. 
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Figure 2.43: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.1% w/w HPMCAS-MF (■), 0.25% w/w HPMCAS-MF (■), 0.5% w/w HPMCAS-
MF (■), 1.0% w/w HPMCAS-MF (■), 1.5% w/w HPMCAS-MF (■), 2.0% w/w 
HPMCAS-MF (■), 5.0% w/w HPMCAS-MF (■) and 10.0% w/w HPMCAS-MF (■) 
when suspended in solutions of pH 1-7 at 25 ± 0.1
o
C (n = 3 ± s.d.). Error from 
particle sizes obtained with three separate nanosuspensions.  






















Figure 2.44: Particle sizes of griseofulvin nanoparticles prepared in presence of 
0.1% w/w HPMCAS-MF (■), 0.25% w/w HPMCAS-MF (■), 0.5% w/w HPMCAS-
MF (■), 1.0% w/w HPMCAS-MF (■), 1.5% w/w HPMCAS-MF (■), 2.0% w/w 
HPMCAS-MF (■), 5.0% w/w HPMCAS-MF (■) and 10.0% w/w HPMCAS-MF (■) 
when suspended in solutions of pH 1-7 at 37 ± 0.1
o
C (n = 3 ± s.d.). Error from 











Wet bead milling (WBM) of eight poorly water-soluble drugs namely albendazole, 
carbamazepine, frusemide, halofantrine, griseofulvin, indomethacin, nabumetone 
and phenytoin was carried out in presence of a range of ionic and non-ionic polymers 
and surfactants. The most effective stabilisers of drug nanoparticles produced by 
WBM could not be attributed to either the physico-chemical properties of the drug 
and/or stabiliser therefore making prior prediction of stabiliser difficult. 
Further, detailed studies were performed using griseofulvin whose nanoparticles 
could only be produced in presence of anionic stabilisers namely sodium dodecyl 
sulphate (SDS), aerosol-OT (AOT) and hypromellose acetate succinate (HPMCAS). 
A minimum effective concentration of anionic stabiliser below which nanoparticles 
could not be produced was observed. Below this concentration there was insufficient 
anionic stabiliser to coat nanoparticles and prevent aggregation during milling. Any 
further increase in the anionic stabiliser concentration in the crude drug suspension 
prior to milling lead to an increase in the zeta potential of the resultant nanoparticles, 
suggesting that increasing amounts of the anionic stabiliser were being adsorbed 
onto the drug nanoparticles. The use of anionic surfactants or polymers in 
formulations intended for oral use is suboptimal due to their incompatibility with 
other ionics, salt and pH changes within the gastrointestinal tract. 
Polymer-surfactant synergy was investigated by including both the non-ionic 
polymer hypromellose (HPMC) and the anionic surfactant in the crude drug 
suspensions before milling. HPMC on its own was unable to stabilise griseofulvin 
nanoparticles during WBM. Incorporation of a constant amount of HPMC 8000 
(namely 1.88% w/w) into surfactant stabiliser solution prior to milling led to a 
reduction of the minimal effective surfactant concentration at which nanoparticles 
could be produced, suggesting that non-ionic polymer and surfactant were co-
adsorbing onto drug surfaces. Lower zeta potentials were measured for the 
nanoparticles milled in presence of non-ionic polymer and anionic surfactant relative 
to those milled with anionic surfactant only, further supporting this hypothesis. 
Using a constant SDS concentration, the effect of polymer molecular weight and 
concentration was investigated. An increase in polymer concentration and molecular 
weight in the crude drug suspension prior to milling was found to decrease milling 
efficiency due to an increase slurry viscosity and polymer diffusion effects. X-ray 
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diffraction was used to screen for milling induced disorder and revealed that in all 
cases tested, crystallinity of griseofulvin was maintained after milling. 
Ostwald ripening was observed in all the griseofulvin nanoparticle formulations 
when stored for a year in their original milled state, that is in presence of excess 
polymer and/or surfactant, at room temperature. Particle growth was higher in 
particles prepared in presence of HPMC and anionic surfactant, particularly when 
either the lowest surfactant concentration was used and/or when the highest polymer 
concentration/molecular weight was used. The nanoparticles at these extremes were 
larger and more polydisperse at production. Nanoparticles prepared in presence of 
HPMCAS were the least stable and aggregated at 1-3 months storage. The HPMCAS 
formulations were quite viscous on production, which probably contributed to 
aggregation due to low interparticle distances.  
The stability of nanoparticles in the gastrointestinal tract, particularly the stomach, 
was investigated by resuspending them in HCl solutions of pH 1-6 and determining 
particle size at 25 ± 0.1ºC and 37 ± 0.1ºC. When the nanoparticles were prepared in 
presence of anionic surfactant, the measured zeta potential was predictive of stability 
with aggregation being seen at low pH‘s in the range 1-3 for nanoparticles 
possessing the lowest zeta potentials. For the nanoparticles prepared in presence of 
HPMC and anionic surfactant, low amounts of anionic surfactant seemed beneficial, 
as nanoparticles prepared with the higher amounts of surfactant tending to aggregate 
at low pH‘s of 1-3. As noted earlier the inclusion of HPMC in the milling slurry 
enabled a reduction in the minimum effective surfactant concentration, thereby 
resulting in a better pH stability of the nanoparticles. The nanoparticles prepared in 
presence of HPMCAS were the least stable of all, with all of these nanoparticles 
aggregating at pH of 4 or less. HPMCAS was thus found to be the least suitable 
























3.1.1 Determination of adsorption isotherms 
Adsorption of solute molecules onto solid surfaces has been important in enabling a 
better understanding of a range of processes in fields as diverse as cosmetology, 
medicine, the pharmaceutical industry and environmental science. The characteristic 
adsorption behaviour of a material is normally described by means of an adsorption 
isotherm, which describes the amount of the adsorbate adsorbed onto a known 
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amount of adsorbent as a function of the adsorbate concentration, at a fixed 
temperature. 
Adsorption isotherms are typically determined indirectly by the depletion method 
(Dejardin, 1982), which measures the amount of adsorbate left in solution after 
adsorption using techniques such as surface tension (Lin et al, 2002; Fainerman et al, 
2009), PCS (Zhao et al, 1995), conductometric titration (Nodehi et al, 2007) and 
colorimetric assays (Govender et al, 2005) amongst others. Many of these techniques 
are not without problems. For example although surface tension measurements have 
been used to determine surfactant adsorption isotherms (Lin et al, 2002; Fainerman 
et al, 2009), measurement errors are very likely because surface tension is sensitive 
to changes in temperature, salt, traces of dust, and the presence of other surface 
active molecules e.g. polymers and some drugs. 
The amount of solute molecule adsorbed can also be established directly using more 
sophisticated techniques such as small angle neutron scattering (SANS) (Qui et al, 
2009), atomic force microscopy (Lipatov et al, 2006) and Fourier transform infrared 
spectroscopy (Habich et al, 2010). These more advanced techniques often provide 
very useful, additional information over that obtained using an indirect method. 
SANS for example, can provide information both on the thickness of an adsorbed 
layer as well as the conformation of the adsorbing molecules (Goodwin 2006). In 
addition, computer modelling programs e.g. Monte Carlo simulations, have been 
used to predict adsorption isotherms (Arnold et al, 2011). 
 
3.1.2 Challenges faced with the present systems 
Despite the successful formulation of a range of poorly water-soluble drugs as 
nanoparticles, mastery of the mechanisms behind nanoparticle stabilisation is 
lacking. In order to fully elucidate the stabilisation mechanism of the nanoparticles, 
it is important to determine the adsorption isotherm of polymer/surfactants on 
nanoparticle surfaces. In comparison to model systems such as polystyrene latex 
beads, the determination of adsorption onto drug nanoparticles prepared by milling, 
as is the case in the present study, is challenging due to particle polydispersity both 
in terms of particle size and shape as well as surface heterogeneity. This chapter 
reports work aimed at determining adsorption isotherms of polymer and/or surfactant 
on the WBM griseofulvin nanoparticles. 
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3.1.3 Surfactant assay 
In the present study a colorimetric method was used to quantify sodium dodecyl 
sulphate (SDS) in µL volume samples (Rusconi et al, 2001). The method is based on 
the use of a cationic carbocyanine dye, called Stains All, whose colour changes from 
an intense fuschia to yellow upon interaction with the sulphate head group present in 
SDS. The colour change of the dye on interaction with SDS is dose proportionate, 
allowing the quantification of SDS by visible light spectroscopy. Furthermore, a 
wide variety of biological compounds such as proteins, nucleic acids and other 
materials such as detergents, salts, buffers, solvents, acids and reducing agents have 
been found not to interfere with the assay (Rusconi et al, 2001). Figure 3.1 shows the 








        
Figure 3.1: Chemical structure of Stains All. 
 
3.1.4 Polymer assay 
The assay of cellulose polymers is particularly difficult because they lack a 
chromophore and cannot therefore be studied using UV/Vis spectroscopy. 
Colorimetric assays (performed by means of complexation of the cellulose polymer 
with a chromophore-containing molecule), size exclusion chromatography and gas 
chromatography are among the many techniques that have been used to quantify 
cellulose polymers in solution. Unfortunately however, most of these techniques 
have problems, for example they are expensive, time consuming and/or grossly 
inaccurate. For example, colorimetric assays of cellulose polymers based on the 
complexation with chromophore-containing molecules have been reported to possess 
standard errors exceeding 40% (Shea et al, 1994). Such methods are particularly 
problematic for low molecular weight and/or polydisperse polymers, as the terminal 
groups of the polymer chains greatly influence the extent of its complexation with 
the chromophore-containing molecules leading to the inaccurate assessment of 
polymer molecular weight and therefore erroneous measurements (Sepassi 2003). An 
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accurate assessment of polymer molecular weight is essential for the present studies 
due to the preferential adsorption, at equilibrium, of higher molecular weight 
polymers onto the drug surface and the possible fractionation, by molecular weight, 
of polymer during milling (Sepassi et al, 2007). 
Previously, an optical rotatory dispersion (ORD) assay method has been described 
for quantification of cellulose polymers in solution. Indeed Sepassi (2003) and 
subsequently Goodwin (2006) have successfully employed ORD methodology to 
determine the extent of the adsorption of hydroxypropylmethylcellulose (HPMC) 
and hydroxypropylmethylcellulose (HPC), respectively onto milled drug 
nanoparticles. Significantly, as the ORD assay Sepassi (2003) and Goodwin (2006) 
developed was found to be molecular weight independent (at least over a wide range 




3.2.1 Sample preparation 
Polymer/surfactant isotherms in the present study were obtained by measuring the 
depletion of the respective entity from solution after contact with the absorbent. The 
WBM drug nanosupensions, prepared as discussed in section 2.2.2-2.2.3, were 
centrifuged for 1.5 hours at 13000 rpm using a Heraus Biofuge Pico ultracentrifuge 
(Fischer scientific Leicestire, UK) in an attempt to completely precipitate the 
nanoparticles. The resultant supernatant was removed from contact with the drug 
nanoparticles and then centrifuged again for 30 minutes to ensure the complete 
sedimentation of the nanoparticles.  
A range of spectroscopic techniques was then used to determine the amount of 
polymer/surfactant remaining in the supernatant, assumed to be the total amount of 
non-absorbed material. The amount of polymer/surfactant adsorbed was calculated 
by subtracting the amount experimentally determined to be non-absorbed from the 
known starting concentration. When determining the surface area of the griseofulvin 
nanoparticles available for adsorption, the nanoparticles were assumed to be 
spherical. This assumption has been previously shown not to introduce significant 
errors into the value of surface area and hence the amount of polymer/surfactant 
absorbed per unit surface area (Sepassi et al, 2007). Calculations used for the 
determination of the nanoparticle‘s surface area are detailed in Appendix 1. The 
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 3.2.2 Stains All colorimetric assay 
Initially a Stains All stock solution (1.8 mM) was prepared by dissolving 1 mg of 
Stains All in 1 mL of isopropanol:water 50:50 (v/v). 1 mL of this stock solution was 
then mixed with 1 mL of formamide and 18 mL of ultrapure water (UPW) to form 
the Stains All intermediate solution (90 µM). The Stains All quantification solution 
(56.25 µM) used for analysis was prepared by diluting 5 mL of the intermediate 
Stains All solution (90 µM) with 3 mL UPW to yield a fuschia coloured solution. 
The UV/Vis spectrum of this quantification solution over the wavelength range 400-
750 nm in a 1 cm path length cell was measured immediately using a Perkin Lambda 
2 UV/Vis spectrophotometer with UPW as blank. The remainder of the 
quantification solution, which had been kept in the dark, was then immediately used 
for analysis. 
In order to obtain a calibration curve 0.4 µL samples containing known amount of 
SDS (0.1-0.5% w/w) and 1.0 µL of AOT (0.1-0.5% w/w) were added into a cuvette 
containing 3 mL of the 56.25 µM Stains All quantification solution. The resultant 
solution was then thoroughly mixed with a Gilson P-1000 pipette and its absorbance 
measured immediately using the same conditions as for the Stains All quantification 
solution. All measurements were made in triplicate. 
The same protocol was followed for analysis of the amount of surfactant remaining 
in the supernatant solution after nanoparticle production, the only differences being 
that in some instances it was necessary first to dilute the supernatant solution to 
ensure that the surfactant concentration was in the quantifiable range for the assay 
and that the blank was the corresponding supernatant solution in the absence of 
Stains All.  
 
3.2.3 Optical rotatory dispersion  
The UV/Vis spectra of solutions of HPMC 8000, 11000, 15000 dissolved in water 
were measured using a Perkin Lambda 2 UV-Vis spectrophotometer in polystyrene 
cuvettes of 10 mm  pathlength. The measurements of the UV/Vis spectra were made 
over a wavelength range of 230-650 nm, with a step size of 2 nm, time per point of 
0.5 sec, and total time per spectrum of 7 min. UPW was used as the blank. Scans 
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were carried out on three separate solutions; therefore the results are expressed in 
triplicate. 
The ORD spectra of solutions of HPMC 8000, 11000, 15000 dissolved in water were 
measured. The samples to be examined were placed in 10 mm path length quartz 
cells and their ORD spectra measured over the wavelength range 230-650 nm using 
a Chirascan spectropolarimeter (Applied Photophysics, UK) with a step size of 2 nm, 
band width 2 nm, time per point of 0.5 sec, and total time per spectrum of 7 min. 
UPW was used as the blank. Scans were carried out on three separate solutions; 
therefore the results are expressed in triplicate. 
 
3.2.4 Circular dichroism 
Circular dichroism (CD) spectra of griseofulvin dissolved in water, 2% w/w HPMC 
8000 aqueous solution and supernatants of griseofulvin nanosuspensions prepared in 
presence of 0.5% w/w SDS and, 0.5% w/w SDS + 1.88% w/w HPMC 8000, were 
obtained. The samples to be examined were placed in 10 mm path length quartz cells 
and their CD spectra measured over the wavelength range 200-500 nm using a 
Chirascan spectropolarimeter (Applied Photophysics, UK) with a step size of 1 nm, 
band width 1 nm, time per point of 0.5 sec, and total time per spectrum of 5 min. 
UPW was used as the blank. Due to their high CD signal, the supernatants of the 
griseofulvin nanosuspensions were diluted prior to analysis. 
 
3.3 Results  
 
3.3.1 Development of Stains All colorimetric surfactant assay 
Figure 3.2 shows the absorbance spectrum of the quantification solution of Stains All 
(56.25 µM) and absorbance of 56.25 µM Stains All in the presence of varying 
concentrations of SDS. As can be seen the Stains All spectrum shows a major 
absorption band at 510 nm, which decreases linearly upon the addition of SDS, while 
at the same time a peak at 453 nm and a shoulder at 438 nm appear (Figure 3.2). The 
shoulder at 438 nm was selected for quantification due to the high linearity between 
its absorbance value and the amount of SDS added (Rusconi et al, 2001). 
The above methodology was adapted for quantification of aerosol-OT (AOT). Like 
SDS, AOT is an anionic surfactant, possessing a sulfosuccinate head group, which 
can interact with the cationic Stains All dye. While the methodology employed was 
the same, a higher volume (1.0 µL) of the corresponding AOT stock solution and 
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sample was required due to the lower sensitivity of the assay for AOT.  The scans 
incorporating AOT samples are shown in Figure 3.3.  




































































(—) Stains all, (—) 0.1% w/w AOT, (—) 0.2% w/w AOT, (—) 0.3% w/w AOT, (—) 
0.4% w/w AOT and (—) 0.5% w/w AOT. Figure inset shows UV scans in the 
wavelength range 400-450 nm 
 
Figure 3.2: UV scans (wavelength range 400-750 nm) of 56.25 µM Stains All alone 
(3 mL), and in the presence of 0.4 μL of a known concentration of SDS solution.  
(—) Stains all, (—) 0.1% w/w SDS, (—) 0.2% w/w SDS, (—) 0.3% w/w SDS, (—) 
0.4% w/w SDS and (—) 0.5% w/w SDS. Figure inset shows UV scans in the 




Figure 3.3: UV scans (wavelength range 400-750 nm) of 56.25 µM Stains All alone 
(3 mL) and in the presence of 1.0 μL of known concentration of AOT solution. 
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Figure 3.4 shows the calibration curves obtained for the determination of surfactant 
concentration in solution using the Stain All assay. As can be seen the variation of 
absorbance with surfactant concentration was linear at the measurement wavelength 
of 438 nm and over the range of surfactant concentrations tested. The curves were 
fitted by linear regression yielding correlation coefficients (R
2
) of 0.9989 and of 
0.9983 for SDS and AOT, respectively. A 56.25 µM solution of Stains All had an 
absorbance of ~ 0.098 and is therefore responsible for the y-intercept of the 
calibration curves at zero surfactant concentration.  
 





























Surfactant concentration (% w/w)
 
Figure 3.4: Calibration curve at 438 nm of 0.4μL  of SDS (■) and 1.0 μL  of AOT (●) 
surfactant solutions (concentration in the range 0-0.5% w/w) in 3 mL of 56.25 µM 
Stains All solution at 438nm. (n = 3 ± s.d.).  
 
The interference, if any, of HPMC polymer (used in the polymer-surfactant 
stabilisation studies) in the Stains All assay was investigated by dissolving surfactant 
in HPMC 8000 or HPMC 15000 solutions in place of water and repeating the assay 
using the appropriate polymer solution as blank. Although the presence of both 
molecular weights of HPMC in the solutions lead to a higher absorbance of the 
Stains All solutions, as can be seen from Figures 3.5 (SDS as surfactant) and 3.6 
(AOT as surfactant), the linearity of the calibration curve was maintained when 
using the appropriate polymer solution as blank.  
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The interference, if any, to the Stains All assay by griseofulvin was also evaluated by 
repeating the experiments in the presence of 0.01% w/w griseofulvin. The presence 
of griseofulvin at this concentration did not alter the absorbance of the Stains All or 
the linearity of the calibration curves (Figures 3.5 and 3.6). 





















Surfactant concentration (% w/w)
 
Figure 3.5: Calibration curves of the absorbance at 438 nm of 0.4 μL SDS surfactant 
solutions (concentration range 0-0.5% w/w) in 3 mL of a 56.25 µM Stains All 
solution in water (■), in 1% w/w HPMC 8000 (▲), in 2% w/w HPMC 8000 (▼).  
Overlaid are the corresponding calibration curves in the presence of griseofulvin; in 
water (●), in 1% w/w HPMC 8000 (♦) and in 2% w/w HPMC 8000 (◄). (n = 3 ± 
s.d.) 























Figure 3.6: Calibration curves of the absorbance at 438 nm of 1.0 μL AOT 
surfactant solutions (concentration range 0-0.5% w/w) in 3 mL of a 56.25 µM Stains 
All solution in water (■), in 1% w/w HPMC 8000 (▲), in 2% w/w HPMC 8000 (▼).  
Overlaid are the corresponding calibration curves in the presence of griseofulvin; in 
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water (●), in 1% w/w HPMC 8000 (♦) and in 2% w/w HPMC 8000 (◄). (n = 3 ± 
s.d.) 
 
3.3.2 Development of optical rotatory dispersion polymer assay  
The UV scans of HPMC 8000, 11000 and 15000 are illustrated in Figures 3.7, 3.8 
and 3.9, respectively. Irrespective of polymer molecular weight, the UV/Vis spectra 
(225 – 650 nm) of the polymer solutions all exhibited an absorbance which peaked at 
~ 275 nm. As HPMC is not expected to exhibit a chromophore over this wavelength 
range, the recorded absorbance may be due to an impurity in the polymer samples 
that possess a chromophore or due to the high polymer concentrations tested. In 
order to ensure that the observed absorbance did not interfere with the ORD 
measurements, the wavelength selected for analysis of the ORD measurements was 
350 nm, a wavelength where the various polymer samples exhibited a low 
absorbance.  
















Figure 3.7: UV/Vis spectra of aqueous solutions of varying HPMC 8000 
concentration HPMC. (—) 1% w/w HPMC 8000, (—), 2% w/w HPMC 8000 (—), 
3% w/w HPMC 8000, (—) 4% w/w HPMC 8000, (—) 5% w/w HPMC 8000 (n = 3).  
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Figure 3.8: UV/Vis spectra of aqueous solutions of varying HPMC 11000 
concentration. (—) 0.5% w/w HPMC 11000, (—) 1% w/w HPMC 11000, (—) 1.5% 
w/w HPMC 11000, (—) 2% w/w HPMC 11000 (n = 3).  
















Figure 3.9: UV/Vis spectra of aqueous solutions of varying HPMC 15000 
concentration. (—) 0.5% w/w HPMC 15000, (—) 1% w/w HPMC 15000, (—) 1.5% 
w/w HPMC 15000, (—) 2% w/w HPMC 15000 (n = 3).  
 
ORD scans of polymer, namely HPMC 8000, 11000 or 15000, dissolved in water are 
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Figure 3.10: ORD spectra of aqueous solutions of varying HPMC 8000 
concentration. (—) 1% w/w HPMC 8000, (—), 2% w/w HPMC 8000 (—), 3% w/w 
HPMC 8000, (—) 4% w/w HPMC 8000, (—) 5% w/w HPMC 8000 (n = 3). 




























Figure 3.11: ORD spectra of aqueous solutions of varying HPMC 11000 
concentration. (—) 0.5% w/w HPMC 11000, (—) 1% w/w HPMC 11000, (—) 1.5% 
w/w HPMC 11000, (—) 2% w/w HPMC 11000 (n = 3). 
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Figure 3.12: ORD spectra of aqueous solutions of varying HPMC 15000 
concentration. (—) 0.5% w/w HPMC 15000, (—) 1% w/w HPMC 15000, (—) 1.5% 
w/w HPMC 15000, (—) 2% w/w HPMC 15000 (n = 3). 
 
The ORD scans of the aqueous HPMC 8000, HPMC 11000 and HPMC 15000 
solutions (concentration range 1-5% w/w for the HPMC 8000 solutions and 0.5-
2.0% w/w for the HPMC 11000 and 15000 solutions) showed a linear variation in 
ORD with concentration, with correlation coefficients of above 0.9985 being 
obtained for the three polymer samples (Figure 3.13). However, in contrast to 
previous ORD measurements on similar polymers (Shadi 2003, Goodwin 2006), the 
variation in ORD with concentration of the three molecular weight polymers did not 
overlay each other. In fact only the curves obtained for the HPMC 11000 and 15000 
polymer solutions were comparable, while the curve obtained for the HPMC 8000 
polymer solutions possessed a much lower negative slope. Analysis of variance 
(ANOVA) of the ORD results for the polymer solutions showed that the differences 
between the curves obtained for the HPMC 8000, 11000 and 15000 solutions were 
significant, F (2, 6) = 21.71, p = 0.00179. The Tukey HSD test was used to analyse 
the differences between the various polymer solutions and showed that any 
differences between the results obtained for the aqueous solutions of HPMC 11000 
and HPMC 15000 were not significant. There where however significant differences 
(p < 0.01) obtained between the aqueous HPMC 8000 and HPMC 11000 polymer 
solutions and between the aqueous HPMC 8000 and HPMC 15000 solutions. 
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Polymer concentration (% w/w)
 
Figure 3.13: ORD calibration curves of aqueous HPMC polymer solutions: (▲) 
HPMC 8000 (1-5% w/w), (●) HPMC 11000 (0.5-2.0% w/w), (▼) HPMC 11000 
(0.5-2.0% w/w) at 350 nm (n = 3 ± s.d.). 
 
The ORD results obtained lead to the suspicion that the differences in the values of 
ORD measured for the HPMC 8000 solutions were due to interference arising from 
the UV absorption seen with the HPMC 8000 solutions (Figure 3.7). In an attempt to 
determine the nature of the impurity, the NMR spectra of the three different 
molecular weight polymers (HPMC 8000, 11000 and 15000) dissolved in D2O were 
measured using a Bruker Avance DRX 400 MHz NMR spectrometer (Bruker, UK), 
however the resultant NMR spectra did not reveal any notable differences in the 
spectra attributable to an impurity (Appendix 2-4).  
It is also possible that the differences in the ORD spectra seen with HPMC 8000 
relative to HPMC 11000 and 15000 could be due to a different substitution pattern. 
This hypothesis could be checked by degrading the three polymers using sonication 
(Goodwin 2006), to a similar molecular weight and measuring the ORD of the 
degraded polymers. This experiment was not performed in the present study. 
Unfortunately, the HPMCAS polymer solutions were unsuitable for spectroscopy 
due to the turbidity of the solutions, which arose because HPMCAS is not entirely 
soluble in water or even in the presence of 10 mM sodium citrate.  
 
Chapter 3 Polymer/surfactant adsorption isotherms 
182 
 
3.3.3 Surfactant adsorption isotherms 
3.3.3.1 Adsorption of anionic surfactant onto griseofulvin nanoparticles: effect 
of surfactant concentration and non-ionic polymer HPMC 8000 
The adsorption isotherm of an anionic surfactant (either SDS or AOT) on 
griseofulvin nanoparticles as a function of starting surfactant concentration (i.e. the 
surfactant concentration used to mill the sample - 0.05-10% w/w) in the absence and 
presence of a constant amount of the non-ionic polymer, HPMC 8000 (namely 
1.88% w/w, i.e. the starting concentration), has been determined.  
 
Surfactant only systems 
The lowest starting concentration of anionic surfactant (either SDS or AOT) that 
could produce stable grisofulvin nanoparticles was determined to be 0.25% w/w 
(Tables 3.1 and 3.2). Although surfactant adsorption on the griseofulvin particles 
may have occurred at concentrations below this limiting concentration, the amount 
of surfactant present was obviously not sufficient to coat the particles and prevent 
their subsequent aggregation.  
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Table 3.1: SDS adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling in presence of varying starting surfactant 





















































10.0% w/w SDS    96.7 
 
9.575 0.425 4.25 2.197 2.285 ± 0.11 
   97.97 9.561 0.439 4.39 2.245 
   95.66 9.538 0.462 4.62 2.233 
5.0% w/w SDS 128.51 4.426 0.574 5.74 2.34 2.224 ± 0.12 
 126.73 4.407 0.593 5.93 2.1 
 130.17 4.451 0.549 5.49 2.168 
2.0% w/w SDS 152.53 1.329 0.671 6.71 2.2 2.079  ± 0.12 
 147.83 1.385 0.615 6.15 2.08 
 148.2 1.42 0.58 5.8 1.957 
1.5% w/w SDS 146.93 0.909 0.591 5.91 2.011 2.085 ± 0.07 
 150.03 0.856 0.644 6.44 2.146 
 151.46 0.865 0.635 6.35 2.096 
1.0% w/w SDS 154.12 0.51 0.49 4.9 1.59 1.628 ± 0.03 
 158.08 0.478 0.522 5.22 1.651 
 155.4 0.489 0.511 5.11 1.644 
0.5% w/w SDS 155.12 0.222 0.273 2.78 0.895 0.986 ± 0.08 
 150.42 0.191 0.309 3.09 1.029 
 150.47 0.189 0.311 3.11 1.033 
0.25% w/w SDS 133.34 0.087 0.163 1.63 0.613 0.627 ± 0.02 




0.085 0.165 1.65 0.619 
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Table 3.2: AOT adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling in presence of varying starting surfactant 
concentrations (n = 3 ± s.d.). The three rows of data per formulation represent results obtained from three separate nanosupension formulations. 


























  5.0% w/w AOT 127.1 4.449 0.551 5.51 2.168 2.272 ± 0.16 
 126.69 4.377 0.623 6.23 2.459 
 124.7 4.454 0.546 5.46 2.188 
  2.0% w/w AOT 155.06 1.358 0.642 6.42 2.069 2.021 ± 0.06 
 152.3 1.403 0.597 5.97 1.96 
 150.36 1.388 0.612 6.12 2.035 
  1.5% w/w AOT 158.21 0.951 0.549 5.49 1.733 1.847 ± 0.11 
 154.19 0.929 0.571 5.71 1.851 
 151.58 0.907 0.593 5.93 1.957 
  1.0% w/w/ AOT 155.23 0.597 0.403 4.03 1.298 1.345  ± 0.09 
 158.76 0.590 0.410 4.10 1.293 
 152.48 0.560 0.440 4.40 1.44 
  0.5% w/w AOT 159.93 0.238 0.262 2.62 0.818 0.874 ± 0.06 
 162.52 0.196 0.304 3.04 0.936 
 164.07 0.215 0.285 2.85 0.868 
  0.25% w/w AOT 140.26 0.068 0.182 1.82 0.649 0.692 ± 0.04 
 143.26 0.045 0.205 2.05 0.716 
 142.83 0.047 0.203 2.03 0.711 
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When the amount of surfactant adsorbed was plotted against the initial concentration 
of surfactant, a typical ‗Somasundaran–Fluerstenau‘ ionic surfactant isotherm 
(Somasudaran et al, 1997) was obtained for both surfactants on the griseofulvin 
nanoparticles (Figures 3.14 (for SDS) and 3.15 (for AOT)).  



































Figure 3.14: SDS adsorption isotherms on griseofulvin nanoparticles prepared by 6 
h milling in the absence (●) and in the presence (■) of the non-ionic polymer, HPMC 
8000, starting concentration 1.88% w/w (n = 3 ± s.d.). 


































Figure 3.15: AOT adsorption isotherms on griseofulvin nanoparticles prepared by 6 
h milling in the absence (●) and in the presence (■) of the non-ionic polymer, HPMC 
8000, starting concentration (n = 3 ± s.d.). 
 
The four regions of the Somasundaran-Fluerstenau adsorption isotherm (section 
1.3.1), characteristic of a charged surfactant adsorbing onto an oppositely charged 
surface, could be observed in Figures 3.14 and 3.15. Region I, which occurs at the 
lowest surfactant concentrations, is characterised by a linear increase in surfactant 
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adsorption with concentration. In this region absorption is governed by electrostatic 
interactions between surfactant head group and the drug surface. Following this is 
Region II where there is a sudden increase in surfactant adsorption attributable to the 
formation of surface aggregates. In Region III there is a reduction in surfactant 
adsorption due to the electrical neutralization of the absorbing surface causing 
repulsion to the adsorption of more surfactant. At this stage in the adsorption 
isotherm, the lateral attractive forces between the surfactant molecules prevail. In 
Region IV the maximum amount of surfactant has been adsorbed and this region is 
characterised by the formation of a plateau. Griseofulvin is however a neutral 
compound; thus electrostatic interactions are unlikely to be driving to the surfactant 
adsorption. Instead the surfactants may be adsorbing with their tails onto the drug 
surfaces with the charged surfactant head groups stabilising the nanoparticles. 
The amount of surfactant adsorbed onto the griseofulvin nanoparticles was similar 
for both surfactants, with maximum values for surfactant absorption of ~ 2.2 mg/m
2
 
being obtained. The area per surfactant molecule when adsorbed onto the drug 
nanoparticle was calculated in order to determine the likely conformation of the 
surfactant on the nanoparticle surface. The calculations used for determination of 
area per absorbed surfactant molecule are described in Appendix 5. Tables 3.3 and 
3.4 show the areas per adsorbed surfactant molecule calculated for SDS and AOT, 
respectively when adsorbed on the surface of the griseofulvin nanoparticles. Surface 
tension measurements (2.3.2.2) determined that the area per molecule occupied by 
the surfactant when in a surfactant monolayer at the air-liquid interface – established 
to be 90 and 53 Å
2
 for AOT and SDS, respectively. From the calculated surfactant 
area per molecule on the nanoparticle surfaces it is possible to postulate the 
conformation of the adsorbed surfactant molecules at the nanoparticle surfaces. 
Figures 3.16a and b give the possible adsorption mechanisms of SDS and AOT 










Chapter 3 Polymer/surfactant adsorption isotherms 
187 
 
Table 3.3: Area per adsorbed SDS molecule on griseofulvin nanoparticles prepared 
by 6 h milling in the absence and presence of 1.88% w/w of the non-ionic polymer, 
HPMC 8000 (n = 3).  
 
Formulation (starting 













with 1.88% w/w 
HPMC 8000 
10.0% SDS               21   26.5  
5.0% SDS               21.5   30.7  
2.0% SDS               23   32.5  
1.5% SDS               23  34.6  
1.0% SDS    29.4   44.2 
0.5% SDS    48.6   69.7 
0.25% SDS    76.4              73 
0.1% SDS NF 126.4 
0.05% SDS NF 243.1 
        NF = not formed – no stable nanoparticles produced  
 
Table 3.4: Area per adsorbed AOT molecule on griseofulvin nanoparticles prepared 
by 6 h milling in the absence and presence of the 1.88% w/w non-ionic polymer, 
HPMC 8000 (n = 3). 
 
Formulation (starting 













with 1.88% w/w 
HPMC 8000 
5.0% AOT   32.5  44.1 
2.0% AOT   36.5  46.6 
1.5% AOT              40   52.2 
1.0% AOT  54.9  70.2 
0.5% AOT  84.5 106.4 
0.25% AOT 106.7 114.8 
0.1% AOT NF 200.1 
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Figure 3.16 (a): Schematic diagram illustrating the proposed adsorption mechanism 
of SDS on griseofulvin nanoparticle surfaces with increasing surfactant adsorption. 
ASL >> the area of the 
surfactant head group 
ASL = half the area  
of the surfactant head group 
 
Surfactant bilayer 
ASL = the area of the 
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Figure 3.16 (b): Schematic diagram illustrating the proposed adsorption mechanism 
of AOT on griseofulvin nanoparticle surfaces with increasing surfactant adsorption. 
 
ASL >> the area of the 
surfactant head group 
ASL = half the area  





ASL = third the area  




ASL = the area of the  
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At low levels of AOT or SDS adsorption (i.e. a starting surfactant concentration of 
0.25% w/w), the area occupied by each surfactant molecule is greater than that of the 
cross sectional area of the surfactant at the air-water interface indicating a relaxed 
orientation of the surfactant with, most likely, the surfactant tails lying parallel or 
close to the surface of the griseofulvin nanoparticle. From a comparison of the area 
per molecule when the surfactants are close packed at the air-water interface (Table 
2.6), the formation of a surfactant monolayer at the solid-liquid interface on the 
griseofulvin nanoparticles was considered to occur at surfactant concentrations of ~ 
0.5% w/w AOT or SDS. It is thought that a surfactant monolayer is formed either by 
the charged surfactant head groups absorbing directly onto the griseofulvin surface 
such that the surfactant tails are orientated perpendicular to the solid-liquid interface 
or by the tail groups of the surfactant absorbing directly into the surface, or possibly 
the surfactant molecules adsorbing with head groups and hydrocarbon chains 
alternately anchoring on the drug surface. Another scenario that would lead to 
surfactant area per molecule equal to that of a surfactant monolayer is formation of 
hemi-micelles (assuming the surfactant is tightly packed within the hemi-micelle) 
with the hydrophobic surfactant chains anchored onto the drug surface. While the 
formation of hemimicelles is a possibility in the case of SDS, it is less likely to be 
the case with AOT, which forms bilayers as opposed to micelles when dispersed in 
water. At present, it is not possible to determine which scenario is correct. 
The calculated area per surfactant molecule on the griseofulvin nanoparticles was 
found to decrease upon increasing surfactant adsorption, probably due to repulsion 
between the surfactant head groups. At the highest starting surfactant concentrations 
of between 1.5-10.0% w/w, the calculated area per surfactant molecule on 
griseofulvin nanoparticles is about half and a third of the values obtained for SDS 
and AOT, respectively, when the surfactant molecules are close packed at the air-
water interface. This result possibly indicates the formation of surfactant bilayers and 
trilayers on the surface of the SDS and AOT-stabilised griseofulvin nanoparticles 
respectively. Knowledge of the packing of surfactant molecules at a drug surface can 
help predict the thickness of the adsorbed layer, for example when a monolayer of 
surfactant is present, the thickness of the layer will be approximately equal to the 
length of the surfactant molecule, while when a bilayer is present, the layer thickness 
will be approximately double that thickness.  
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As can be seen from Tables 3.1-3.2 the amount of surfactant remaining in the 
supernatant after its‘ adsorption onto the drug particles is, in most cases, greater than 
the cmc of the surfactants‘ (i.e. 0.107% w/w and 0.128% w/w for AOT and SDS, 
respectively). The presence of surfactant micelles in the drug nanosuspensions may 
be expected to promote drug solubilisation and lead to Ostwald ripening as observed 
in section 2.3.8. 
 
Polymer-surfactant systems 
Notable differences were observed in the adsorption of anionic surfactant onto the 
griseofulvin nanoparticles when milled in the presence of a starting concentration of 
1.88% of the non-ionic polymer, HPMC 8000, compared to when griseofulvin was 
milled in the absence of polymer (Figures 3.14 and 3.15). Interestingly both anionic 
surfactants, once again behaved in a similar manner to each other. 
Firstly, in the presence of the non-ionic polymer, HPMC 8000, griseofulvin 
nanoparticle production occurred at surfactant concentrations lower than the 
minimum effective surfactant concentration of 0.25% w/w determined with the 
surfactant only formulations. At low surfactant concentrations, namely 0.05, 0.1 % 
w/w SDS and 0.1% w/w AOT, virtually all of the surfactant present was adsorbed on 
the griseofulvin nanoparticles (Tables 3.5, 3.6). Nanoparticle stabilisation at these 
lower surfactant concentrations was only seen when the nanoparticles were prepared 
in the presence of non-ionic polymer, suggesting that polymer-surfactant co-
adsorption is occurring at the griseofulvin nanoparticle surface. Indeed surface 
tension studies in section 2.3.2.2 revealed the presence of polymer surfactant 
interactions at the air-liquid interface, and thus we can also expect a corresponding 
interaction at the solid-liquid interface.   
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Table 3.5: SDS adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling in presence of varying starting surfactant 
concentrations and non-ionic polymer (1.88% w/w HPMC 8000) (n =3 ± s.d.). The three rows of data per formulation represent results obtained 
from three separate nanosupension formulations. Table continued on next page. 
Formulation 
























1.88% HPMC 8000 + 10.0% SDS 95.15 9.641 0.359 3.59 1.886 1.809 ± 0.07 
 96.24 9.656 0.344 3.44 1.787 
 93.23 9.673 0.327 3.27 1.754 
1.88% HPMC 8000 + 5.0% SDS 138.06 4.568 0.432 4.32 1.564 1.559 ± 0.03 
 134.11 4.591 0.409 4.09 1.525 
 140.93 4.552 0.448 4.48 1.589 
1.88% HPMC 8000 + 2.0% SDS 138.59 1.587 0.413 4.13 1.490 1.472 ± 0.04 
 140.19 1.58 0.42 4.2 1.498 
 137.3 1.608 0.392 3.92 1.428 
1.88% HPMC 8000 + 1.5% SDS 140.67 1.138 0.362 3.62 1.287 1.384 ± 0.10 
 138.87 1.171 0.383 3.83 1.379 
 137.57 1.091 0.409 4.09 1.486 
1.88% HPMC 8000 + 1.0% SDS 147.46 0.659 0.341 3.41 1.156 1.084 ± 0.07 
 146.57 0.69 0.3 3 1.023 
 144.72 0.694 0.31 3.1 1.071 
1.88% HPMC 8000 + 0.5% SDS 164.59 0.27 0.230 2.3 0.698 0.687 ± 0.02 
 166.18 0.266 0.234 2.34 0.703 
 163.16 0.284 0.216 2.16 0.661 
1.88% HPMC 8000 + 0.25% SDS 132.66 0.075 0.175 1.75 0.661 0.656 ± 0.03 
 136.79 0.063 0.187 1.87 0.685 
 132.69 0.085 0.165 1.65 0.622 
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Table 3.5: SDS adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling in presence of varying starting surfactant 
concentrations and non-ionic polymer (1.88% w/w HPMC 8000) (n =3 ± s.d.). The three rows of data per formulation represent results obtained 
from three separate nanosupension formulations. Table continued from previous page. 
 
 Formulation 
























1.88% HPMC 8000 + 0.1% SDS 127.06 0.009 0.091 0.91 0.359 0.379  ±0.02 
 129.53 0.001 0.099 0.99 0.383 
 127.09 0.0 0.1 1.0 0.393 
1.88% HPMC 8000 + 0.05% SDS 123.48 0.003 0.047 0.47 0.191 0.197  ±0.01 
 126.05 0.0 0.05 0.5 0.198 
 123.52 0.0 0.05 0.5 0.202 
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Table 3.6: AOT adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling in presence of varying starting surfactant 
concentrations and non-ionic polymer (1.88% w/w HPMC 8000) (n =3 ± s.d.).  The three rows of data per formulation represent results obtained 
from three separate nanosupension formulations. 
 
Formulation 

























1.88% HPMC 8000 + 5.0% AOT 105.9 4.618 0.382 3.82 1.804 1.673 ± 0.15 
 107 4.677 0.323 3.23 1.509 
 104.29 4.644 0.356 3.56 1.707 
1.88% HPMC 8000 + 2.0% AOT 118.20 1.627 0.373 3.73 1.578 1.585  ± 0.04 
 115.75 1.642 0.358 3.58 1.547 
 119.20 1.612 0.388 3.88 1.628 
1.88% HPMC 8000 + 1.5% AOT 126.28 1.175 0.325 3.25 1.285 1.415 ± 0.08 
 123.59 1.153 0.347 3.47 1.404 
 121.73 1.175 0.325 3.25 1.333 
1.88% HPMC 8000 + 1.0% AOT 135.76 0.709 0.291 2.91 1.072 1.052  ± 0.07 
 134.08 0.701 0.229 2.99 1.113 
 130.56 0.746 0.254 2.54 0.972 
1.88% HPMC 8000 + 0.5% AOT 153.27 0.331 0.169 1.69 0.551 0.694 ± 0.13 
 147.67 0.285 0.215 2.15 0.729 
 154.27 0.253 0.247 2.47 0.801 
1.88% HPMC 8000 + 0.25% 
AOT 
136.48 0.08 0.170 1.7 0.624 0.643 ± 0.03 
 136.66 0.064 0.186 1.86 0.68 
 138.93 0.076 0.174 1.74 0.626 
1.88% HPMC 8000 + 0.1%  AOT 123.22 0.014 0.086 0.86 0.35 0.369 ± 0.03 
 125.01 0.0 0.1 1.0 0.4 
 125.47 0.01 0.09 0.9 0.359 
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Interestingly, at the surfactant concentration that griseofulvin nanoparticles were 
prepared in the absence of polymer, namely 0.25% w/w, the amount of surfactant 
adsorbed was similar to that seen in the presence of polymer, possibly suggesting 
that the polymer was being adsorbed onto a pre-adsorbed surfactant layer on the 
griseofulvin nanoparticles.  
In the presence of polymer, a short plateau in the level of surfactant adsorption was 
observed at a surfactant concentration of between 0.25-0.5% w/w. This plateau could 
be indicative of the formation of a monolayer of absorbate, possibly consisting of 
polymer/surfactant complexes. Upon further increasing the surfactant concentration, 
there was a further increase in surfactant adsorption before another plateau was 
reached at surfactant concentrations greater than 1.5% w/w. The second plateau is 
likely to be a consequence of the formation of layers of surfactant and polymer on 
the drug surface. The adsorption of surfactant on griseofulvin nanoparticles from 
polymer-surfactant systems was consistently lower than surfactant adsorption from 
surfactant only systems suggestive of the simultaneous adsorption of the polymer 
and surfactant. Simultaneous polymer-surfactant adsorption was also seen by 
Sakagami et al (2002) who studied the adsorption of poly (1-vinylpyrrolidone-co-
acrylic acid) and SDS onto positively charged alumina.  
The area per surfactant molecule calculated for the griseofulvin nanoparticles 
prepared using a mixture of polymer and surfactant was higher than that obtained in 
the corresponding surfactant only system (Tables 3.3 and 3.4) suggesting a more 
relaxed conformation of the surfactant, possibly due to a reduction in the repulsion 
between the surfactant head groups in the presence of co-adsorbed polymer. 
However, as before, the area per surfactant molecule at the nanoparticle surface 
decreased with an increase in the surfactant starting concentration, corresponding to 
a higher level of surfactant adsorption. The dramatic decrease in the area per 
surfactant molecule at the highest levels of surfactant adsorption, points towards the 
possible formation of surfactant multilayers on the surface of the griseofulvin 
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3.3.3.2 Adsorption of anionic surfactant onto griseofulvin nanoparticles: effect 
of non-ionic polymer molecular weight  
The variation of the amount of SDS adsorbed on griseofulvin nanoparticles prepared 
using 0.5% SDS, both in absence and presence of an increasing concentration of 
either HPMC 8000 and HPMC 15000 was investigated. 
As can be seen from Tables 3.7-3.8, the amount of SDS adsorbed on the 
nanoparticles was less in the presence of polymer than in its absence, suggestive of 
the simultaneous adsorption of surfactant and polymer. Surface tension studies in 
section 2.3.2.2 revealed polymer surfactant interactions at the air-liquid interface, 
thus it is not unreasonable to propose a similar interaction between the surfactant and 
polymer at the solid-liquid interface. It is worth noting however, that regardless of 
polymer molecular weight, HPMC when used as sole stabiliser did not adsorbed onto 
griseofulvin and therefore did not allow the production of griseofulvin nanoparticles 
(section 2.3.1).  
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Table 3.7: SDS adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling at a constant surface concentration of 0.5 % w/w 
SDS and in the presence of varying concentrations of the non-ionic polymer, HPMC 8000 (n = 3 ± s.d.). The three rows of data per formulation 


























5% HPMC 8000 + 0.5% SDS 87.29 0.417 0.083 0.83 0.477 0.431 ± 0.05 
 90.4 0.422 0.078 0.78 0.43 
 91.79 0.43 0.07 0.7 0.384 
2.5% HPMC 8000 + 0.5% SDS 136.28 0.327 0.173 1.73 0.636 0.653 ± 0.04 
 132.99 0.333 0.167 1.67 0.627 
 134.83 0.312 0.188 1.88 0.696 
1.88% HPMC 8000 + 0.5% SDS 164.59 0.27 0.23 2.3 0.698 0.687 ± 0.02 
 166.18 0.266 0.234 2.34 0.703 
 163.16 0.284 0.216 2.16 0.661 
1.5% HPMC 8000 + 0.5% SDS 166.38 0.27 0.23 2.3 0.69 0.696 ± 0.01 
 169.32 0.262 0.238 2.38 0.702 
 167.74 0.266 0.234 2.34 0.696 
1.0% HPMC 8000 + 0.5% SDS 172.87 0.27 0.23 2.3 0.664 0.716 ± 0.05 
 171.01 0.254 0.246 2.46 0.718 
 173.67 0.234 0.266 2.66 0.765 
0.5% HPMC 8000 + 0.5% SDS 178.95 0.224 0.276 2.76 0.77 0.789 ± 0.02 
 175.97 0.22 0.28 2.8 0.794 
 175.3 0.218 0.282 2.82 0.803 
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Table 3.7: SDS adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling at a constant surface concentration of 0.5 % w/w 
SDS and in the presence of varying concentrations of the non-ionic polymer, HPMC 8000 (n = 3 ± s.d.). The three rows of data per formulation 






































0.1% HPMC 8000 + 0.5% SDS 158.82 0.198 0.302 3.02 0.949 0.978 ± 0.06 
 161.75 0.163 0.337 3.37 1.043 
 158.21 0.202 0.298 2.98 0.94 
0.5% w/w SDS 155.12 0.222 0.273 2.78 0.895 0.986 ±  0.08 
 150.42 0.191 0.309 3.09 1.029 
 150.47 0.189 0.311 3.11 1.033 
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Table 3.8: SDS adsorption parameters on griseofulvin nanoparticles prepared by 6 h milling at a constant surface concentration of 0.5 % w/w 
SDS and in the presence of varying concentrations of the non-ionic polymer, HPMC 15000 (n = 3 ± s.d.). The three rows of data per formulation 
represent results obtained from three separate nanosupension formulations. 
 
Formulation 






















1.5% HPMC 15000 + 0.5% SDS 86.90 0.408 0.092 0.92 0.527 0.542 ± 0.06 
 89.06 0.392 0.108 1.08 0.606 
 87.78 0.414 0.086 0.86 0.490 
1.0% HPMC 15000 + 0.5% SDS 127.36 0.294 0.206 2.06 0.808 0.807 ± 0.05 
 124.94 0.308 0.192 1.92 0.769 
 127.88 0.284 0.216 2.16 0.845 
0.5% HPMC 15000 + 0.5% SDS 167.74 0.222 0.278 2.78 0.827 0.858 ± 0.03 
 169.04 0.200 0.300 3.0 0.886 
 164.55 0.216 0.284 2.84 0.862 
0.1% HPMC 15000 + 0.5% SDS 158.03 0.204 0.296 2.96 0.935 0.978 ± 0.05 
 156.53 0.179 0.321 3.21 1.027 
 157.19 0.194 0.306 3.06 0.972 
0.5% SDS 155.12 0.222 0.273 2.78 0.895 0.986 ±  0.08 
 150.42 0.191 0.309 3.09 1.029 
 150.47 0.189 0.311 3.11 1.033 
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Regarding the mechanism of adsorption of non-ionic polymer in the presence of 
anionic surfactant, it can be hypothesized that the negatively charged surfactant and 
the non-ionic polymer, HPMC, interact in solution to form a polymer-surfactant 
complex, which is then adsorbed onto the griseofulvin surface. There are several 
literature reports of surfactant/polymer mixtures altering adsorption profiles, 
whereby a non adsorbing entity is adsorbed on a surface by the anchoring effect of a 
co-adsorbent e.g. the non-ionic surfactant, pentadecylethoxylated nonyl phenol 
(NP15), only adsorbs onto alumina in the presence of the cationic surfactant, 
tetradecyl trimethyl ammonium chloride (TTAC) (Huang et al, 1996). Similarly the 
anionic surfactant, SDS, only adsorbs on alumina in the presence of polyethylene 
oxide (Maltesh et al, 1992) while hydroxypropylcellulose adsorbs on hydroxypatite 
only in presence of anionic SDS (Shimabayashi et al, 2002). 
The amount of SDS adsorbed onto the griseofulvin nanoparticles in presence of the 
lowest polymer concentration, namely 0.1% w/w HPMC 8000 and 15000, was 
similar for both polymer molecular weights and similar to the amount of SDS 
adsorbed in the absence of polymer (Tables 3.7-3.8). As illustrated in Figure 3.17, 
SDS adsorption on the griseofulvin nanoparticles decreases with increasing polymer 
concentration. Comparing the two polymers, SDS adsorption tended to be higher on 
the griseofulvin nanoparticles prepared in presence of the higher molecular weight 
polymer with the exception of the highest HPMC 15000 concentration of 1.5 %w/w. 
However, the differences observed in the extent of surfactant adsorption onto the 
griseofulvin nanoparticles in the presence of the two polymers studied in the present 
project were not considered significant. Similarly, no polymer molecular weight 
effects on polymer-surfactant interactions were seen in the surface tension studies. 
Interestingly, literature reports suggest that, at equilibrium, higher molecular 
polymers tend to be adsorbed better onto surfaces than their lower molecular weight 
counterparts (Santhiya et al, 1998; Khraisheh et al, 2005). 
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Figure 3.17: SDS adsorption isotherms on griseofulvin nanoparticles prepared by 6 
h milling in the presence of varying concentrations of  HPMC 8000 (■) and HPMC 
15000 (●), SDS concentration kept constant at 0.5% w/w (n = 3 ± s.d.). 
 
Table 3.9 shows the area per surfactant molecule obtained with the different polymer 
containing formulations. The area of the close packed SDS molecule at the air-water 
interface, as determined from surface tension measurements, was found to be 53 Å
2
 
(2.3.2.2) while the area per surfactant molecule calculated for the nanoparticles 
prepared in presence of 0.5% w/w SDS (no polymer) was very similar, which due to 
the assumptions made in the calculation is reassuring. In presence of an increasing 
concentration of polymer, the area per SDS molecule increases, suggesting a less 
constrained SDS conformation, possibly with the surfactant tails lying parallel to the 
drug surface. It is likely that the presence of co-adsorbed polymer decreases 
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Table 3.9: Area per surfactant molecule on griseofulvin nanoparticles prepared by 6 
h milling at a constant surfactant concentration of 0.5% w/w SDS and in the 
presence of varying concentrations of the non-ionic polymers, HPMC 8000 and 
HPMC 15000 (n = 3). 
 
Formulation 














(SDS / HPMC 
15000) 
0.5% SDS + 10.0% HPMC NF NF 
0.5% SDS + 5.0% HPMC 111.1 NF 
0.5% SDS + 2.5% HPMC 73.3 NF 
0.5% SDS + 1.88% HPMC 69.7 NF 
0.5% SDS + 1.5% HPMC 68.8 88.4 
0.5% SDS + 1.0% HPMC 66.9 59.3 
0.5% SDS + 0.5% HPMC 60.7 55.8 
0.5% SDS + 0.1% HPMC 49             49 
0.5% SDS 48.6 48.6 
           NF = not formed – no stable nanoparticles produced  
 
In general, the area per SDS molecule calculated was lower in nanoparticles 
prepared in presence of higher molecular weight polymer HPMC 15000, than those 
prepared using HPMC 8000. The reason for this finding is the larger surface 
area/smaller size of the nanoparticles prepared in presence of the lower molecular 
weight polymer. 
 
3.3.4 Polymer adsorption isotherms 
ORD measurements of the supernatants revealed a high level of interference around 
the wavelength of interest thereby rendering it impossible to determine the 
concentration of polymer remaining in the supernatant and therefore the amount 
absorbed onto the surface of the griseofulvin nanoparticle. Figure 3.18 shows the 
ORD spectra of griseofulvin dissolved in water and in a 1.88% w/w HPMC 8000 
aqueous solution, as well as the spectra of supernatants of griseofulvin 
nanosuspensions prepared in presence of 0.5% w/w SDS, and 0.5% w/w SDS + 
1.88% w/w HPMC 8000. (Note that griseofulvin is optically active exhibiting a 
positive peak in its ORD spectra at between 354 -364 nm (B.P 2010)).  
Chapter 3 Polymer/surfactant adsorption isotherms 
203 
 


























Figure 3.18: ORD spectra of griseofulvin dissolved in water (—), griseofulvin 
dissolved in an aqueous solution of 1.88% w/w HPMC 8000 (—), supernatant from a 
griseofulvin nanosuspension prepared using 0.5% w/w SDS (—) and supernatant 
from a griseofulvin nanosuspension prepared using 0.5% SDS w/w + 1.88% w/w 
HPMC 8000 (—). 
 
The nature of this interference was further investigated by determining the circular 
dichroism (CD) of these supernatant systems and comparing them with the spectra 
obtained for a saturated solution of griseofulvin in water. The CD measurements 
revealed the presence of griseofulvin in the two supernatants as can be seen in Figure 
3.19. Significantly, the amount of griseofulvin detected was higher in the supernatant 
from the nanoparticle preparation containing polymer, indicating that the polymer 
was solubilising more drug, probably via means of a polymer-surfactant complex, 
than could dissolve in water in its absence. This discovery suggested that 
griseofulvin might not be ideal for formulating as nanoparticles via WBM, - WBM is 
best for very water-insoluble drugs. The presence of dissolved drug in the various 
supernatants supports the hypothesis that the formulations might not exhibit a long 
term stability due to Ostwald ripening – see section 2.3.8.  
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Figure 3.19: CD spectra of an aqueous solution of 2% w/w HPMC 8000 (—), 
griseofulvin dissolved in water (—), 1:2 diluted supernatant from griseofulvin 
nanosuspension prepared using 0.5% w/w SDS (—) and 1:10 diluted supernatant 
from griseofulvin nanosuspension prepared using 0.5% SDS w/w + 1.88% w/w 
HPMC 8000 (—). 
 
Significantly, nanoparticles of the very water-insoluble drugs, nabumetone and 
halofantrine, prepared by WBM were stable for one year when stored under similar 
conditions to those used in the present study (Shadi 2003, Goodwin 2006). In the 
pharmaceutical industry, as the nanoparticles may be processed into dry powder 
within a day of preparation, the higher aqueous solubility of griseofulvin might not 
be a limitation. In addition, it should be realised that the fact that some griseofulvin 
‗dissolves‘ introduces a degree of error in the estimation of surface area necessary 
for the adsorption studies. 
A programme of work was instigated to attempt to analyse the concentration of 
HPMC in the supernatants. This included:  
 Liquid-liquid extraction 
As griseofulvin is much more soluble in organic solvents than aqueous solvents and 
HPMC much more soluble in water, attempts were made to extract griseofulvin from 
the aqueous supernatant solutions using a range of organic solvents, namely 
chloroform, methylene chloride, pentane, hexane, toluene, diethyl ether, ethyl 
acetate. However all attempts were unsuccessful due to the surface active nature of 
the water-soluble polymer, HPMC, which tends to form a film at the liquid-liquid 
interface (Wollenweber et al, 2000). Attempts to break the HPMC films formed at 
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the water-organic solvent interface by the addition of electrolyte, changes in 
temperature and centrifugation were unsuccessful. 
 Size exclusion chromatography 
Taking advantage of the difference in molecular size between the polymer, surfactant 
and drug, size exclusion chromatography was investigated as a means of separating 
the polymer, surfactant and griseofulvin. Using a Sephadex 20 column and a range 
of solvent systems consisting of water:methanol (100:0, 20:80, 40:60, 80:20, 0:100), 
supernatants were eluted and the components of each eluent fraction determined. 
Although the surfactant and polymer were effectively separated, eluting in different 
fractions, griseofulvin was present in all fractions, possibly due to solubilisation of 
the drug within polymer and surfactant complexes. It had hoped that the addition of 
methanol may ‗break‘ the complex but unfortunately when 100% of methanol was 
used the polymer did not exhibit sufficient solubility in the methanol for the 
extraction to take place.  
 Weighing the freeze dried mass of sample supernatants 
The most basic method of measuring adsorption by depletion is to freeze dry the 
supernatant and weigh the adsorbate remaining in solution. Sample supernatants in 
the current study were freeze dried and the amounts of surfactant and griseofuvin 
analytically determined to be present in the supernatant subtracted in order to 
quantify the amount of polymer in the supernatant. The amounts of surfactant and 
griseofulvin present were determined by means of the Stains All assay and UV 
spectroscopy, respectively. Unfortunately, however, the amount of polymer obtained 
was inaccurate due to very high standard errors and is thus not reported here. 
Other techniques used to assay cellulose polymer were considered, although none of 
these techniques were considered ideal for the current samples. 
 Fluorescently labelled polymers 
Fluorescent probes such as fluorene, pyrene and fluorescein have been successfully 
used to label polymers (Winnik et al, 1987, 1989; Ahmed et al, 2001) for assay.  
However most of these labels impart a partial charge to the labelled polymer. The 
presence of a slight charge on the polymer chains would alter the polymer‘s 
adsorption profile on the drug particles making for erroneous results. 
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 Colorimetric assays 
Previous attempts to quantify HPMC using colorimetric assays were grossly 
inaccurate due to the polymer molecular weight dependence of this technique 
(Sepassi 2003). 
 High performance liquid chromatography 
High performance liquid chromatography (HPLC) has been used to assay cellulosic 
polymers. However HPLC was unsuitable for the current systems comprising of 
different polymer molecular weights and the fractionation of polymers that may 
occur during milling which would make the data analysis extremely complicated. In 
addition, the presence of surfactant and dissolved griseofulvin in the samples would 
be a further challenge. 
Though it was not possible to obtain polymer adsorption isotherms on the 
griseofulvin nanoparticles by the depletion method, due to interference by dissolved 
griseofulvin, the surfactant adsorption isotherms on the drug surfaces are highly 
suggestive of polymer-surfactant co-adsorption. Small angle neutron scattering 
experiments presented in Chapter 4 will be used to further investigate the adsorption 




This chapter presents work aimed at determining the adsorption isotherms of 
polymer and/or surfactant onto the milled griseofulvin drug nanoparticles by 
measuring the depletion of polymer and/or surfactant from solution.  A colorimetric 
Stains All assay was used to determine the amount of anionic surfactant left in 
solution after milling, while optical rotatory dispersion was used to assay HPMC 
polymer remaining in solution after milling. Unfortunately the HPMCAS adsorption 
isotherms could not be determined due to the turbid nature of HPMCAS samples 
making them unsuitable for spectroscopy. The resultant surfactant adsorption 
isotherms revealed the adsorption of anionic surfactant onto the griseofulvin particle 
surfaces. Interestingly a characteristic ‗Somasundaran-Fluerstenau‘ isotherm, for 
ionic surfactant adsorbing onto a surface of opposite charge, was obtained suggesting 
that electrostatic interactions were driving the adsorption process of SDS and AOT 
onto the griseofulvin nanoparticles. 
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Milling results in section 2.3.1 revealed that only anionic compounds (surfactants or 
polymers) could adsorb onto the surface of griseofulvin particles upon milling and 
provide effective stabilisation for nanoparticle production. None of the non-ionic or 
cationic stabilisers tested were effective in stabilising griseofulvin nanoparticles. 
Crystals of organic solids have been shown to have anisotropic surfaces, with the 
surface chemistry of each crystal facet being dependent on the differential exposure 
and concentration of the constituent chemical groups at the surface. Heng et al 
(2006) reported that milling of crystalline solids exposes the crystal facet with the 
weakest attachment energy, with the dominance of the surface properties of this facet 
increasing as particle size is reduced. Recent studies by Shariare et al (2012) have 
shown that inter-planar d-spacings and the corrugation of lattice slip planes are 
superior to attachment energy calculations in prediction of the fracture of crystalline 
material. 
The amount of anionic surfactant adsorbed onto the griseofulvin particles increased 
with increasing starting surfactant concentration in the milling slurry. Calculating the 
area per surfactant molecule adsorbed on the drug surfaces and comparing it with 
area per surfactant molecule in the air-water monolayer as determined by surface 
tension measurements, allowed an assessment of the possible conformation of the 
surfactant molecules on the surface of griseofulvin. At low levels of surfactant 
adsorption, the surfactant molecules were considered to be either lying flat on the 
surface of griseofulvin or forming hemimicelles. As the amount of adsorbed 
surfactant increased there was formation of a surfactant monolayer and thereafter a 
surfactant bilayer/trilayer, on the surface of griseofulvin. 
When the non-ionic polymer HPMC was included in the milling slurry containing 
anionic surfactant, the amount of surfactant adsorbed was consistently lower, 
indicating HPMC and anionic surfactant could be co-adsorbing onto the drug 
surfaces. In addition the area per surfactant molecule adsorbed onto the drug surfaces 
was slightly larger in the HPMC-surfactant formulations relative to the surfactant 
only formulations suggesting a more relaxed conformation of adsorbed surfactant – 
which we could reasonably assume to be due to presence of non-ionic polymer on 
the griseofulvin surfaces thus reducing surfactant charge repulsion. 
It was not possible to determine the amount of the HPMC adsorbed onto the drug 
surface by measuring its concentration in the nanosuspension supernatant due to the 
interference arising from dissolved griseofulvin (which is optically active). However 
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the differences in the surfactant adsorption isotherms when nanoparticles were 
prepared in absence/presence of HPMC were suggestive of polymer-surfactant co-
adsorption on the surface of griseofulvin. Further investigations into the adsorption 
of polymer and/or surfactant onto the griseofulvin nanoparticles using small angle 












































Small angle neutron scattering (SANS) is a sophisticated technique, which allows 
the determination of the size, shape and even orientation of colloidal particles in 
solution (King 1995). Neutrons can provide structural information on length scales 
from a fraction of an angstrom to tens of hundreds of angstroms (i.e. from the atomic 
scale through the macromolecular to the smaller end of the colloidal size range) and 
is useful for the study of polymers in solution, surfactant micelles, microemulsions 
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and adsorbed polymer and/or surfactant layers. Furthermore, the exploitation of 
contrast matching (or the ‗neutron‘ refractive index, explained later) can provide 
very detailed information about structure/sub-structure in multi component systems. 
Although depletion methods are frequently used to investigate the adsorption of 
polymer/surfactant onto solid surfaces, such methods can only give an indication of 
the adsorbed amounts of material. SANS on the other hand, allows the elucidation of 
not only adsorbed amounts but also the thickness and bound fraction of the adsorbate 
layer and thus provides a more complete picture of adsorption. In addition the 
volume fraction profile, which is variation in the concentration of adsorbate with 
distance from the surface, can also be obtained (King et al, 2000).  
Numerous reports of SANS investigations into adsorption of polymers or surfactants 
onto solid particles are available in literature. However these studies are often 
performed using well characterised, monodisperse small spherical systems such as 
silica or latex beads. For example Qui et al (2008) studied the adsorption of 
polyethylene onto colloidal silica particles, while Penfold et al (1996) studied the 
adsorption of non-ionic surfactants on silica sol particles. SANS adsorption studies 
on milled particles, which are inherently polydisperse both in size and shape, have 
not been published. 
Previous researchers in our group (Sepassi 2003; Goodwin 2006) successfully 
utilised SANS to characterise polymer adsorption on nabumetone and halofantrine 
nanopartices prepared by WBM. In these cases only polymer, namely HPMC, HPC 
or PVP, was used to stabilise the nanoparticles. In the present study however, a more 
complicated stabilising system was used consisting of polymer and surfactant, which 
are assumed to be co-adsorbed onto the griseofulvin nanoparticles. Although the 
depletion experiments in Chapter 3 confirmed the adsorption of anionic surfactant 
onto the nanoparticle surfaces, no quantiative results were obtained for polymer 
adsorption. The overarching aim of this part of the study therefore, was to determine 
the adsorption isotherm for the non-ionic polymer (HPMC) onto the surface of the 
griseofulvin nanoparticles. In addition, the absorption of anionic surfactant was also 
quantified in order to corroborate the results obtained from the depletion 
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4.2 Neutrons and their sources 
 
Neutrons, which were discovered by Chadwick (1932), have a zero charge, a mass of 
1.0087 atomic mass units, a spin of 1/2 and a magnetic moment of -1.9132 nuclear 
magnetons. Each neutron has a half-life of 894 seconds and decays into a proton, an 
electron and an antineutrino. Neutrons are highly penetrating and are scattered by 
nuclei in samples, by unpaired electron spins (dipoles) in magnetic samples and 
reflected from some surfaces - properties which can be used to probe both bulk and 
surface sample characteristics (Hammouda 1995).  
 
Neutron sources 
Neutrons are mainly produced from fission reactors or spallation sources. There are 
currently about 200 neutron sources in the world across Europe, Asia, Africa and 
America. Figure 4.1 shows the neutron and X-ray sources in Europe which include 













In a fission reactor, heavy nuclides such as uranium-235 or plutonium-239 are 
bombarded by a neutron source which leads to fragmentation of the heavy nuclide, 
releasing fission fragments; gamma rays and fast (high energy) neutrons at 2 MeV. 
The fission chain reaction continues and thus reactor sources are a continuous flow 
of neutrons. These fast neutrons are subsequently shielded and slowed to produce 
cold (low energy) neutrons suitable for experiments.  
Reactor sources around the world include HFIR-Oak Ridge National Laboratory, 
USA, HFBR-Brookhaven National Laboratory, USA, NIST-The National Institute of 
Standards and Technology, USA, MURR-The University of Missouri, USA, CRNL-
Chalk River, Canada, IAE-Beijing, China, DRHUVA-Bombay, India, ILL-Grenoble, 
France, NLHEP-Tsukuba, Japan, NERF-Petten, The Netherlands, Bhabha ARC 
Bombay, India, IFF-Julich, Germany, JRR3-Tokai Mura, Japan, KFKI-Budapest, 
Hungary, HWRR-Chengdo, China, LLB-Saclay, France, HMI-Berlin, Germany and 
VVR-M Leningrad, Russia.  
 
Spallattion sources 
In spallation sources, high energy H
-
 are produced and linearly accelerated before 
being spun in a synchrotron to achieve very high energies (500-800 MeV). Once 
they reach this energy they are used to bombard a neutron rich target e.g. Tungsten-
183 or Uranium-238. The result is the production of fast neutrons and few gamma 
rays. These high energy neutrons are then moderated before being used for 
experiments. Most spallation sources operate in pulsed mode. 
Spallation sources around the world include IPNS-Argonne, USA, ISIS-Rutherford, 
UK, WNR/PSR LANSCE-Los Alamos, USA, and KENS-Tsukuba, Japan.  
 
4.3 SANS instruments 
 
Steady state instruments (reactor sources)  
The main components of a SANS instrument on a steady state (or reactor source) are 
beam filters to remove unwanted gamma or epithermal neutrons, monochromators to 
select the wavelengths desired, a collimation chamber to focus the neutron beam, 
sample chamber with heating/cooling system, evacuated post sample flight path, an 
area detector and a set of beam stops to prevent the main (unscattered) neutron beam 
damaging the detector. Advantages of reactor source instruments include 
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straightforward data analysis and better resolution at high d-spacings (low Q) 
making such instruments suitable for studying magnetic samples, structures with 
large unit cells and ab-initio structures in solution (Hammouda 1995). 
 
Time of flight instruments (PULSED spallation sources) 
Time of flight (TOF) SANS instruments on a pulsed spallation source comprise 
many of the features described above (including collimation, sample chamber, flight 
paths, area detector, etc) as well as some specific features such as a source chopper 
which is used to define the starting neutron pulse and an area detector synchronized 
to the source chopper so that a number of wavelength frames are recorded for each 
pulse. No monochromator is necessary with TOF instruments at pulsed spallation 
sources. Supermirror benders and frame overlap mirrors can be used to remove short 
and high wavelength neutrons respectively. Prompt gamma rays emitted during the 
spallation reaction are eliminated by paralyzing the detection system for the first 
microsecond after each pulse.  
Data reduction becomes more complex with TOF instruments since most corrections 
(transmission, monitor normalization, detector efficiency, linearity, uniformity, etc) 
are wavelength dependent. Time-of-flight instruments have the advantage, on the 
other hand, of measuring a wide Q range at the same time. Also the large number of 
wavelength frames can be kept separate therefore yielding very high wavelength 
resolution, which is useful for highly ordered scattering structures (Hammouda 
1995). 
Two steady state instruments were used in the present study namely D11 (ILL, 
France) and SANS 2 (PSI, Switzerland) are discussed in further detail below. 
 
4.3.1 D11 at Institut Laue-Langevin 
D11 at ILL (France) shown in Figures 4.2–4.3 offers the lowest momentum transfer 
and background of all the world‘s SANS instruments. D11 receives neutrons from 
the vertical cold source of the ILL high flux reactor, which is situated about 100 m 
from the first part of the instrument (the selector) and about 140 m from the sample 









Figure 4.2: Geometry of a continuous source diffractometer, D11 at the ILL, France 
 
The polychromatic beam from the cold source is monochromated by a helical slot 
(ASTRIUM) velocity selector, which selects neutrons of ± 9 % about a mean 
wavelength determined by the rotation speed of the drum. The neutrons are then 
collimated by a series of moveable glass guides. Guide sections are inserted into or 
removed from the beam depending on the incident beam divergence required. The 
sample zone, situated 40 m down-stream from the velocity selector, may be equipped 
with various sample environments such as an automatic temperature controlled 
sample changer, cryostat, magnet, shearing cell, Bohlin rheometer, dilution 
refrigerator, horizontal sample-changer under vacuum, etc. 





multi-detector mounted on a moveable trolley within the evacuated detector tube. 
The detector may be placed at any distance between 1.2 and 39 m from the sample 
position, giving a total accessible momentum transfer range of 0.0003 to 0.1 Å
 
(D11 
characteristics, ILL website). 
 
 





Figure 4.3: Photograph of the D11 instrument. Picture courtesy of ILL, France 
 
4.3.2 SANS 2 at Paul Scherrer Institut 
SANS 2 at PSI (Switzerland) shown in Figure 4.4 is one of the SANS instruments at 
the SINQ beam line, a continous spallation source, the first of its kind worldwide. 
The incoming neutrons are monochromized by a mechanical velocity selector to 
produce a neutron wavelength range of 4.5 - 20 Å. Collimation is performed in the 
six meter long collimation section, consisting of one fixed and five moveable one-
meter sections allowing the neutron source pin-hole to be moved from one to six 
meters in steps of one meter away from the sample position. The whole system, i.e. 
collimators, sample chamber and detector tank can be operated in a single vacuum 
system without windows in order to lower background.  
Scattered neutrons are detected on an area-sensitive multi-wire proportional neutron 
detector of 64 cm diameter and 128×128 pixels. The detector can be moved 
continuously from one to six meters away from the sample position. The accessible 













Figure 4.4: Photograph of the SANS 2 instrument. Picture courtesy of the PSI, 
Switzerland. 
 
4.4 SANS in comparison with other techniques 
Various forms of radiation scatter energy (Table 4.1) and can be used for 
experimental investigations. The choice of technique in a particular experiment is 
guided by structure, shape, size of domains of sample of interest. 
 
Table 4.1: Characteristics of the various radiations used in scattering experiments 
(Hammouda 1995) 
 
Radiation type Light X-Rays Neutrons Electrons 























1-5 mm < 1 mm 1-2 mm 100um 
Problems Dust scattering Absorption, 
destructive 
Low fluxes Low 
penetration  
 
Neutron scattering offers a range of advantages over other scattering techniques 
including a high penetration of most elements allowing the study of bulk properties, 
its non destructive nature allowing repetitive measurements and scattering length 
densities independent of atomic number leading to isotope effects e.g. deuterium 







Chapter 4 Small angle neutron scattering 
217 
 













) is often used for contrast matching. Experimentally, there is 
no need to clarify SANS samples and opaque samples can be studied. 
 
Figure 4.5: Neutrons are scattered from nuclei while X-rays are scattered from 
electrons. Scattering lengths for a few elements relevant to polymers are compared. 
Ti and U have also been included. Negative neutron scattering lengths are 
represented by dark circles (Hammouda 1995). 
 
Disadvantages of SANS include the expense involved in building and maintaining 
neutron facilities as well as the expense of deuterating samples, low neutron fluxes 
from these facilities as well the need for relatively large volume of samples. Highly 
concentrated samples are liable to multiple scattering thereby making data analysis 
more difficult. 
 
4.5 SANS theory and measurements 
 
4.5.1 Scattering vector 
When neutrons come into contact with a sample they may undergo one of a series of 
events, including absorption, multiple, coherent or incoherent scattering, or be 
transmitted through the sample. Figure 4.6 shows the coherent scattering of neutrons 
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through a sample. The scattering vector (or momentum transfer) is the modulus of 




Figure 4.6: Scattering of neutrons by a sample. Picture courtesy of National Institute 
of Standards and Technology (NIST). 
 
The magnitude of the scattering vector (Q) is given by: 
 














                    (Equation 4.1)
 
 
where θ is the scattering angle, λ is the incident neutron wavelength and n is the 
neutron refractive index which is approximately 1. Q has dimensions of length
-1
 and 



















                                                    (Equation 4.2)
 
 





                                                              (Equation 4.3) 
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where d is the molecular length scale obtainable over a particular Q range. 
 
Equations 4.1 and 4.3 are critical to SANS experiments and help predict the 
accessible Q range of an instrument as well as the range of sample length scales it 
can probe. 
 
4.5.2 Scattering length density and contrast matching 
The neutron scattering length density (ρ SLD) of a molecule comprising of i atoms can 






                                            (Equation 4.4)
 
 
where D is the bulk density of the scattering body, NA is Avogadro‘s constant, Mw is 
molecular weight and bi is bound coherent scattering length density of atom i. ρ SLD 
has dimensions of length
-2
 and can be negative. 
 
The contrast term in any experiment is defined as the square of the difference 
between the scattering length density of the part of sample of interest (ρp) and the 
scattering length density of the surrounding medium (ρm). If (ρp - ρm)
2
 is equal to 
zero, then the sample is said to be contrast matched. At the contrast match there is no 
scattering (King 1995). 
Contrast matching is a powerful tool as it enables the study of multicomponent 
samples in detail. For example in scattering studies studying a layer of absorbed 
polymer on a particle, the particle can be contrast matched to the surrounding media 
rendering it effectively ‗invisible‘, therefore scattering is obtained only from the 
region of interest, namely the adsorbed layer (Figure 4.7). A mixture of deuterated 
and protonated solvents are often used in contrast matching taking advantage of the 
different scattering length densities of H and D. Table 4.2 shows the scattering 









               
                         










                                 H2O                                                 H2O/D2O mix 
                                                                                  Contrast match point 
 
Figure 4.7: A schematic illustration of the contrast matching of a particle using a 
mixture of H2O and D2O to enable characterization of scattered layer  
 
Table 4.2: Neutron scattering length densities of commonly used hydrogenous and 
deuterated solvents (King 1995) 
 









Water - 0.56 + 6.38 
Octane - 0.53 + 6.43 
Cyclohexane - 0.28 + 6.70 
Toluene + 0.94 + 5.66 
Chloroform + 2.39 + 3.16 
 
4.5.3 SANS measurements 
Experiment plan 
A successful SANS experiment requires careful planning and consideration of 
desired Q range, sample size, environment (temperature, pressure, magnetic field), 
and sample counting time. The required Q range is determined by the length scales 
of interest, e.g. to probe large structures such as those of interest in the present study, 
a very low Q range is required. The instrument configuration is altered to achieve the 
desired Q range.  
H20 H20 D20 
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SANS can be used to examine liquid, solid or gel samples with the concentration of 
amount required being dependent upon the sample under study. Deuterated solvents 
are preferred as the sample medium since their incoherent scattering is significantly 
lower in comparison to hydrogenous solvents and therefore lower counting times are 
required to produce the necessary statistics. In a SANS experiment the coherent 
scattering contains important structural information while the incoherent scattering is 
the flat background and reduces the accessible Q range of the measurement (Choi 
2000).  
 
Data collection and handling 
Raw SANS data consists of integer numbers with no statistical errors, which must be 
reduced to give anisotropic data (real data with calculated statistical errors) and 
finally isotropic data (one dimensional scattering information). The first step of data 
treatment involves scattering and transmission data from sample, scattering from 
empty sample holder, an incoherent calibration scatter e.g. water or vanadium, 
background as well as absolute scaling factors. From these data corrected anisotropic 
files are obtained. The second step, reduction of two-dimensional data into one 
dimension, is performed by radial averaging and requires input of the position of a 
beam centre (Keiderling 2002).  
Apart from neutrons scattered by the sample, neutrons are also scattered by the 
empty sample cell, windows, collimation slits, or air. In addition stray neutrons, 
cosmic radiation or detector dark current can also reach the detector (Choi 2000). 
Therefore in addition to sample scattering measurements, transmission, background, 
empty beam, detector sensitivity and blocked beam measurements are needed for 
data correction.  
 
















                    (Equation 4.5)
 
 
where ICOR, ISAM, IBKG are the corrected scattering intensity, scattering intensity due 
to sample and background respectively, Tsample + cell , Tsample are the transmissions due 
to sample plus cell and cell respectively, and IEMP, IBKG intensity due to empty beam 
and blocked beam respectively. 
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I CORCAL                   (Equation 4.6)
 
 
where ICAL is the calibrated scattering intensity. 
 
The absolute scaling yields a critical SANS parameter, namely the differential 








































 is the differential scattering cross section, ICAL is the calibrated 
scattering intensity,  is the incident neutron flux, A is the sample area, d is the 
sample thickness,  is the solid angle of each pixel, ε is the detector efficiency and 
t is the counting time. 
 
Information concerning the size, shape and interaction between scattering centres in 
a sample is derived from the differential scattering cross section (Choi 2000).  
 
4.6 SANS data interpretations 
 
4.6.1 Models 
SANS data from adsorbed layers is normally characterised at the zero contrast match 
point to give adsorption isotherms and volume fraction profiles. Away from the zero 
contrast match points, the measured scattering is due to both the adsorbed layer and 
the particle making it much more difficult to obtain any information (Cosgrove et al, 
1987). Models used to interpret SANS data from adsorbed polymer/surfactant layers 
are outlined below. 
 
 




This is the simplest model in which the size and shape of both bare and coated 
particle are determined. The thickness of the adsorbed layer is then simply obtained 
by subtraction. The drawback to this technique is that SANS is relatively insensitive 
to the few, well solvated, highly extended polymer tails at the periphery of adsorbed 
layer (King et al, 2000). The need for the measurement of the bare particles makes 
Guinier approximation unsuitable for the current study in which it is impossible to 
formulate drug nanoparticles without an adsorbed polymer/surfactant layer. 
 
Core shell model 
This approach models the particle and the adsorbed layer as two homologous 
concentric spheres (Figure 4.8). If the scattering length density of the particle is 
matched to that of the surrounding media, then the thickness of the spherical shell 
(i.e. the absorbed layer) can be deduced from the form factor. The drawback with 
this technique is that it assumes a uniform scattering length density throughout the 
adsorbed layer and thus a block profile volume fraction (King et al, 2000). The core 
shell model is therefore more useful in modelling the adsorption of short chain 































Figure 4.8 (a): Schematic representation of the ‗core shell‘ model of an adsorbed 
layer onto a particle where ρm, ρl, ρp are the scattering length densities of media, 
adsorbed layer and particle respectively while Rp is the radius of the bare particle and 
Rl is the radius of the particle plus the adsorbed layer respectively. (b) The block 
volume fraction profile corresponding to the ‗core shell‘ model of adsorbed layer 
onto a particle (King et al, 2000).  
 
Inversion technique 
This technique enables fitting parameters to be obtained without assuming a volume 
fraction (Φz). In fact this method can be used to determine the volume fraction of the 
absorbed layer (King et al, 2000). This model determines how the average density of 
the polymer chains vary with the distance (z) perpendicular to the interface, the layer 
thickness, the adsorbed amount (determined by integrating the area under the volume 
fraction profile curve), and the average fraction of the bound segments (determined 
from the portion of segments at z = 0) (Figure 4.9). The volume profiles obtained 
depend on the nature of the attachment of the polymer at the solid surface of the 
particle. For example, exponential profiles whereby the volume fraction decreases 
with distance from the interface are obtained with physically adsorbed polymers 
(Figure 4.9 (a)). Block copolymers with one block attached to the interface may 
display a parabolic volume fraction profile, while grafted polymers terminally 






















Figure 4.9 (a): Example of an exponential volume fraction profile of an adsorbed 
homopolymer, which shows how the polymer density (Φ) varies with distance from 
the interface (z). Labelled is the bound fraction (shaded dark blue),‹p›; the second 
moment of the thickness of the adsorbed layer, σ; the adsorbed amount (shaded 
blue), Γ; the span of the polymer layer, l (King et al, 2000). 
 
           
 
                            (b)                                                                      (c) 
 
Figure 4.9 (b-c): Example of a parabolic volume fraction profile of a block 
copolymer (b) and Gaussian volume fraction profile of a terminally grafted polymer 
(c) adsorbed on a solid surface, showing how the polymer density (Φ) varies with 
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4.6.2 SANDrA program 
SANS data in the present study was fitted to a surface Guinier model (King et al, 
2000) using the program SANDrA which enables both the amount and thickness of 
the adsorbed layer to be determined without assuming a volume fraction profile. 
 





















is the differential scattering cross section, P(Q) is the form factor, 
S(Q) is the structure factor and B is the background. 
 
The form factor is defined by 
 
     2)()()( QFppQFppQP lmlpmp               (Equation 4.9) 
 
where FPQ is the intra particle form factor for the core particle, FlQ is the intra layer 
form factor for the adsorbed polymer. 
 
The three major terms contributing to the form factor are the core particle, the 
adsorbed layer and the particle-surface interference. The contribution by the core 
particle and adsorbed layer can be ignored at the contrast match point (at which our 
experiments were carried out). If the particle radius is much greater than the 
adsorbed layer and ignoring the end fluctuations, the particle-surface interference 
can also be disregarded. Fortunately the drug particles in the current study are much 
larger (250-300 nm) than the thickness of the adsorbed surfactant/polymer layers and 
as a consequence therefore, the SANS data can be fitted with the limiting form of the 
layer scattering to partial form factor. 
 


























      (Equation 4.10) 
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where Γ is the amount of polymer adsorbed, σ is the second moment of the mean of 






Griseofulvin (97%) was purchased from Acros Organics (Geel, Belgium). 
Hydroxypropylmethylcellulose (HPMC) with a nominal molecular weight of 8K 
(Methocel E3LV (HPMC 8)) was obtained from Dow Company (Michigan, USA). 
All other chemicals were purchased from Sigma-Aldrich Co. Limited (Poole, UK). 
Chemicals were of the highest grade available and were used as received without 
further purification. Ultra pure water (UPW), obtained from a well seasoned, all 
glass still (D4000 Distinction, Sterling, UK) and D2O (99.9%) from Sigma-Aldrich 
(Gillingham, UK) was used for all the SANS experiments. 
  
4.7.2 Preparation of nanoparticles for SANS 
The production of nanoparticles was carried out by wet bead milling of crude 
griseofulvin suspensions (2.2.2) using 0.44 mm YTZ beads as described in section 
2.2.3. 10 g of griseofulvin was added to a 40 g suspension comprising of water and 
respective stabilisers giving a drug loading of 20% w/w. The resultant nanoparticles 
were then separated from the YTZ beads using a 60 mesh sieve. 
About 2 mL of the resultant griseofulvin nanosuspension was centrifuged for 90 min 
in a Heraus centrifuge as described in section 3.2.1.The weights of supernatant and 
pellet were carefully recorded and supernatant replaced with an equivalent weight of 
D2O/H2O solvent mix. The volume fraction of the milled and re-suspended 
nanosuspensions was 14.7% v/v. This nanosuspension was then diluted to give a 
volume fraction of 3.5% using appropriate mixture of D2O and H2O. Selection of a 
3.5% volume fraction for the SANS experiments was a balance of reducing to a 
minimum multiple scattering due to particle-particle interactions and obtaining 
sufficient scattering to be measured (Sepassi 2003; Goodwin 2006). 
 
4.7.3 Determination of contrast match point 
The scattering length density of griseofulvin and corresponding contrast solvent was 
calculated (section 4.5.2) using atom scattering length densities from the NIST 
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 and a 43.25: 56.75% v/v D2O/H2O contrast 
match solvent. The contrast match point was confirmed experimentally by 
determining the scattering intensity of nanoparticles prepared in a range of solvents 
containing different volume ratios of D2O/H2O (namely 30:70, 35:65. 40:60, 43:57, 
45:55 and 50:50). The scattering intensity of the nanoparticles in the various solvents 
was then plotted against Q, with the solvent composition in which there was the 
minimum scatter being selected as the contrast match solvent, as at this composition 
scattering arises solely from the absorbed layer. Thereafter contrast match solvent 
was used to re-suspend all the nanoparticles for examination using SANS. 
 
4.7.4 Sample selection  
Samples studied at ILL were griseofulvin nanoparticles prepared using 0.25, 0.5, 1.0 
and 1.5% w/w SDS/AOT, both in absence and presence of 1.88% w/w HPMC 8000. 
These experiments were designed to observe the effect of polymer, and of surfactant 
concentration, on the extent of polymer/surfactant adsorption. The volume fraction 
used in these experiments was 3.5% v/v, which had previously been determined as 
optimal for the present types of experiments (Sepassi 2003, Goodwin 2006).  
The second set of samples studied at PSI comprised of griseofulvin nanoparticles 
prepared with 1.5% w/w SDS/AOT, both in absence and presence of 1.88% w/w 
HPMC 8000. The limited number of samples studied was due to the lower intensity 
flux of the beam line. In addition, a nanoparticle volume fraction of 14.7% v/v (as 
opposed to 3.5% v/v) was used to try and increase the sample scattering. 
 
4.7.5 SANS measurements 
SANS measurements were carried out at D11 at Institut Laue-Langevin (Grenoble, 
France) and SANS 2 at Paul Scherrer Institute (Villigen, Switzerland). While it 
would have been ideal to carry out both experiments using D11 at the ILL due to it 
being a more intense neutron source, the highly competitive nature of neutron 
experiments meant it was not possible. The main limitation of performing the 
experiments at two different facilities is the different intensities of the sources, 
although different instrument geometries also meant that differing Q ranges were 
accessible. For example the ILL experiments were carried out at a detector distances 
of 5 and 15 m using neutrons of a wavelength of 6 ± 0.6 Å accessing a Q range of 
0.006 to 0.14 Å
 –1
 while the SANS 2 experiments were carried out at detector 
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distances of 2 and 6 m at a wavelengths of 5, 10 and 18 Å accessing a Q range of 
0.04 to 1.4 Å
 -1
. Ideally the experiments should be performed at as low a Q range as 
possible due to the large size (in terms of SANS) of the nanoparticles  
Transmission measurements were carried out at one detector distance (namely 6 m at 
SINQ, 15 m at ILL). Samples were placed in 1 mm quartz cells and measured for 2 
and 120 min each for transmission and scattering runs respectively at ILL. Sample 
measurement times were ~ two times longer at SINQ. Measurements of direct beam, 
empty sample cell, water and dispersing solvent were all performed to enable 
subsequent data reduction. Experiments were performed at 25 ± 0.1ºC. 
 
4.7.6 Data reduction 
The principle of the SANS data reduction is identical at both faculties, although the 
specific programs used are dependent on the particular facility as each has its own 
preferred software package for use on its instruments. In principle, a mask file is 
created to remove data points at and around the beam stop and around the outermost 
perimeter of the detector as well as any damaged pixels on the detector. The data is 
then corrected with transmission files, radially averaged before being calibrated with 
the detector response.  
D11 neutron data reduction was carried out using GRASP, a Matlab postscript 
application used for graphical analysis, inspection and reduction of SANS data from 
ILL instruments (Dewhurst 2003). SANS 2 neutron data was reduced by BERSANS, 
a similar software with graphical interface used for all SINQ instruments (Keiderling 
2002). Another additional step in the data reduction involves merging of data from 
different detector distances to give a single curve. The merging of both ILL and 
SANS 2 data was carried out using OriginPro 8 software. 
 
4.7.7 Data fitting 
SANS data was fitted using the SANDrA program, a volume fraction independent 
surface Guiner model (King 2000). This program models the differential scattering 
cross section to obtain an estimate of the amount of polymer adsorbed (Γ) and the 
second moment of thickness (σ) of the adsorbed polymer layer. A detailed discussion 
of the equations used by the program is given in section 4.6. The parameters input in 
the SANDrA program in the present study are given in Table 4.3. The best model fit 
is attained at chi squares of between 0.82975 and 1.17025. 
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d-SDS + Gris 1.01 5.36 × 10
10 
 2.98 × 10
10 
1500 





h-SDS + HPMC + Gris 1.33 1.31 × 10
10
 -1.07 × 10
10
 1500 
d-SDS + HPMC + Gris 1.33 1.31 × 10
10
 -1.07 × 10
10
 1500 
AOT + HPMC + Gris 1.33 1.31 × 10
10




The volume fraction of the ILL samples was 0.035, while that of the SINQ samples 
was 0.147. 






4.8 Results  
 
4.8.1 Contrast matching 
The contrast match solvent for griseofulvin obtained by scattering length density 
calculations was 43.25% v/v D2O: 56.75% v/v H2O. In order to confirm this 
theoretical calculation, experimentally griseofulvin nanoparticles (prepared in 
presence of 0.5% w/w SDS) were re-suspended in aqueous solvent containing 
varying amounts of D2O. The neutron scattering intensities of these samples were 
measured and the variation in intensity with Q determined (Figure 4.10). From the 
data presented in Figure 4.10, the scattering intensity at a Q value of 0 was 
determined for each solvent composition and plotted against the % v/v D2O in re-
suspending solvent (Figure 4.11). 
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Figure 4.10: Variation in neutron scattering intensity as a function of Q for  
griseofulvin nanoparticles prepared in presence of 0.5% w/w SDS re-suspended in 
solvents of different D2O/H2O compositions namely: 30% v/v (―), 35% v/v (―), 
40% v/v (
…..
), 43% v/v (―), 45% v/v (―) and 50% v/v (…..). Measurements carried 
out on D11 at 25 ± 0.1ºC. 












y = 8599.561 - 870.022x + 33.278x
2 
















Figure 4.11: Variation of neutron scattering intensity at Q = 0 for griseofulvin 
nanoparticles, prepared in presence of 0.5% w/w SDS, with the % v/v D2O present in 
the resuspending solvent. Measurements carried out on D11 at 25 ± 0.1ºC. 
 
Reassuringly, the nanoparticles re-suspended in 43% v/v D2O had the lowest 
experimentally measured scattering intensity (Figure 4.10-4.11) thereby confirming 
the theoretically calculated contrast match point for griseofulvin. At this solvent 
composition any scattering measured from the nanoparticle suspensions was solely 
due to the adsorbed surfactant layer. As a consequence, therefore solvent containing 
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43% v/v D2O was used to re-suspend the nanoparticles for all other SANS 
experiments. 
 
4.8.2 Data reduction 
Data reduction was carried out using GRASP and BERSANS software for ILL and 
SANS 2 data, respectively. Merging of reduced SANS data at the different Q ranges 
was performed using OriginPro 8.0. Figure 4.12 shows an example of merged SANS 
data obtained at two detector distances from grisofulvin nanoparticles prepared in 
presence of 1.5% w/w SDS + 1.88% w/w/ HPMC 8000. 


























Figure 4.12: Merging of SANS data at 5 m (ᵻ) and 15 m (ᵻ) detector distances from 
griseofulvin nanoparticles prepared in presence of 1.5% w/w SDS + 1.88% w/w 
HPMC 8000. Measurements performed on D11 at 25 ± 0.1ºC. 
 
4.8.3 Fitting of contrast matched data  
4.8.3.1 Surfactant systems 
ILL data 
The surfactant samples comprised of griseofulvin nanoparticles prepared in the 
presence of 0.25% w/w SDS, 0.5% w/w SDS, 1.0% w/w SDS, 1.5% w/w SDS, 
0.25% w/w AOT, 0.5% w/w AOT, 1.0% w/w AOT and 1.5% w/w AOT. The SANS 
data obtained for these surfactant stabilised samples was modelled using adsorption 
parameters obtained from spectroscopic measurements (Tables 4.4-4.5) and particle 
radius of 1500 Ǻ to obtain expected fits shown in red (Figures 4.13-4.14( a-d)). The 
surfactant adsorption mechanisms proposed in section 3.3.3.1 were used to estimate 
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the thickness of the adsorbed layer, with a surfactant monolayer fixed at ~ 1.8 nm 
(Hubbard et al, 2005) and ~ 1.4 nm (Xu et al, 2004) for SDS and AOT, respectively. 
The data fits assuming a particle radius if 1500 Ǻ were poor (chi squares of 4.532-
98.7864). Interestingly however there was a better agreement between SANS data 
and expected fits when a higher particle radius of 6000 Å was used (fits shown in 
blue in Figures 4.13-4.14 (a-d)), suggesting that either PCS underestimated the size 
of the nanoparticles and/or that the nanoparticles were flocculated/aggregated. 
Indeed these surfactant stabilised nanoparticles were visibly cloudy on removal from 
the neutron sample chamber indicating physical instability. The data fits assuming a 
particle radius if 6000 Ǻ gave chi squares of between 1.8763 and 5.8799. 
 
Table 4.4: Surfactant adsorption parameters onto griseofulvin nanoparticles 








0.25% SDS  0.627 0.5 
0.5% SDS  0.986 1.8 
1.0% SDS  1.628 2.4 
1.5% SDS  2.085 3.6 
 
Table 4.5: Surfactant adsorption parameters onto griseofulvin nanoparticles 








0.25% AOT  0.692 0.5 
0.5% AOT  0.874 1.4 
1.0% AOT  1.345 2.1 
1.5% AOT  1.847 2.8 
 
All other formulations were fitted assuming a particle radius of 1500 Ǻ inorder to 
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Figures 4.13 (a-d): SANS data of griseofulvin nanoparticles prepared in presence of 
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Figures 4.14 (a-d): SANS data of griseofulvin nanoparticles prepared in presence of 
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SANS 2 data 
Griseofulvin nanoparticles prepared at one surfactant concentration namely 1.5% 
w/w h-SDS, d-SDS and AOT were analysed. These samples were studied at high 
volume fraction of 14.7% v/v. The surfactant stabilised nanoparticles were cloudy 
with visible aggregates and some sedimentation on removal from the neutron sample 
chamber indicating physical instability- particularly the 1.5% w/w AOT sample. 
SANS data obtained for these surfactant stabilised samples in Figures 4.15 (a-c) was 
modelled using adsorbed amount determined spectroscopically (Table 4.4-4.5) and 
particle size of 1500 Ǻ to obtain expected fits shown in red (chi squares of 3.532-
58.7864). The scattering from the SINQ surfactant only systems was minimal, which 
is in agreement with the data obtained from the samples analysed in ILL (Figures 
4.13-4.14 (a-d)) and the fact that the data collected at SINQ did not go down to as 
low a Q value as that measured at the ILL. One interesting observation, seen only 
with SINQ data, was that the 1.5% w/w AOT sample seemed to have the notably 
stronger scatter than the 1.5% w/w SDS samples. It is worth commenting that the 
concentration of nanoparticles used for this study were much higher than those used 
on D11 at the ILL and as a consequence interparticulate interactions may have been 
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Figures 4.15 (a-c): SANS data of griseofulvin nanoparticles prepared in presence of 
1.5% w/w d-SDS, 1.5% w/w h-SDS and 1.5% w/w AOT. 
 
4.8.3.2 Polymer-surfactant systems 
SANS data from nanoparticles prepared in presence of polymer and surfactant 
exhibited a markedly higher scatter compared to those prepared with surfactant only, 
supporting the hypothesis of co-adsorbed non-ionic polymer on the nanoparticle 
surfaces. As noted earlier, anionic surfactant was found to adsorb onto griseofulvin 
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nanoparticles while non-ionic polymer when used as sole stabiliser did not. However 
in the presence of HPMC, changes in anionic surfactant adsorption and nanoparticle 
stabilisation were seen, strongly suggestive of co-adsorption were observed (section 
3.3.2). We postulate that a polymer-surfactant complex is formed at the nanoparticle 
surfaces, with anionic surfactant serving as an anchor for HPMC adsorption. 
Previous members in our group (Sepassi 2003, Goodwin 2006) successfully fitted 
neutron data of polymer (HPMC, HPC or PVP) adsorbing on nabumetone and 
halofantrine nanoparticles using the SANDrA program. However, our griseofulvin 
systems present an added challenge in that they also contain adsorbed surfactant at 
the nanoparticle surfaces. The ORD assay (section 3.4) was unsuccessful therefore 
we have no prior determination of amount of polymer adsorbed, thus the results from 
the SANS experiments were used to provide an estimate of polymer adsorption onto 
the griseofulvin nanoparticles.  
 
ILL data 
The polymer data was fitted by the SANDrA guinier approximation. In order to do 
this some assumptions had to be made. Firstly, it was established by the depletion 
method that, even in the presence of HPMC, these nanoparticles adsorbed anionic 
surfactant on their surface. Therefore SANS data from the surfactant only 
formulations was subtracted from that of the corresponding polymer-surfactant 
formulations. The resultant SANS data was then fitted to determine amount of 
absorbed polymer. Scattering data was fitted to obtain the best visual fits to the data 
and lowest chi squares (1.6718-2.0194). The fits to the experimental data thus 
obtained are represented by the red lines in Figures 4.16-4.17 (a-d). In this way the 
SANS data was successfully fitted to quantify the amount of adsorbed polymer 
(Table 4.6-4.7). The results revealed that HPMC 8000 was adsorbing onto 
griseofulvin nanoparticles together with the anionic surfactant. The absorbed 
amounts of HPMC were in the region of 0.3-0.9 mg/m
2
 – similar to values quoted in 
literature (Sawyer et al, 2001) but much lower than those obtained by Sepassi (2003) 
and Goodwin (2006) in our group, perhaps not surprisingly as HPMC was the sole 
stabiliser in their studies. Sepassi (2003) and Goodwin (2006) studied adsorption of 
HPMC 8000 onto nabumetone and halofantrine nanoparticles obtaining adsorption 
values of 4.6 mg/m
2
 and 2.4 mg/m
2
 respectively using a particle radius of 4000 Ǻ.  
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Figures 4.16 (a-d): SANS data of griseofulvin nanoparticles prepared in presence of 
1.88% w/w HPMC 8000 + either 0.25% w/w SDS, 0.5% w/w SDS, 1.0% w/w SDS 
or 1.5% w/w SDS. 
 
 
Table 4.6: Fitted parameters obtained from SANS data of griseofulvin nanoparticles 
prepared in presence of varying concentrations of SDS + 1.88% w/w HPMC 8000 
 






0.25% w/w SDS + 1.88% w/w HPMC 8000 0.57 3.98 
0.5% w/w SDS + 1.88% w/w HPMC 8000 0.3 3.65 
1.0% w/w SDS + 1.88% w/w HPMC 8000 0.68 4.01 
1.5% w/w SDS + 1.88% w/w HPMC 8000 0.73 4.76 
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Figures 4.17 (a-d): SANS data of griseofulvin nanoparticles prepared in presence of 
1.88% w/w HPMC 8000 + either 0.25% w/w AOT, 0.5% w/w AOT, 1.0% w/w AOT 
or 1.5% w/w AOT. 
 
Table 4.7: Fitted parameters obtained from SANS data of griseofulvin nanoparticles 








0.25% w/w AOT + 1.88% w/w HPMC 8000 0.7 6.80 
0.5% w/w AOT + 1.88% w/w HPMC 8000 0.49 3.15 
1.0% w/w AOT + 1.88% w/w HPMC 8000 0.33 4.21 
1.5% w/w AOT + 1.88% w/w HPMC 8000 0.94 6.36 
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Figure 4.18 shows the variation in the amount of HPMC 8000 adsorbed (as 
determined by SANS) with starting surfactant concentration. Figure 4.19 shows the 
variation in the thickness of adsorbed HPMC 8000 layer with starting surfactant 
concentration. The average thickness of the adsorbed polymer layer was ~ 4 nm, 
while the thickness of a fully stretched HPMC 8000 layer, adsorbing with anchoring 
trains and outstretched tails, is 10.6 nm as determined by Sepassi (2003). These data 
suggest therefore that, in the present study, the polymer was lying flat on the surface 
of the griesofulvin nanoparticles. The thickness of the polymer layer obtained with 
the SDS-stabilised systems was more consistent that that obtained with the 
formulations containing AOT.  











Starting surfactant concentration(% w/w)
 
Figures 4.18: Amount of polymer adsorbed (Γ) onto griseofulvin nanoparticles 
prepared in presence of 1.88% w/w HPMC 8000 + either SDS (■) or AOT (●) on 
fitting SANS data with SANDrA. 
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 moment of thickness of adsorbed polymer layer (σ) on griseofulvin 
nanoparticles prepared in presence of 1.88% w/w HPMC 8000 + either SDS (■) or 
AOT (●) on fitting SANS data with SANDrA. 
 
SANS 2 data 
Samples at one surfactant concentration namely 1.5% w/w SDS, d-SDS and AOT in 
presence of 1.88% w/w HPMC 8000 were analysed. The SANS data was fitted (chi 
squares: 2.2518 - 3.6237) to obtain experimental fits shown in red (Figures 4.20 (a-
c)) and presented in Table 4.8. The adsorption parameters indicated a very thin (~1 
nm) but highly dense polymer layer which is unrealistic and suggests 
underestimation of volume fraction due to nanoparticle sedimentation. It must be 
noted, however, that the concentration of nanoparticles used for this study were 
much higher than those used on D11 at the ILL and as a consequence interparticulate 
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(a)                                                           (b) 
































 1.5% w/w d-SDS + 
1.88% w/w HPMC 8000
































 1.5% w/w h-SDS + 
1.88% w/w HPMC 8000
    
(c)                                                            
































 1.5% w/w AOT + 
1.88% w/w HPMC 8000
 
Figures 4.20 (a-c): SANS data of griseofulvin nanoparticles prepared in presence of 
1.88% w/w HPMC 8000 + either 1.5% w/w d-SDS, 1.5% w/w h-SDS or 1.5% w/w 
AOT. 
 
Table 4.8: Fitting parameters obtained from SANS data of griseofulvin 
nanoparticles prepared in presence of 1.88% w/w HPMC 8000 + either 1.5% w/w d-
SDS, 1.5% w/w h-SDS or 1.5% w/w AOT. 
 





1.5% d-SDS + 1.88% HPMC 8000 11.21 1.19 
1.5% h-SDS + 1.88% HPMC 8000 11.3 1.42 
1.5% AOT + 1.88% HPMC 8000 8.92 1.76 




Small angle neutron scattering (SANS) was used to investigate the adsorption of 
surfactant and/or polymer on the griseofulvin nanoparticles. Spectroscopic studies in 
Chapter 3 revealed the adsorption of anionic surfactant onto griseofulvin 
nanoparticles, but the amount of polymer adsorbed could not be determined due to 
interference by dissolved griseofulvin. Thus SANS was used to examine the polymer 
adsorption isotherms onto the griseofulvin nanoparticles. The SANS experiments 
were performed at ILL, France and SANS 2, Switzerland. SANS allows for detailed 
characterisation of adsorption providing information on the adsorbed amounts, 
thickness of adsorbed layer and the volume fraction profile. At the contrast match 
point, the particle and solvent neutron scattering lengths are matched thus only 
scattering from the adsorbed layer seen. 
Both griseofulvin nanoparticles prepared in presence of anionic surfactant alone and 
in presence of anionic surfactant and non ionic polymer HPMC 8000 were studied. 
Notably the scatter from nanoparticles prepared in presence of 1.88% w/w HPMC 
8000 polymer and anionic surfactant where consistently higher than the 
corresponding nanoparticles prepared in presence of anionic surfactant alone. The 
results from polymer-surfactant systems were corrected by subtraction of surfactant 
scatter then fitted to obtain the adsorbed polymer layer. Fitting of the resultant 
scattering revealed that HPMC 8000 was co-adsorbed onto griseofulvin 
nanoparticles together with anionic surfactant. The amounts of co-adsorbed polymer 
were 0.3-0.9 mg/m
2























5.1.1 Surface energy of pharmaceutical crystals 
The surface energy of crystalline pharmaceutical solids influences manufacturing 
processes such as powder flow, granulation, compaction and the interaction with 
excipients (Wu et al, 2010). Of particular interest to the current work is the effect of 
surface energy of the milled drug crystals on the adsorption of stabilisers. No 
predictive model is currently available to aid in the selection of appropriate 
stabilisers for the production of drug nanoparticles by wet bead milling and the 
surface energetics of the drug crystals may provide useful insight.  
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Organic crystalline solids have been demonstrated to have anisotropic facet 
dependent surface chemistry. The surface chemistry of each crystal facet varies as 
the crystallographic planes dissect the unit cell at different angles and planar 
orientations exposing differing chemical groups and concentrations of those groups 
(Heng et al, 2006 a, b, c). During milling the crystal fractures to expose the weakest 
attachment face, with properties of this weakest attachment face dominating the 
milled state (York et al, 1998). The attachment energy is defined as the fraction of 
the total energy released upon the attachment of a lattice slice onto a growing 
surface. Previous authors have used a variety of techniques to characterise the 
surface energetics of particulate crystalline pharmaceuticals. For example York et al 
(1998) used inverse gas chromatography and computer modelling to characterise the 
surface energies of milled d,l-propanolol, while Heng et al (2006 a, b, c) used sessile 
contact angle measurements and X-ray photoelectron spectroscopy to elucidate the 
anisotropic surface chemistry of macroscopic aspirin, paracetamol and ibuprofen 
crystals. However, more recent studies by Shariare et al (2012) have shown that 
inter-planar d-spacings and the corrugation of lattice slip planes are superior to 
attachment energy calculations in prediction of the fracture of crystalline material. 
 
5.1.2 Current work plan 
The drug-stabiliser screen described in section 2.3.1 revealed that griseofulvin 
nanoparticles could only be produced in the presence of anionic stabilisers. Studies 
were performed to determine the surface energy of the griseofulvin crystal and its 
fracture plane. This work included growing macroscopic crystals of griseofulvin and 
characterising the individual crystal facets using contact angle measurements, X-ray 
photoelectron spectroscopy and single crystal X-ray diffraction. 
In addition computer modelling was used to investigate the crystal surface energy at 
the (001), (010), (100), (-001), (-010) and (-100) planes of the griseofulvin crystals 
as well as the other drugs tested in section 2.3.1 namely albendazole, carbamazepine, 




5.2.1 Macroscopic crystallisation of griseofulvin 
Griseofulvin, as obtained from the manufacturer, was dissolved in acetone and 
stirred at ambient temperature for 24 h until the solubility limit of griseofulvin in 
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acetone was reached. Seed crystals of ~ 1-2 mm length were obtained by allowing 
the saturated solution to evaporate slowly over 2-3 days with stirring. The seed 
crystals were then suspended  in a drug saturated acetone solution by means of a 
single aramid fibre (5 μm thickness) and macroscopic griseofulvin crystals (~ 1 cm) 
grown at ambient temperature by the slow solvent evaporation over a period of 3-4 
months in the absence of stirring. 
 
5.2.2 Contact angle measurements 
Sessile contact angle measurements were made using a Krüss Drop Shape Analyser 
(DSA 10, Krüss GmbH, Hamburg, Germany). Deionized water, diiodomethane, 
ethylene glycol and formamide were used as probe liquids. The properties of the 
probe liquids are given in Table 5.1. Static contact angles were obtained using a drop 
volume of ~ 1.5 μL. A minimum of three droplets of each liquid on each of the eight 
crystal facets were used. The droplets were monitored with a CCD camera and 
analysed by the Drop Shape Analysis software supplied with the instrument. The 
droplet contour was fitted by the tangent method to obtain both the left and right 
contact angles of the drop. Measurements were performed at ambient temperature. 
 
5.2.3 Surface energy calculations 
The Owens Wendt approach (Owens et al, 1969) was used to calculate surface 
energies of the crystal facets (Equation 1.30). The dispersive and polar components 
of the probe liquids used for the surface energy calculations are given in Table 5.1. 
 
Table 5.1: Properties of probe liquids used for contact angle measurements (Heng et 
al, 2006 c). 
 
















Diiodomethane > 99 3325 50.8 50.8 0.0 
Water deionized 998 72.8 21.8 51.0 
Ethylene glycol > 99 1109 48.0 29.0 19.0 
Formamide > 99.5 1139 58.0 39.0 19.0 
Where γLV is the liquid-vapour interfacial energy with both dispersive (γLd) and polar components 
(γLp).  
 
5.2.4 Single crystal X-ray diffraction 
Single crystal X-ray diffraction (XRD) experiments were kindly performed by Dr. 
Kenneth Shankland  at the Chemical Analysis Facility, University of Reading. Data 
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were collected using an Oxford Gemini-Ultra diffractometer (Agilent technologies, 
UK). 
 
5.2.5 X-ray photoelectron spectroscopy 
X-ray photoelectron spectroscopy (XPS) experiments were kindly performed by Dr. 
Steve Hinder at the Surface Analysis Laboratory, University of Surrey. XPS data 
from individual facets of a macroscopic griseofulvin crystal were collected using a 
Theta Probe XPS instrument (Thermo Scientific, UK). 
 
5.2.6 Computer modelling 
The computer software MERCURY (Macrae et al, 2006) was used to generate drug 
crystals using the individual crystallographic information files (CIF) obtained from 
the Cambridge Structural Database. Crystal program database (PDB) files were then 
generated using the packing option after inputting the space group and the unit cell 
parameters from the Cambridge Structural Database. The freely available version of 
MERCURY, which was used for the modelling, did not include access to the 
Bravais-Friedel-Donnay-Harker model calculations for a (crude) prediction of crystal 
morphology. Therefore the crystals generated in the present study were all 
rectangular in shape, and may not necessarily represent the actual crystal 
morphology.  
After MERCURY was used to generate the crystals, two in-house software programs 
namely ACCESS and EPOT (Barlow, 2011) were used to determine the charge per 
unit area and the electrostatic potential of the drug crystals at various crystal planes 
namely (001), (010), (100), (-001), (-010) and (-100). ACCESS reads the crystal 
PDB files together with partial atomic charge data and computes the charge per unit 
area for the individual crystal faces. EPOT reads the crystal PDB files together with 
the partial atomic charge data and then calculates the electrostatic potential across 
planes parallel with each of the crystal faces (3 angstroms beyond the centre of the 
furthermost atom on the test face). 
The various drug crystal parameters used for modelling are given in Table 5.2. As 
phenytoin CIF was only available as a co-crystal with choline, and the halofantrine 
CIF contained disordered molecules, phenytoin and halofantrine were excluded from 
the computer modelling studies. 
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a b c α β γ 
Space 
group
 CCDC code Reference 
Albendazole  Monoclinic 24.317 5.413 19.738 90 97.71 90 C2/c BOGFUZ Alhalawen et al, 2007 
Carbamazepine  Monoclinic 7.529 11.148 15.47 90 92.91 90 P21/c CBMZPNΦ1 Reboul et al, 1981 
Frusemide  Triclinic 10.467 15.801 9.584 71.87 115.04 108.48 P1 FURSEMΦ1 Lamotte et al,1978 
Griseofulvin  Tetragonal 8.969 8.969 19.951 90 90 90 P41 GRISFL03 Loew et al, 2004 
Indomethacin Triclinic 9.236 9.62 10.887 69.9 87.33 69.5 P1 INDMETΦI Cox et al, 2003 
Nabutemone Monoclinic 22.054 5.327 22.483 90 110.83 90 P21/c XOCXVI Prabhakar et al, 1999 





5.3.1 Growth of macroscopic griseofulvin crystals 
The macroscopic griseofulvin crystals obtained were bipyramidal with the vertical 
axis longer than the horizontal axis (Figures 5.1 a-b). Griseofulvin has previously 
been crystallised in acetone using supercritical CO2 as an antisolvent (DeGioannis et 
al, 2004) where upon two morphologies were obtained depending on the speed of 
stirring; namely needle-like or bipyramidal crystals. Both the needle and bipyramidal 
crystals had similar XRD patterns, therefore excluding the presence of 
polymorphism. 
The growth of the griseofulvin crystals was slow, taking several months. In addition 
the griseofulvin crystals could not be grown larger than ~ 1 cm, beyond this size 
secondary nucleation occurred. Interestingly, secondary nucleation occurred only on 
the tip of one pyramid‘s surface, suggesting that the two pyramids may possess 
different surface properties. As the Miller indices of the griseofulvin crystal are yet 
undetermined, the crystal facets were denoted facet 1-8 as shown in Figure 5.1 b. 
 
                             
       
       (a )                                                                                         (b) 
Top pyramid:      Facet  1   2   3   4 
Bottom pyramid: Facet  8  7   6    5 
 
Figure 5.1: Picture of a griseofulvin macroscopic crystal grown in acetone solution 
(a) and the corresponding crystal morphology (b). 
 
The macroscopic crystals were dried under ambient conditions prior to get rid of 





5 6 7 
8 
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5.3.2 Contact angle measurements on the griseofulvin crystal 
Contact angle measurements revealed an anisotropic wetting behaviour of the 
griseofulvin bipyramidal crystal (Table 5.3). Although the four facets comprising 
each pyramid possessed very similar contact angles with the various probe liquids, 
the two pyramids exhibited very different contact angles. The contact angles of all 
polar liquids (water, formamide and ethylene glycol) were lower in the pyramid 
possessing facets 5-8. In contrast, the pyramid consisting of facets 1-4 was much 
more hydrophobic with a water contact angle approximately 35º higher than that 
obtained on facets 5-8.  
 
Table 5.3: Results for static contact angles (°) on the griseofulvin crystal facets. 
 
Facets Water Formamide Ethylene glycol Diiodomethane 
1 79.6 ± 2.4 43.7 ± 2.3 44.7 ± 3.7 25.0 ± 2.5 
2 79.1 ± 2.3 40.1 ± 3.1 46.6 ± 3.9 28.7 ± 3.1 
3 78.6 ± 2.7 43.7 ± 2.4 43.5 ± 3.3 26.4 ± 2.6 
4 79.3 ± 2.0 41.8 ± 2.6 41.4 ± 2.2 26.3 ± 2.7 
5 43.6 ± 3.4 15.2 ± 2.5 24.5 ± 4.1 42.9 ± 3.1 
6 45.2 ± 3.9 16.1 ± 3.1 21.3 ± 2.8 43.5 ± 2.8 
7 44.8 ± 3.5 17.5 ± 2.9 21.6 ± 1.9 40.1 ± 4.0 
8 45.0 ± 2.1 14.6 ± 2.7 19.5 ± 2.1 40.8 ± 3.6 
 
The order of hydrophilicity of the facet – assessed using the contact angle of water; 
{Facet 5 ≈ Facet 6 ≈ Facet 7 ≈ Facet 8} > {Facet 1 ≈ Facet 2 ≈ Facet 3 ≈ Facet 4} 
 
Diiodomethane is a purely dispersive interacting liquid and is used to probe 
hydrogen binding potential. The pyramid containing facets 1-4 had a diiodomethane 
contact angle of approximately 15ºC lower than that obtained on facets 5-8.  
 
The order of the Van der Waals type of interactions – assessed using the contact 
angle of diiodomethane; 
{Facet 1 ≈ Facet 2 ≈ Facet 3 ≈ Facet 4} > {Facet 5 ≈ Facet 6 ≈ Facet 7 ≈ Facet 8}  
 
The variation of the crystal facet contact angles as well as their deduced 
hydrophilicity and hydrogen binding potential, suggest that different chemical 
groups are exposed on the surface of the two pyramids. Interestingly the secondary 
nucleation seen during the griseofulvin crystal growth (section 5.3.1) was found to 
occur only on the tip of the hydrophilic crystal comprising facets 5-8. 
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5.3.3 Surface energy calculations of griseofulvin crystal 
The contact angle data was analysed by the Owens-Wendt approach to obtain surface 
energies given in Table 5.4. As can be seen there was a facet dependent variation in 
the dispersive, polar and total surface energies.  
 











) γ (mJ/m2) γS
p/γ 
1 46.2 ± 1.1 4.8 ± 0.8 51.0 ± 1.4 0.1 
2 44.7 ± 1.3 5.9 ± 1.2 50.6 ± 1.6 0.1 
3 45.6 ± 0.9 5.2 ± 0.9 50.8 ± 1.8 0.1 
4 45.7 ± 1.2 4.0 ± 0.8 49.7 ± 1.5 0.1 
5 38.1 ± 2 46.9 ± 2.4 85.0 ± 2.8 0.6 
6 37.8 ± 1.7 41.6 ± 1.8 79.4 ± 2.5 0.5 
7 39.6 ± 2.1 43.1 ± 1.5 82.7 ± 3.0 0.5 
8 39.2 ± 1.8 41.7 ± 1.3 80.9 ± 2.6 0.5 
 
Dispersive energies;  
{Facet 1 ≈ Facet 2 ≈ Facet 3 ≈ Facet 4} > {Facet 5 ≈ Facet 6 ≈ Facet 7 ≈ Facet 8} 
 
Polar energies; 
{Facet 5 ≈ Facet 6 ≈ Facet 7 ≈ Facet 8} > {Facet 1 ≈ Facet 2 ≈ Facet 3 ≈ Facet 4} 
 
Total surface energies; 
{Facet 5 ≈ Facet 6 ≈ Facet 7 ≈ Facet 8} > {Facet 1 ≈ Facet 2 ≈ Facet 3 ≈ Facet 4} 
 
The hydrophilic pyramid comprising facets 5-8 possessed higher polar and total 
surface energies in comparison with the hydrophobic pyramid comprising facets 1-4. 
In contrast, the hydrophobic pyramid had higher dispersive energies. 
 
5.3.4 Single crystal X-ray diffraction of the griseofulvin crystal 
The single crystal X-ray diffraction results revealed a tetragonal crystals with space 
parameters of a = b = 8.969 and c = 19.9, a result in agreement with values recorded 
in the Cambridge crystallographic database (Loew 2004) confirming that it was the 
griseofulvin form previously identified. The Miller indexing of the griseofulvin 
crystal had not been performed at the time of writing. 
 
 
Chapter 5 Crystallographic studies 
253 
 
5.3.5 X-ray photoelectron spectroscopy of the griseofulvin crystal 
XPS spectra was collected initially over a wide range of energies, then at a narrower 
range for the observed peaks (C1s, O1s e.t.c.) from both the top and bottom facets of 
the griseofulvin crystal (Appendix 6-9). A rough estimation of composition was then 
calculated giving a slightly higher O/C atomic compostition for the hydrophilic 
bottom pyramid surface. 
The deconvolution and fitting of the peaks inorder to determine chemical 
functionalities exposed at each facet had not been performed at time of writing. 
 
5.3.6 Computer modelling 
 
5.3.6.1 Griseofulvin crystal   
The percentage polar area and the electrostatic potential of the griseofulvin crystal 
across the (001), (010), (100), (-001), (-010) and (-100) planes are given in Table 5.5 
(along with the corresponding results for the other drugs studied) and Figures 5.2 (a-
f) respectively. A summary of the particle sizes obtained after milling griseofulvin 
with various stabilisers is given in Table 5.6 directly above Figures 5.2 (a-f).  
The (001) plane of the griseofulvin crystal, which was the least polar of the studied 
griseofulvin crystal planes had a net positive electrostatic potential.  
 
Table 5.5: The percentage polar area of the drug crystals across the (001), (010), 
(100), (-001), (-010) and (-100) planes.  
 
Drug (001) (010) (100) (-001) (-010) (-100) 
Albendazole  44.6 26.7 51.5 44.6 27.2 51.5 
Carbamazepine  22.3 14.9 13.4 22.3 14.9 13.4 
Frusemide  46.5 53.8 59.6 48.5 53.8 59.6 
Griseofulvin  14.4 26.5 27.9 38.5 21.1 23.7 
Indomethacin 24.2 49.9 47.2 24.2 49.9 47.2 
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Table 5.6: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of griseofulvin in presence of a range of stabilisers (stabiliser 















Griseofulvin M M M M M M 276.0 M 









































































































Electrostatic potential across facet (010) of the griseofulvin crystal
 

























































































































































































































Electrostatic potential across facet (-100) of the griseofulvin crystal
 
 
Figures 5.2 (a-f): Electrostatic potential (meV) of the griseofulvin crystal across 
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5.3.6.2 Other drug crystals 
The percentage polar area and the electrostatic potential of the albendazole, 
carbamazepine, frusemide, indomethacin and nabumetone crystals across the (001), 
(010), (100), (-001), (-010) and (-100) planes are given in Table 5.5 and Figures 5.3-
5.7 (a-f) respectively. A summary of the particle sizes obtained after milling the 
drugs with different stabilisers is given in the corresponding table (Tables 5.7-5.11) 
above each set of figures. 
There was no clear pattern seen between the studied crystal facets and the properties 
of the stabilisers found to be effective during milling. In case of albendazole, 
carbamazepine, frusemide, indomethacin and nabumetone it is possibly that a 
different plane from the ones studied here is the crystal fracture plane. 
 
Table 5.7: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of albendazole in presence of a range of stabilisers (stabiliser 















Albendazole 513.4 316.2 406.8 440 M M 309.4 463.5 














































































































































































































































































































































Electrostatic potential across facet (-100) of the albendazole crystal
 
 
Figures 5.3 (a-f): Electrostatic potential (meV) of the albendazole crystal across 
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Table 5.8: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of carbamazepine in presence of a range of stabilisers 















Carbamazepine 482.9 730.0 M M M M M M 








































































































Electrostatic potential across facet (010) of the carbamazepine crystal
 

























































































































































































































Electrostatic potential across facet (-100) of the carbamazepine crystal
 
 
Figures 5.4 (a-f): Electrostatic potential (meV) of the carbamazepine crystal across 
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Table 5.9: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of frusemide in presence of a range of stabilisers (stabiliser 















Frusemide 246.4 199.6 380 234.9 347.8 417.3 M M 








































































































Electrostatic potential across facet (010) of the frusemide crystal
 
 

























































































































































































































Electrostatic potential across facet (-100) of the frusemide crystal
 
 
Figures 5.5 (a-f): Electrostatic potential (meV) of the frusemide crystal across facets 
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Table 5.10: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of indomethacin in presence of a range of stabilisers 















Indomethacin 237 210 320 260 640 308.9 M M 






































































































































































































































































































































Figures 5.6 (a-f): Electrostatic potential (meV) of the indomethacin crystal across 
facets (001), (010), (100), (-001), (-010) and (-100) respectively. 
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Table 5.11: Particle size (nm) obtained using photon correlation spectroscopy after 6 
hours wet bead milling of nabumetone in presence of a range of stabilisers (stabiliser 















Nabumetone 388.3 359.1 M M M M M M 








































































































































































































































































































































Figures 5.7 (a-f): Electrostatic potential (meV) of the nabumetone crystal across 








Crystallographic studies were performed in order to establish the effect of the drug 
crystal surface energy on the drug-stabiliser interaction during milling. Crystals 
generally fracture along a particular face, whose properties dominate the milled state 
(York et al, 1998). Indeed it was hoped that prior knowledge of the fracture plane 
properties may enable prediction of suitable stabilisers for production of crystalline 
drug nanoparticles by wet bead milling. 
Macroscopic griseofulvin crystals were grown in acetone yielding bipyramidal 
crystals of ~ 1 cm. Contact angle measurements were performed on each of the eight 
crystal faces using four probe liquids namely water, ethylene glycol, formamide and 
diiodomethane revealing anisotropic wetting behaviour of the two pyramids. Each of 
the four facets forming individual pyramids had very similar wetting properties. One 
pyramid was hydrophilic exhibiting lower contact angles for water, formamide and 
ethylene glycol, while the other pyramid was hydrophobic with a measured contact 
angle for water of more than 35º greater than that obtained for the hydrophilic 
pyramid. The measured contact angle of diiodomethane was greater for the 
hydrophilic pyramid indicating a lower dispersive energy. Surface energy 
calculations performed using the Owens-Wendt approach, determined that the 
hydrophobic pyramid possessed higher dispersive energies and lower polar energies 
than the hydrophilic pyramid. 
Computer modelling was performed to elucidate the percentage polar area and 
electrostatic potential of the (001), (010), (100), (-001), (-010) and (-100) planes of 
the griseofulvin crystal. The (001) plane which was found to be the least polar was 
postulated to be the fracture plane of the griseofulvin crystal. The (001) plane also 
had a net positive electrostatic potential. This result is quite interesting as it would 
explain why griseofulvin could only be stabilised by anionic stabilisers during 
milling. Computer modelling of the (001), (010), (100), (-001), (-010) and (-100) 
planes of albendazole, carbamazepine, frusemide, indomethacin and nabumetone 
crystals was also performed. The properties of the assumed planes of these drug 
crystals were not predictive of stabiliser efficiency during drug milling indicating 
that the plane of fracture may be a plane not investigated in the present study.

















The majority of drugs are administered orally, with their bioavailability being 
dependent on their dissolution within the gut and absorption across the 
gastrointestinal membranes. ~ 40% of newly discovered drugs being poorly water 
soluble (Lipinski 2002) pose a significant formulation challenge to the 
pharmaceutical industry. Poor water drug solubility is associated with poor 
dissolution and bioavailability, high fed to fasted ratio and high inter patient 
variability. Micronisation, salt formation, solubilisation, pH adjustment, 
complexation with cyclodextrins, polymorphism, the use of prodrugs, have been 
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used as formulation strategies to increase drug aqueous solubility. Recently 
formulation of poorly soluble drugs as drug nanoparticles, defined as drug particles 
below 1000 nm in size, using both ‗top down‘ and ‗bottom up‘ approaches has been 
the centre of focus. Top down approaches include media milling and high pressure 
homogenisation whereby the large drug particles are broken down into nano-sized 
particles; while bottom up approaches include crystallisation, precipitation whereby 
nano-sized drug is grown from drug in solution. Nanoparticles are produced in 
presence of stabilisers mainly polymers and/or surfactant which coat that 
nanoparticles on production, thereby providing a barrier against aggregation due to 












the market. Despite success of this technique, the mastery behind the stabilisation 
mechanisms of drug nanoparticles is still lacking. The selection of stabilisers is 
carried out on an empirical basis by trial and error. Furthermore the effective 
stabilisers vary with drug and with technique used to produce the drug nanoparticles. 
The overarching aim of the thesis is to gain a better understanding of nanoparticle 
stabilisation mechanisms by studying effect of different polymers and/or surfactant 
on nanoparticle production, determining polymer/surfactant adsorption isotherms on 
the nanoparticle surfaces and establishing the drug surface energetics. Wet bead 
milling was carried out using Retsch MM 200 mixer mills and yttrium zirconia beads 
(0.44 mm diameter) at a frequency setting of 30Hz for 6 hours with the resultant 
particle size determined by photon correlation spectroscopy. A drug-stabiliser screen 
was carried out using eight poorly water soluble structurally different drugs namely 
albendazole, carbamazepine, frusemide, halofantrine, griseofulvin, indomethacin, 
nabumetone and phenytoin and thirteen pharmaceutically acceptable stabilisers 
including cellulosic polymers, polyvinylpyrrolidone, Pluronic F127, surfactants; 
Tween 80, sodium dodecyl sulphate, aerosol-OT and dodecyltrimethyammonium 
bromide.  The ease of stabiliser selection for nanoparticle production was found to 
increase with drug molecular weight and number of functional groups. The number 
of effective stabilisers was also found to be higher for the least water soluble drugs. 
The drug-stabiliser screen revealed no obvious pattern and each of the drugs studied 
displayed a unique stabilisation profile that could not be predicted from its physical 
or chemical properties.  
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Subsequent work was carried out using the non-ionic drug griseofulvin. Griseofulvin 
nanoparticles could only be produced in presence of anionic stabilisers namely 
sodium dodecyl sulphate, aerosol-OT and hydroxypropylmethylcellulose acetate 
succinate. The production of griseofulvin nanoparticles was effective at drug: 
anionic stabiliser weight ratios of between 2.5:1 and 125:1. Ionic stabilisers are not 
favoured for oral delivery due to their incompatibility with acid, salts and other ionic 
excipients. The use of electrosteric stabilisation using non-ionic polymer 
hydroxypropylmethylcellulose (HPMC) was investigated. Synergistic effects 
between non-ionic polymers and ionic surfactants have been utilised in fields such as 
paint, mineral and cosmetic industries. Inclusion of the non-ionic polymer in the 
milling slurry was aimed at reducing the amount of ionic surfactant required for 
nanoparticle production. Surface tension studies showed the interaction of the non–
ionic polymer HPMC and anionic surfactants (SDS & AOT) at the air-water 
interface. Polymer-surfactant interaction at the solid-drug interface could be 
envisaged with co-adsorption of HPMC and ionic surfactant onto the griseofulvin 
nanoparticles.  
Inclusion of a constant amount (1.88% w/w) of HPMC 8000 in the milling slurry 
lead to a reduction of the minimum concentration of anionic surfactant necessary for 
griseofulvin nanoparticle production. These observations were highly suggestive of 
non-ionic polymer and anionic surfactant co-stabilisation at the nanoparticle 
surfaces. 
The effect of polymer molecular weight and concentration was investigated by 
milling griseofulvin in presence of varying concentrations of HPMC 8000, 15000, 
86000 and constant amount (0.5% w/w) of SDS. Polymer concentration and 
molecular weight effects were observed. Nanoparticles could only be produced up to 
a maximum polymer concentration which decreased with increasing polymer 
molecular weight. For instance, nanoparticles could not be produced in presence of 
HPMC 86000 even at the lowest concentration of 0.1% w/w polymer. These 
observations were attributed to increase in slurry viscosity with polymer molecular 
weight and concentration as well as slower diffusion of the higher molecular 
polymer to cleaved drug surfaces. 
Milling of pharmaceutical crystalline materials may introduce a degree of 
amorphicity due to exposure to mechanical stresses. Powder X-ray diffraction 
(XRD) was used to screen the griseofulvin samples for any milling induced disorder. 
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Similar XRD patterns in terms of peak presence and position were observed before 
and after milling indicating the crystallinity of griseofulvin was maintained. 
Scanning electron microscopy (SEM) of a selection of samples was used to visualise 
the griseofulvin nanoparticles after milling. The SEM particles sizes were in good 
agreement with those obtained by light scattering. 
Polymer/surfactant adsorption was determined indirectly by measuring the depletion 
of respective entity from the supernatant obtained after centrifuging the drug 
nanoparticles. Spectroscopic techniques namely colorimetric stains all assay and 
optical rotatory dispersion (ORD) were used to establish adsorbed amounts of 
polymer and anionic surfactant respectively. Anionic surfactant adsorption onto 
griseofulvin nanoparticles was found to increase with starting surfactant 
concentration, reaching a plateau at about 2.2 mg/m
2
. The adsorption isotherms of 
both surfactants namely SDS and AOT displayed no marked differences. The anionic 
surfactant head group is envisaged to be adsorbing via electrostatic interaction to a 
positively charged griseofulvin surface, with a surfactant bilayer forming at high 
surfactant concentrations. Anionic surfactant adsorption was found to be consistently 
lower (~ 0.6 mg/m
2
) in the non-ionic polymer-anionic surfactant formulations 
compared with surfactant only formulations suggesting the presence of co-adsorbing 
HPMC at the drug surfaces. Polymer adsorption could not be quantified by optical 
rotation due to interference by dissolved griseofulvin which is optically active with a 
peak about the wavelength of interest. Attempts to extract griseofulvin from drug 
supernatants prior to ORD experiments were not successful due to the surface 
activity of the HPMC polymer. 
Small angle neutron scattering (SANS) was used for direct visualisation of the 
polymer/surfactant adsorbed at the drug surfaces. Using D2O:H2O solvent contrast 
matching to the drug‘s neutron refractive index, the drug particles were made 
‗invisible‘. Thus any scattering seen was due to the adsorbed polymer/surfactant 
layer. SANS experiments were carried out at the Institut Laue-Langevin (France) and 
Paul Scherrer Institut (Switzerland). A selection of griseofulvin nanoparicles 
prepared in presence of both surfactant and polymer-surfactant systems were 
selected for neutron studies. Neutron scattering obtained from the nanoparticles 
prepared using polymer-surfactant systems was markedly higher than that from 
nanoparticles prepared using surfactant only systems. The drug-surfactant data could 
not be fitted due to extremely low scatter. The drug-polymer-surfactant data were 
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successfully fitted confirming the earlier hypothesis of polymer-surfactant co-
adsorption at the drug nanoparticle surfaces. The amount of HPMC adsorbing onto 
the drug nanoparticles was found to be 0.3-0.9 mg/m
2
 in presence of either SDS or 
AOT. The thickness obtained for the polymer layer (~ 4 nm) was indicative of a 
polymer lying flat on the drug surfaces.  
Association between a non-ionic polymer and an anionic surfactant is driven by 
hydrophobic interactions between surfactant hydrocarbon chains and hydrophobic 
parts of the polymer as well as by ion-dipole interactions between the ionic 
surfactant headgroups and the dipole of the hydrophilic parts of polymer (Goddard 
1986). Figures 6.1-6.2 give schematic illustrations of the proposed interactions of the 
anionic surfactants and non-ionic polymer at the air-water and liquid-solid interfaces 
and in bulk liquid solution. In bulk solution SDS micelles are likely to interact with 
hydrophobic parts of polymer forming a ‗pearl-necklace‘ model, while AOT which 
forms lamellar phase in bulk is likely interact with both hydrophobic and hydrophilic 
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Figure 6.1: Schematic diagram illustrating the proposed interaction mechanism of 
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Figure 6.2: Schematic diagram illustrating the proposed interaction mechanism of 
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Griseofulvin nanoparticles were stored, as prepared in excess polymer/surfactant, for 
1 year under ambient conditions and particle size monitored. Ostwald ripening was 
found to occur in all formulations due to the dissolution and reprecipitation of 
griseofulvin. The growth in particle size was more pronounced in the HPMC 
polymer-anionic surfactant formulations particularly at low anionic surfactant 
concentrations and high polymer concentration/molecular weight. It can be 
postulated that HPMC increased the solubilisation of griseofulvin leading to higher 
nanoparticle instability. Nanoparticles formulated in presence of anionic polymer 
HPMCAS were the least stable with most aggregating 1-3 months after storage. 
HPMCAS was the least suitable stabiliser for griseofulvin nanoparticles, which 
could partially explained by viscosity effects. The HPMCAS nanosuspensions were 
notably viscous on production. The Ostwald ripening seen with griseofulvin (64 
μg/mL at 25ºC) may be explained by its high aqueous solubility, relative to 
nabumetone (4.7 μg/mL at 25ºC) and halofantrine (< 1.0 μg/mL at 25ºC) whose 
nanoparticles prepared and stored under similar conditions were stable for 1 year. 
Simulation of the gastrointestinal stability of a nanoparticle formulation is important 
as the stomach microclimate favours aggregation, which may negate benefits 
conferred by particle size reduction (Zimmerman et al, 2001). pH stability of the 
nanoparticles was studied by monitoring particle size of griseofulvin nanoparticles 
resuspended in hydrochloric acid solutions of pH 1-6 and water - pH 7. The 
HPMCAS stabilised griseofulvin nanoparticles were the least stable, aggregating to 
form a visible cloudy precipitate on contact with a hydrochloric acid solution of pH 
in the range 1-4. HPMCAS was the least suitable stabiliser for griseofulvin 
nanoparticles intended for oral delivery. Some griseofulvin nanoparticles prepared in 
presence of anionic surfactant, aggregated on contact with a hydrochloric acid 
solution of pH in the range 1-2. Nanoparticles with the greatest amount of adsorbed 
surfactant and thus the higher zeta potential were least likely to aggregate at low pH. 
Electrosterically stabilised nanoparticles prepared in presence of anionic surfactant 
and non-ionic polymer HPMC were more stable at low surfactant concentrations, 
indicating non-ionic polymer conferred some protective effect. 
Griseofulvin nanoparticles could only be produced in presence of anionic stabilisers, 
even though it is a neutral drug. The nature of surfaces exposed during milling 
depends on how the crystals fracture, with the properties of the weakest attachment 
face dominating (Heng et al, 2006 a,b,c). In a bid to characterise griseofulvin surface 
Chapter 6 General discussion 
282 
 
energetics, sessile contact angle measurements were performed on macroscopic 
griseofulvin crystals (~ 1 cm) grown in acetone. Deionized water, formamide, 
ethylene glycol and diiodomethane were used as the liquid probes. The wetting 
results and surface energy calculations revealed anisotropic facet dependent surface 
chemistry of the griseofulvin crystal. Further work into determination of the 
chemical groups exposed at the various crystal surfaces and more so the drug‘s 





































Wet bead milling, in which a drug is milled in the presence of a solution of 
pharmaceutical acceptable stabilisers, is a promising technique for the formulation of 
poorly water-soluble drugs. The research investigated the use of non-ionic polymer-
ionic surfactant systems for the production of drug nanoparticles by wet bead 
milling.  
Interactions between the non-ionic polymer hydroxypropylmethylcellulose (HPMC) 
and anionic surfactants sodium dodecyl sulphate (SDS) and aerosol-OT (AOT) at the 
air-liquid interface, liquid-solid interface and in bulk solution were established. 
Surface tension measurements as a function of the anionic surfactant concentration 
were carried out both in absence and presence of 0.1% w/w HPMC 8000. In the 




presence of polymer, a break point corresponding to the critical aggregation 
concentration (cac) was observed indicating the formation of HPMC-anionic 
surfactant complexes in the bulk solution. HPMC is surface active therefore we can 
envisage the adsorption of both the non-ionic polymer and the anionic surfactant at 
the air-liquid interface. 
Polymer-surfactant interactions at the liquid-solid interface were investigated by 
milling griseofulvin whose nanoparticles could only be produced in presence of 
anionic surfactants in the presence of HPMC. The inclusion of HPMC in the drug 
milling slurry led to co-adsorption of HPMC and anionic surfactant on the 
griseofulvin nanoparticle surfaces. Notably HPMC on its own did not adsorb on 
griseofulvin particle surfaces. In addition there was a reduction in the amount of 
adsorbed anionic surfactant when polymer was co-adsorbing indicating synergistic 
effects at the liquid-solid interface. However, inclusion of high concentrations or 
higher molecular weight polymers in the milling slurry led to slower production of 
nanoparticles attributable to an increase in slurry viscosity thus cushioning of the 
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Appendix 1: Calculation of the surface area of nanoparticles 
 





rV   
 
where V is volume of particle and r is radius 






The total volume of the grioseofulvin nanoparticles was determined using the known 
suspension mass of 10 g and a griseofulvin density of 1.455 g/cm
3
. 










suspensioninparticlesofNumber   
 
The number of particles in this formulation is 8.2716 × 10
14
. 
Surface area of one drug particle could be determined and then multiplied by total 
number of nanoparticles in formulation to give the total surface area of 
nanoparticles. 
 
24 rSA   
 
where SA is surface area of particle and r is radius 




, multiplied by total 













H-NMR of HPMC 8000 
 





H-NMR of HPMC 11000 
 





H-NMR of HPMC 15000 
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Appendix 5: Calculation of the surfactant area per molecule 
 
The amount of adsorbate mg/m
2









)/( 2  
 
where amount of adsorbate is the amount of polymer/surfactant adsorbed, total mass 
of suspension is 50 g and total surface area of drug particles is calculated as shown in 
Appendix 1. 
 









1020   
 
where amount of adsorbate is the amount of polymer/surfactant adsorbed, surf is 
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Appendix 6: Survey X-ray photoelectron spectra of griseofulvin pyramid comprising facets 1-4 
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Appendix 8: Survey X-ray photoelectron spectra of griseofulvin pyramid comprising facets 5-8 
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Appendix 9: High resolution X-ray photoelectron spectra of griseofulvin pyramid comprising facets 5-8 
 
C1s O1s F1s 
Si2p 
